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Introduction	  
Stroke	  is	  the	  leading	  cause	  of	  death	  and	  disability	  amongst	  South	  Africans	  older	  
than	  60	  years.	  	  The	  majority	  of	  stroke	  patients	  in	  South	  Africa	  are	  managed	  in	  
general	  medical	  wards	  where	  little	  is	  known	  about	  the	  quality	  and	  cost	  of	  care.	  	  The	  
aim	  of	  this	  study	  was	  to	  determine	  the	  cost	  of	  stroke	  care	  and	  to	  identify	  factors	  
associated	  with	  increased	  expense,	  as	  well	  as	  to	  evaluate	  the	  quality	  of	  stroke	  care	  
in	  general	  medical	  wards	  in	  order	  to	  identify	  areas	  where	  quality	  of	  care	  could	  be	  
improved.	  
Methods	  
We	  conducted	  a	  retrospective	  folder	  review	  of	  all	  acute	  stroke	  admissions	  to	  the	  
general	  medical	  wards	  at	  Groote	  Schuur	  Hospital	  from	  1	  January	  to	  31	  December	  
2012.	  	  Patients	  younger	  than	  45	  years	  and	  those	  that	  received	  thrombolysis	  were	  
excluded.	  	  The	  hospital’s	  finance	  department	  provided	  the	  bed	  costs,	  as	  well	  as	  
expenditure	  on	  consumables,	  pharmacy,	  laboratory	  and	  radiology	  for	  each	  subject.	  
The	  quality	  of	  care	  was	  measured	  according	  to	  the	  South	  African	  Stroke	  Guidelines.	  
Results	  
The	  inpatient	  care	  of	  261	  patients	  was	  evaluated.	  	  Although	  neuroradiology	  was	  
performed	  on	  95%	  of	  patients,	  carotid	  duplex	  Doppler	  ultrasonography	  and	  
echocardiography	  were	  not	  often	  done.	  	  Although	  all	  patients	  with	  ischaemic	  stroke	  
received	  inpatient	  antiplatelet	  or	  anti-­‐coagulation	  therapy,	  not	  all	  risk	  factors	  were	  
adequately	  addressed	  on	  discharge.	  	  The	  median	  cost	  of	  a	  stroke	  admission	  was	  
R19,072.07	  (IQR	  R10,899.85	  to	  R27,789.43).	  	  The	  strongest	  correlation	  with	  cost	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was	  with	  length	  of	  stay	  (LOS),	  r	  =	  0.9977.	  	  The	  median	  LOS	  was	  6	  days	  (IQR	  3	  to	  9	  
days).	  	  Using	  non-­‐parametric	  univariable	  analysis,	  clinical	  factors	  prolonging	  LOS	  
were	  previous	  stroke	  (P	  =	  0.028)	  and	  inpatient	  complications:	  fever	  (P	  <	  0.001),	  
urinary	  tract	  infections	  (P	  <	  0.001)	  and	  acute	  kidney	  injury	  (P	  <	  0.001).	  	  The	  LOS	  
increased	  as	  the	  number	  of	  inpatient	  complications	  increased	  (P	  =	  0.059).	  	  Mortality	  
was	  20%	  and	  68%	  of	  patients	  experienced	  at	  least	  one	  medical	  complication	  during	  
admission.	  	  Fever	  and	  pneumonia	  were	  predictors	  of	  death.	  	  Pneumonia	  was	  less	  
prevalent	  amongst	  patients	  who	  were	  mobilised	  early	  (P	  =	  0.002).	  	  Early	  nutritional	  
support	  was	  beneficial	  in	  reducing	  the	  incidence	  of	  acute	  kidney	  injury	  (P	  <	  0.001).	  	  
The	  median	  LOS	  was	  significantly	  prolonged	  by	  delaying	  speech	  therapy	  (P	  <	  0.001),	  
nutritional	  support	  (P	  <	  0.01),	  physiotherapy	  (P	  <	  0.01)	  and	  occupational	  therapy	  (P	  
<	  0.001).	  	  Discharge	  to	  inpatient	  rehabilitation	  centres	  significantly	  prolonged	  LOS	  




This	  is	  the	  first	  study	  evaluating	  the	  cost	  of	  acute	  stroke	  care	  in	  South	  Africa.	  	  
Length	  of	  stay	  was	  the	  greatest	  determinant	  of	  cost.	  	  Improving	  the	  quality	  of	  care	  
to	  reduce	  the	  number	  of	  complications,	  early	  referral	  to	  allied	  health	  professionals	  
and	  effective	  discharge	  planning	  would	  result	  in	  shorter	  length	  of	  hospital	  stay	  and	  
therefore	  cost	  saving.	  	  There	  is	  a	  need	  for	  increased	  access	  to	  stroke	  unit	  beds,	  
albeit	  dedicated	  stroke	  beds	  in	  the	  general	  medical	  wards,	  to	  ensure	  specialised	  
nursing	  care	  and	  early	  inpatient	  rehabilitation	  to	  reduce	  the	  number	  of	  inpatient	  
complications,	  as	  well	  as	  implementation	  of	  protocols	  to	  allow	  for	  better	  adherence	  
to	  national	  guidelines.	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Chapter	  1:	   Structured	  literature	  review	  
	  




This	  literature	  review	  was	  conducted	  to	  explore	  the	  international	  and	  local	  stroke	  
guidelines,	  the	  recommended	  management	  and	  expected	  quality	  of	  stroke	  care,	  as	  
well	  as	  the	  economic	  impact	  that	  stroke	  has	  internationally	  and	  on	  South	  African	  





	   Literature	  search	  
	  
Full-­‐text	  articles	  and	  publications	  from	  1989	  to	  2014	  were	  identified	  by	  conducting	  
a	  literature	  search	  in	  Google	  Scholar	  and	  PubMed/MEDLINE	  databases	  through	  the	  
University	  of	  Cape	  Town’s	  online	  library	  access.	  	  The	  terms	  used	  for	  the	  electronic	  
search	  included	  “stroke	  and	  cost”,	  “stroke	  and	  length	  of	  stay”,	  “stroke	  and	  quality	  
of	  care”,	  “stroke	  and	  South	  Africa”,	  “stroke	  and	  guidelines”,	  “stroke	  and	  
epidemiology”,	  	  “stroke	  and	  risk	  factors”,	  “stroke	  and	  subtypes”,	  “stroke	  and	  
management”,	  “stroke	  and	  complications”	  and	  “stroke	  and	  rehabilitation”.	  	  The	  
search	  was	  restricted	  to	  articles	  published	  in	  English,	  but	  included	  articles	  from	  
Africa,	  Europe,	  North	  and	  South	  America,	  Asia	  and	  Australia.	  
Articles	  were	  imported	  into	  Mendelay	  Desktop	  version	  1.10.3	  and	  categorized	  
according	  to	  the	  above	  search	  criteria.	  	  Citations	  and	  referencing	  to	  articles	  used	  in	  
the	  literature	  review	  were	  done	  through	  the	  Mendelay	  citation	  plugin	  in	  Microsoft	  
Word	  for	  Mac	  2011	  version	  14.3.9.	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Results	  
	  
A	  total	  of	  115	  articles	  were	  identified	  through	  the	  online	  search,	  of	  which	  22	  
discussed	  the	  cost	  of	  stroke	  care	  and	  16	  reviewed	  the	  length	  of	  stay	  in	  stroke	  care.	  	  
Stroke	  management	  was	  dealt	  with	  in	  11	  articles	  and	  7	  reviewed	  methods	  of	  
assessing	  quality	  of	  stroke	  care.	  	  Four	  stroke	  guidelines	  were	  reviewed	  (including	  
South	  African	  Stroke	  Guidelines,	  American	  Heart/Stroke	  Association	  Guidelines,	  
European	  Stroke	  Organisation	  Guidelines,	  the	  World	  Health	  Organisation	  (WHO)	  
guidelines).	  	  Moreover,	  15	  publications	  explored	  epidemiology	  of	  stroke	  and	  non-­‐
communicable	  diseases	  of	  which	  4	  focused	  on	  South	  Africa.	  	  The	  risk	  factors	  and	  
comorbidities	  of	  stroke	  were	  reviewed	  in	  8	  publications.	  	  Stroke	  subtypes	  and	  
stroke	  classifications	  were	  discussed	  in	  6	  articles,	  whereas	  22	  publications	  explored	  
the	  complications	  of	  stroke.	  	  A	  further	  10	  articles	  were	  reviewed	  for	  its	  discussion	  







Cerebrovascular	  accidents	  remain	  the	  second	  leading	  cause	  of	  mortality	  and	  most	  
frequent	  cause	  of	  permanent	  disability	  in	  the	  world.1-­‐5	  	  Worldwide,	  stroke	  
accounted	  for	  5.7	  million	  deaths	  and	  contributed	  to	  46.6	  million	  Disability	  Adjusted	  
Life	  Years	  (DALYs)	  in	  2008.2,6	  	  In	  South	  Africa,	  stroke	  accounts	  for	  17.7%	  of	  female	  
and	  12.2%	  of	  male	  deaths	  in	  persons	  of	  60	  years	  of	  age	  and	  older,	  making	  it	  the	  
leading	  cause	  of	  death	  in	  this	  age	  group.7	  	  In	  a	  report	  published	  by	  the	  Western	  
Cape	  Department	  of	  Health	  and	  the	  City	  of	  Cape	  Town	  in	  2008,	  it	  was	  estimated	  
that	  the	  stroke	  mortality	  in	  females	  ranged	  from	  108.1	  to	  131.5	  deaths	  per	  100	  000	  
in	  Mitchell’s	  Plain	  and	  Khayelitsha	  respectively,	  whereas	  in	  males	  the	  deaths	  per	  
100	  000	  ranged	  from	  125.8	  in	  Khayelitsha	  to	  136.6	  in	  Mitchell’s	  Plain.8	  	  From	  this	  
can	  be	  inferred	  that	  cerebrovascular	  disease	  places	  a	  considerable	  burden	  on	  local	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acute	  and	  chronic	  health	  care	  resources.	  	  Mayosi	  et	  al	  reported	  that	  this	  burden	  of	  
disease	  is	  the	  result	  of	  the	  increase	  of	  cardiovascular	  risk	  factors	  present	  in	  urban	  
and	  rural	  South	  Africa,	  and	  is	  predicted	  to	  increase	  considerably	  if	  the	  appropriate	  
action	  is	  not	  taken.9-­‐13	  
Due	  to	  the	  high	  incidence	  of	  acute	  stroke,	  stroke	  care	  imposes	  a	  major	  economic	  
burden	  on	  health	  care	  services	  around	  the	  world.14-­‐16	  	  The	  International	  Comparison	  
of	  Stroke	  Cost	  Studies	  estimated	  that	  health	  care	  costs	  for	  stroke	  represented	  
between	  2%	  and	  7%	  of	  total	  healthcare	  expenditures.17,18	  	  In	  addition	  to	  the	  direct	  
costs	  to	  health	  care	  services,	  there	  are	  indirect	  costs	  incurred	  by	  the	  loss	  of	  
productivity	  resulting	  from	  post	  stroke	  functional	  disability	  and	  death.19,20	  	  In	  the	  
United	  States	  of	  America,	  the	  total	  cost	  of	  stroke	  in	  2008	  was	  $65.5	  billion,	  of	  which	  
$43.8	  billion	  (67%)	  were	  direct	  costs	  related	  to	  stroke	  care	  and	  $21.7	  billion	  (33%)	  
were	  indirect	  costs.20	  	  	  In	  the	  European	  Union,	  a	  total	  of	  €27	  billion	  is	  spent	  on	  
stroke	  yearly,	  of	  which	  €18.5	  billion	  (68.5%)	  relates	  to	  the	  direct	  cost	  of	  stroke	  care	  
and	  €8.5	  billion	  (31.5%)	  relates	  to	  indirect	  costs	  of	  functional	  impairment.20	  	  	  
Although	  little	  is	  known	  about	  the	  health	  care	  expenditure	  on	  stroke	  in	  South	  
Africa,	  it	  is	  estimated	  that	  stroke	  is	  20%	  more	  prevalent	  in	  low	  and	  middle-­‐income	  
countries	  than	  in	  high-­‐income	  countries,	  where	  the	  impact	  on	  limited	  health	  care	  
resources	  would	  be	  greater	  than	  in	  developed	  countries.6	  	  Cost	  containment	  and	  
rationalisation	  of	  health	  care	  resource	  allocation	  is	  therefore	  of	  paramount	  
importance	  in	  face	  of	  escalating	  health	  care	  costs	  worldwide.21,22	  	  
Cost	  is	  predicted	  by	  length	  of	  stay	  
The	  inpatient	  treatment	  of	  acute	  stroke	  and	  post-­‐stroke	  rehabilitation	  are	  
expensive.23	  	  	  Amongst	  all	  the	  predictors	  of	  inpatient	  cost,	  length	  of	  stay	  (LOS)	  has	  
the	  strongest	  association	  with	  the	  total	  cost	  of	  an	  admission,	  and	  is	  therefore	  the	  
most	  important	  determinant	  of	  hospitalisation	  costs	  in	  patients	  with	  acute	  	  
stroke.14,15,24,27	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Length	  of	  stay	  is	  not	  only	  the	  major	  determinant	  of	  the	  cost	  of	  acute	  stroke	  care,	  
but	  the	  factors	  influencing	  LOS	  and	  their	  management	  can	  be	  used	  as	  indicators	  of	  
the	  quality	  of	  stroke	  care.28	  	  In	  light	  of	  the	  health	  care	  resource	  constraints	  and	  
inexorably	  growing	  demand	  for	  inpatient	  beds	  in	  developing	  countries,	  it	  is	  
therefore	  very	  important	  to	  identify	  the	  factors	  that	  prolong	  LOS	  and	  how	  they	  can	  
be	  modified	  to	  ensure	  that	  bed	  use	  is	  cost-­‐efficient	  and	  remains	  efficacious.14,29,30	  
Demographic	  influence	  on	  length	  of	  stay	  
Although	  many	  studies	  have	  shown	  that	  age	  and	  gender	  do	  not	  have	  an	  influence	  
on	  LOS,14,26,31	  	  Chow	  et	  al	  found	  that	  younger	  patients	  were	  likely	  to	  have	  more	  
expensive	  stroke	  care	  than	  their	  elder	  counterparts.32	  	  This	  is	  explained	  by	  the	  need	  
for	  more	  extensive	  investigations	  in	  younger	  stroke	  patients.32	  
The	  influence	  of	  risk	  factors	  and	  comorbidities	  on	  length	  of	  stay	  
Hypertension	  remains	  the	  most	  important	  modifiable	  risk	  factor	  for	  stroke	  and	  
continues	  to	  rise	  in	  prevalence.33,34	  	  Similarly,	  there	  is	  an	  increase	  in	  the	  prevalence	  
of	  diabetes	  mellitus	  worldwide,	  which	  is	  an	  important	  independent	  risk	  factor	  for	  
stroke.33,34	  	  In	  addition,	  there	  is	  an	  increased	  prevalence	  of	  ischaemic	  heart	  disease	  
and	  atrial	  fibrillation	  in	  ageing	  populations,	  which	  are	  important	  risk	  factors	  for	  
stroke.34	  	  	  Studies	  have	  shown	  that	  comorbidities	  such	  as	  hypertension,	  diabetes	  
mellitus	  and	  ischaemic	  heart	  disease	  do	  not	  significantly	  contribute	  to	  prolonged	  
LOS.14,26,31	  	  However,	  Koton	  et	  al	  reported	  that	  patients	  with	  atrial	  fibrillation	  or	  
congestive	  heart	  failure	  prior	  to	  their	  admission	  for	  acute	  stroke	  had	  a	  prolonged	  
LOS.15	  
Arboix	  et	  al	  reported	  that	  health	  care	  campaigns	  promoting	  smoking	  cessation	  
resulted	  in	  an	  increased	  public	  awareness	  of	  the	  dangers	  of	  smoking	  and	  could	  be	  
contributing	  to	  the	  decline	  of	  smoking	  as	  a	  risk	  factor	  for	  stroke.34,35	  	  There	  is	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controversy	  with	  regards	  to	  the	  impact	  of	  smoking	  on	  LOS	  of	  patients	  with	  stroke.	  	  
Appelros	  et	  al	  reported	  a	  prolonged	  LOS	  for	  acute	  stroke	  in	  smokers,	  whereas	  
Chang	  et	  al	  found	  a	  shorter	  LOS.14,28	  	  However,	  Edjoc	  et	  al	  reported	  smoking	  was	  
associated	  with	  poorer	  functional	  outcomes	  at	  discharge,	  as	  well	  as	  an	  increased	  
mortality	  within	  one	  year	  of	  the	  acute	  cerebrovascular	  event.36	  	  	  
	  
Stroke	  recurrence	  has	  been	  reported	  to	  be	  associated	  with	  prolonged	  LOS.37	  	  This	  
could	  be	  explained	  by	  the	  greater	  neurological	  impairment	  in	  patients	  with	  acute	  
stroke	  who	  have	  had	  previous	  strokes.37	  
	  
The	  influence	  of	  stroke	  severity	  on	  length	  of	  stay	  
	  
Stroke	  severity	  is	  strongly	  associated	  with	  LOS.14,28	  	  Appelros	  et	  al	  reported	  that	  for	  
each	  point	  the	  National	  Institute	  of	  Health	  Stroke	  Scale	  (NIHSS)	  score	  is	  increased	  
the	  LOS	  was	  prolonged	  by	  0.8	  days.28	  	  Similarly,	  Chang	  et	  al	  showed	  that	  this	  held	  
true	  for	  a	  NIHSS	  score	  of	  up	  to	  15,	  from	  which	  point	  the	  LOS	  decreased	  by	  1	  day	  for	  
every	  point	  increase	  in	  the	  NHISS	  score.14	  	  The	  decreased	  LOS	  that	  was	  observed	  in	  
patients	  with	  high	  NIHSS	  scores	  (i.e.	  patients	  with	  severe	  strokes)	  can	  explained	  by	  
an	  increase	  in	  mortality.14,26	  	  It	  was	  reported	  by	  Koton	  et	  al	  that	  patients	  with	  
severe	  strokes	  are	  at	  increased	  risk	  of	  early	  death.15	  
	  
Amongst	  the	  clinical	  parameters	  used	  in	  calculating	  the	  NIHSS	  score,	  Appelros	  et	  al	  
reported	  that	  unilateral	  neglect,	  leg	  paresis	  and	  level	  of	  consciousness	  were	  the	  
most	  important	  clinical	  factors	  influencing	  LOS.28	  
	  
Stroke	  subtypes	  and	  their	  influence	  on	  length	  of	  stay	  
	  
Huang	  et	  al	  reported	  that	  stroke	  subtypes	  impacted	  significantly	  on	  LOS	  and	  health	  
care	  cost.37	  	  	  In	  that	  study,	  patients	  with	  total	  anterior	  circulation	  infarcts	  (TACI)	  or	  
posterior	  circulation	  infarcts	  (POCI)	  had	  mean	  lengths	  of	  stay	  of	  17.8	  and	  16.1	  
respectively,	  whereas	  patients	  with	  partial	  anterior	  circulation	  infarcts	  (PACI)	  and	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lacunar	  infarcts	  (LACI)	  stayed	  for	  a	  mean	  of	  11.69	  and	  11.6	  days	  respectively	  (P	  <	  
0.001).37	  	  Similarly,	  Dodel	  et	  al	  reported	  that	  large	  vessel	  infarcts	  affecting	  more	  
than	  50%	  of	  the	  volume	  of	  a	  cerebral	  hemisphere	  were	  more	  likely	  to	  have	  a	  longer	  
LOS.38	  
	  
In	  studies	  by	  Reed	  et	  al	  and	  Dodel	  et	  al	  it	  was	  reported	  that	  there	  is	  no	  statistically	  
significant	  difference	  in	  LOS	  in	  patients	  with	  ischaemic	  stroke	  and	  those	  with	  
haemorrhagic	  stroke.38,39	  
	  
It	  was	  reported	  by	  Dodel	  et	  al	  that	  stroke	  laterality	  has	  no	  influence	  on	  the	  length	  of	  
stay	  or	  cost	  of	  an	  acute	  admission	  for	  stroke.39	  	  	  
	  
The	  influence	  of	  medical	  complications	  on	  length	  of	  stay	  
	  
Davenport	  et	  al	  reported	  that	  complications	  are	  found	  in	  up	  to	  59%	  of	  patients	  
admitted	  with	  acute	  stroke,	  amongst	  which	  60%	  of	  patients	  have	  more	  than	  one	  
complication	  during	  their	  admission.40	  	  These	  complications	  include	  cardiovascular	  
dysfunction,	  hyperglycaemia,	  pneumonia,	  urinary	  tract	  infections,	  pressure	  ulcers,	  
venous	  thromboembolism	  and	  gastro-­‐intestinal	  bleeding.40-­‐42	  	  Complications	  are	  
more	  frequently	  encountered	  in	  the	  elderly,	  in	  patients	  with	  severe	  strokes	  and	  in	  
patients	  with	  pre-­‐stroke	  disability.40	  
	  
Ingeman	  et	  al	  reported	  that	  patients	  who	  developed	  inpatient	  complications	  were	  
more	  likely	  to	  have	  a	  worse	  outcome.41	  	  Medical	  complications	  are	  largely	  
preventable	  and	  are	  therefore	  considered	  as	  a	  negative	  indicator	  of	  quality	  of	  
stroke	  care.43,44	  	  Complications	  significantly	  contribute	  to	  a	  prolonged	  LOS,	  as	  
demonstrated	  by	  Lee	  et	  al	  who	  reported	  that	  the	  occurrence	  of	  infections	  was	  
associated	  with	  a	  5.24	  higher	  risk	  of	  prolonged	  hospital	  admission.30	  	  	  Furthermore,	  
complications	  contribute	  to	  deconditioning,	  which	  delays	  rehabilitation	  and	  hinders	  
successful	  functional	  recovery	  and	  which	  ultimately	  has	  a	  negative	  impact	  on	  the	  
quality	  of	  life	  (QOL)	  of	  patients	  who	  have	  had	  a	  stroke.29,40,41,44,45	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Zorowitz	  et	  al	  reported	  that	  stroke	  is	  often	  accompanied	  by	  cardiovascular	  
dysfunction,	  with	  as	  much	  as	  90%	  of	  patients	  having	  an	  abnormal	  ECG	  during	  
admission.42	  	  The	  treatment	  of	  blood	  pressure	  after	  acute	  stroke	  remains	  
controversial,	  but	  hypotension	  and	  systolic	  pressures	  greater	  than	  220mmHg	  
should	  be	  avoided.46	  	  Severe	  hypertension	  may	  predispose	  to	  myocardial	  ischaemia	  
and	  decompensated	  cardiac	  failure	  after	  stroke,	  which	  contribute	  to	  unfavourable	  
outcomes	  and	  prolong	  LOS.42,45	  
	  
Langhorne	  et	  al	  reported	  that	  hyperglycaemia	  has	  been	  associated	  with	  poor	  
outcome	  after	  stroke.47	  	  However,	  evidence	  to	  support	  tight	  glycaemic	  control	  with	  
insulin	  infusions	  after	  stroke	  remains	  limited.33	  	  The	  current	  recommendations	  by	  
the	  South	  African	  Stroke	  Society	  is	  to	  treat	  hyperglycaemia	  with	  insulin	  if	  the	  blood	  
glucose	  is	  more	  than	  10	  mmol/L.33	  
	  
In	  studies	  by	  Katzan	  et	  al	  and	  Heuschman	  et	  al	  it	  was	  estimated	  that	  a	  third	  of	  
deaths	  after	  acute	  stroke	  could	  be	  related	  to	  pneumonia,	  which	  makes	  it	  the	  most	  
common	  non-­‐neurological	  cause	  of	  death.42,48,49	  	  Vermeij	  et	  al	  reported	  that	  
pneumonia	  has	  an	  association	  with	  poor	  outcome	  at	  one	  year	  after	  an	  acute	  
cerebrovascular	  event.50	  	  	  
	  
Cerebral,	  cerebellar	  as	  well	  as	  brain	  stem	  strokes	  can	  impair	  the	  physiology	  of	  
swallowing.51	  	  A	  third	  of	  patients	  with	  dysphagia	  develop	  pneumonia,	  but	  not	  all	  
patients	  with	  pneumonia	  have	  dysphagia	  and	  aspiration.48,52	  	  Katzan	  et	  al	  reported	  
that	  the	  crude	  relative	  risks	  for	  developing	  pneumonia	  were	  2.7	  in	  patients	  with	  
haemorrhagic	  stroke,	  5.8	  in	  patients	  with	  coma	  and	  2.69	  in	  patients	  with	  paralysis	  
(P	  =	  0.001).48	  	  Hinchley	  et	  al	  reported	  that	  a	  formal	  dysphagia	  screening	  tool	  for	  
acute	  stroke	  reduced	  the	  occurrence	  of	  pneumonia	  three	  fold.52	  	  International	  
guidelines	  suggest	  that	  patients	  with	  impaired	  swallowing	  should	  receive	  
nasogastric	  feeding.33,46,47,52-­‐54	  	  Furthermore,	  patients	  with	  dysphagia	  should	  be	  
nursed	  in	  a	  semi-­‐upright	  position	  and	  be	  offered	  oropharyngeal	  suctioning	  if	  they	  
are	  unable	  to	  handle	  their	  own	  secretions.45	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Dysphagia	  is	  associated	  with	  worse	  outcomes	  following	  acute	  stroke,	  as	  it	  not	  only	  
increases	  the	  risk	  of	  developing	  pneumonia,	  but	  it	  also	  predisposes	  the	  patient	  to	  
malnutrition	  and	  the	  risk	  of	  developing	  a	  catabolic	  state,	  as	  well	  as	  dehydration	  
which	  results	  in	  acute	  kidney	  injury.33,42,45,46,54,55	  	  These	  complications	  could	  be	  
avoided	  by	  timeous	  insertion	  of	  a	  nasogastric	  tube	  and	  the	  initiation	  of	  appropriate	  
feeding.33,46	  
	  
Urinary	  tract	  infections	  (UTI)	  are	  frequently	  encountered	  in	  patients	  with	  acute	  
stroke,	  particularly	  in	  patients	  with	  severe	  stroke.54	  	  Aslanyan	  et	  al	  reported	  that	  
UTI	  after	  stroke	  does	  not	  increase	  the	  risk	  of	  mortality,53	  but	  that	  UTI	  was	  
associated	  with	  poorer	  functional	  recovery,	  as	  evidenced	  by	  an	  odds	  ratio	  of	  4.8	  for	  
having	  a	  Rankin	  score	  more	  than	  2	  three	  months	  after	  the	  acute	  cerebrovascular	  
event.53	  	  Urethral	  catheters	  should	  be	  used	  conservatively,	  and	  when	  used,	  patients	  
should	  be	  monitored	  closely	  for	  urinary	  tract	  infections.33,46,53,54	  	  Antibiotics	  should	  
best	  be	  reserved	  for	  patients	  with	  evidence	  of	  infection.33,54	  
	  
Weimar	  et	  al	  reported	  that	  fever,	  which	  is	  a	  marker	  of	  infections	  such	  as	  pneumonia	  
and	  urinary	  tract	  infections,	  has	  an	  odds	  ratio	  of	  2.931	  as	  an	  independent	  predictor	  
of	  incomplete	  functional	  recovery	  or	  mortality.56	  	  Careful	  temperature	  monitoring	  
would	  assist	  in	  rapid	  detection	  of	  fever,	  which	  would	  expedite	  the	  investigation	  and	  
treatment	  of	  underling	  infective	  processes.54	  	  The	  South	  African	  Stroke	  Society	  
recommends	  antipyretic	  treatment	  if	  the	  temperature	  is	  greater	  than	  37.5°C,	  as	  
experimental	  studies	  have	  shown	  that	  fever	  increases	  infarct	  size.33	  	  	  
	  
Pressure	  ulcers	  are	  prevented	  by	  rigorous	  nursing	  care,	  which	  includes	  frequent	  
turning	  and	  incontinence	  care.	  	  Pressure	  ulcers	  should	  be	  treated	  by	  relieving	  
pressure	  on	  the	  affected	  area	  by	  more	  frequent	  turning	  and	  the	  application	  of	  the	  
appropriate	  dressings.42,47	  
	  
Venous	  thromboembolism	  is	  an	  uncommon	  complication	  following	  acute	  stroke,	  
but	  remains	  an	  important	  contributor	  to	  mortality.41	  	  Heuschmann	  et	  al	  reported	  
that	  0.4%	  of	  patients	  in	  the	  German	  Stroke	  Registry	  had	  venous	  thromboembolism;	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46.8%	  of	  these	  patients	  died	  from	  pulmonary	  embolism.57	  	  The	  hazards	  ratio	  for	  
death	  in	  venous	  thromboembolism	  in	  that	  study	  is	  14.3	  (P	  =	  0.001).57	  	  Zorowitz	  et	  al	  
reported	  that	  deep	  vein	  thrombosis	  (DVT)	  occurred	  in	  up	  to	  75%	  of	  patients	  who	  
were	  not	  given	  thrombo-­‐prophylaxis	  during	  their	  admission.42	  	  Early	  mobilisation	  
has	  been	  shown	  to	  reduce	  the	  risk	  of	  DVT	  in	  patients	  with	  acute	  stroke	  five	  fold.42	  
	  
Zorowitz	  et	  al	  reported	  that	  gastrointestinal	  bleeding	  occurred	  in	  1	  to	  3%	  of	  
patients	  in	  their	  study	  admitted	  for	  acute	  stroke.42	  	  	  Erosive	  gastric	  changes	  were	  
found	  in	  up	  to	  50%	  of	  patients	  in	  that	  cohort.42	  	  Aspirin	  is	  thought	  to	  contribute	  to	  
gastritis.42	  	  Patients	  who	  received	  thrombolysis	  or	  receive	  dual	  anti-­‐platelet	  therapy	  
are	  at	  risk	  of	  life	  threatening	  gastro-­‐intestinal	  bleeds,	  and	  gastric	  protection	  with	  
proton	  pump	  inhibitors	  is	  indicated	  in	  these	  patients.42,45	  
	  
The	  influence	  of	  neurological	  complications	  on	  length	  of	  stay	  
	  
Neurological	  complications	  include	  cerebral	  oedema,	  secondary	  haemorrhagic	  
conversion	  and	  seizures.58	  	  Balami	  et	  al	  reported	  that	  neurological	  complications	  
occur	  less	  commonly	  than	  medical	  complications,	  but	  has	  potentially	  serious	  short	  
term	  and	  long	  term	  effects	  on	  outcome.58	  	  Neurological	  complications	  contribute	  to	  
delayed	  rehabilitation	  and	  worse	  functional	  recovery,	  as	  well	  as	  prolonged	  hospital	  
stays	  with	  increased	  cost	  and	  death.58	  	  	  
	  
Cerebral	  oedema	  occurs	  in	  up	  to	  10	  to	  20%	  of	  anterior	  circulation	  infarcts.54	  	  The	  
extent	  of	  oedema	  is	  largely	  determined	  by	  the	  volume	  of	  the	  infarct.54,58	  	  Cerebral	  
oedema	  and	  the	  resultant	  raised	  intracranial	  pressures	  remain	  an	  important	  risk	  
factor	  of	  death.58	  	  Heuschmann	  et	  al	  reported	  that	  the	  hazards	  ratio	  for	  death	  in	  
patients	  with	  raised	  intracranial	  pressure	  was	  16.8	  (P	  <	  0.001).57	  	  Patients	  with	  
cerebral	  oedema	  following	  acute	  stroke	  should	  be	  closely	  monitored	  within	  the	  first	  
few	  days	  and	  are	  best	  managed	  with	  the	  head	  of	  the	  bed	  elevated	  by	  20	  to	  30	  
degrees	  to	  facilitate	  venous	  drainage.33,46,58	  	  Decompressive	  surgery	  can	  be	  life	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saving,	  but	  is	  only	  indicated	  in	  selected	  patients	  with	  substantial	  cerebral	  oedema	  
resulting	  in	  brain	  shift.33,54,58	  
Balami	  et	  al	  reported	  that	  secondary	  haemorrhagic	  conversion	  is	  uncommon	  (0.6%)	  
in	  patients	  who	  did	  not	  receive	  thrombolysis.58	  	  There	  is	  no	  treatment	  to	  reduce	  the	  
risk	  of	  developing	  haemorrhagic	  conversion.58	  	  Neurosurgery,	  i.e.	  clot	  evacuation,	  
can	  be	  considered	  in	  patients	  with	  expanding	  haematomas.58	  	  	  
Adams	  et	  al	  reported	  that	  early	  seizures	  (occurring	  within	  two	  weeks	  after	  the	  acute	  
stroke)	  occur	  in	  up	  to	  33	  %	  of	  patients	  and	  late	  seizures	  in	  up	  to	  67%	  patients.54	  	  
Balami	  et	  al	  reported	  that	  2.5	  to	  4%	  of	  patients	  develop	  epilepsy,	  i.e.	  recurrent	  
seizures,	  after	  acute	  stroke.58	  	  There	  is	  no	  evidence	  to	  suggest	  the	  routine	  
prescription	  of	  anti-­‐convulsant	  therapy	  for	  the	  prophylaxis	  of	  seizures.33,54,58	  	  
Current	  guidelines	  recommend	  that	  seizures	  should	  be	  treated	  in	  accordance	  with	  
general	  principles	  of	  seizure	  management.33,46,54,59
Preventing	  neurological	  and	  medical	  complications	  after	  stroke,	  as	  well	  as	  early	  
identification	  and	  effective	  treatment	  of	  such	  complications	  contribute	  to	  a	  
reduction	  in	  morbidity	  and	  mortality.40
Quality	  care	  proves	  to	  be	  cost-­‐efficient	  
There	  is	  an	  association	  between	  good	  quality	  care	  and	  shorter	  length	  of	  stay	  in	  the	  
stroke	  unit.60	  	  Schouten	  et	  al	  reported	  that	  the	  LOS	  was	  reduced	  from	  18.3	  to	  13.3	  
days	  by	  implementing	  a	  quality	  improvement	  programme	  for	  patients	  admitted	  
with	  acute	  stroke	  in	  Sweden.61	  	  	  In	  that	  study,	  the	  stroke	  service	  teams	  that	  scored	  
higher	  in	  the	  team	  functioning	  scores	  achieved	  the	  shortest	  LOS	  amongst	  stroke	  
patients.61	  	  Similarly,	  Svendsen	  et	  al	  reported	  that	  LOS	  was	  reduced	  by	  50%	  by	  
effecting	  high	  quality	  care	  in	  Denmark.62	  	  The	  criteria	  used	  to	  measure	  the	  quality	  of	  
stroke	  care	  in	  Svendsen	  et	  al’s	  study	  included	  early	  admission	  to	  a	  dedicated	  stroke	  
unit,	  early	  introduction	  of	  antiplatelet	  therapy	  or	  anticoagulation,	  early	  radiological	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investigation	  by	  means	  of	  CT	  or	  MRI,	  early	  dysphagia	  screening,	  early	  nutritional	  
assessment	  and	  identifying	  those	  at	  risk	  of	  constipation,	  early	  intermittent	  
catherisation,	  early	  DVT	  prophylaxis	  and	  mobilisation	  and	  early	  assessment	  by	  the	  
physiotherapist	  and	  occupational	  therapist.62	  
	  
Lim	  et	  al	  reported	  that	  patients	  with	  physical	  disability	  benefit	  from	  early	  
physiotherapy	  by	  preventing	  deconditioning	  and	  thereby	  resulting	  in	  shorter	  LOS.29	  	  
In	  a	  study	  by	  Feys	  et	  al	  it	  was	  reported	  that	  patients	  that	  received	  early	  intensive	  
physiotherapy	  for	  severe	  motor	  deficit	  in	  the	  arm	  had	  a	  significant	  improvement	  in	  
motor	  function	  as	  compared	  with	  the	  control	  group	  in	  that	  study.63	  	  Christensen	  et	  
al	  suggested	  that	  better	  functional	  recovery	  may	  result	  in	  a	  lesser	  chance	  of	  
readmission,	  thus	  decreasing	  long	  term	  cost	  of	  health	  care.64	  
	  
Ingeman	  et	  al	  reported	  that	  early	  mobilisation	  also	  reduced	  the	  risk	  of	  developing	  
inpatient	  complications.65	  	  In	  that	  study,	  mobilising	  within	  the	  first	  day	  of	  admission	  
was	  associated	  with	  an	  adjusted	  odds	  ratio	  of	  0.43	  for	  developing	  pneumonia,	  0.56	  
for	  developing	  urinary	  tract	  infection	  and	  0.43	  for	  developing	  pressure	  ulcers.65	  
	  
Organised	  stroke	  unit	  model	  of	  care	  has	  been	  shown	  to	  reduce	  complications	  and	  
result	  in	  better	  functional	  outcomes	  following	  stroke.66,67	  	  Although	  treating	  
patients	  in	  a	  stroke	  unit	  is	  more	  expensive	  than	  treating	  patients	  in	  a	  conventional	  
ward,	  the	  outcome	  in	  stroke	  units	  by	  far	  exceeds	  that	  of	  conventional	  wards.18	  	  
Epifanov	  et	  al	  reported	  that	  admission	  to	  a	  stroke	  unit	  in	  Germany	  was	  13.4%	  more	  
expensive	  for	  ischaemic	  stroke	  than	  admission	  to	  a	  general	  neurological	  ward	  in	  the	  
same	  hospital	  for	  the	  same	  condition.18	  	  The	  increase	  in	  cost	  could	  largely	  be	  
accounted	  for	  by	  expenditures	  on	  the	  increased	  numbers	  of	  medical	  personnel	  
needed	  to	  work	  in	  the	  stroke	  unit.	  	  However,	  the	  same	  study	  reported	  that	  the	  
length	  of	  stay	  per	  admission	  was	  significantly	  shorter	  in	  the	  stroke	  unit,	  11.9	  days	  in	  
the	  stroke	  unit	  as	  compared	  to	  16.9	  days	  in	  the	  general	  neurology	  wards.18	  
	  
In	  a	  systematic	  review	  by	  Seenan	  et	  al,	  stroke	  units	  had	  superior	  outcomes	  to	  
conventional	  wards.68	  	  In	  that	  review	  the	  stroke	  unit	  was	  associated	  with	  an	  odds	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ratio	  for	  death	  of	  0.79	  (P	  <	  0.001).68	  	  A	  systematic	  review	  by	  Govan	  et	  al	  reported	  
that	  patients	  managed	  in	  a	  stroke	  unit	  developed	  less	  complications	  when	  
compared	  to	  those	  managed	  in	  general	  medical	  wards.67	  	  The	  odds	  ratios	  were	  
reported	  to	  be	  0.6	  for	  developing	  pneumonia,	  0.81	  for	  dehydration	  and	  0.44	  for	  
having	  bedsores	  when	  managed	  in	  the	  stroke	  unit	  as	  compared	  with	  general	  
medical	  wards.67	  
	  
Improved	  outcomes	  in	  stroke	  units	  are	  achieved	  by	  improved	  diagnostic	  accuracy,	  
appropriate	  monitoring	  and	  the	  prevention	  of	  complications	  resulting	  from	  efficient	  
management	  by	  a	  multidisciplinary	  team,	  specialised	  nursing	  care,	  early	  
rehabilitation	  and	  better	  discharge	  planning.18,47,66,69,70	  	  
	  
The	  impact	  of	  investigations	  and	  procedures	  on	  length	  of	  stay	  
	  
De	  Carvalho	  et	  al	  reported	  that	  delays	  in	  complementary	  evaluations	  and	  
procedures	  such	  as	  endoscopy	  and	  surgery	  resulted	  in	  increased	  cost	  of	  care	  
through	  prolonged	  LOS	  and	  an	  increase	  in	  inpatient	  complications.71	  	  	  
	  
Kim	  et	  al	  reported	  that	  patients	  with	  stroke	  who	  underwent	  surgery	  had	  a	  2.1	  times	  
longer	  LOS	  than	  patients	  that	  did	  not	  have	  surgery.23	  	  Tu	  et	  al	  it	  reported	  that	  
surgery	  contributed	  significantly	  to	  the	  cost	  of	  an	  admission,	  as	  evidenced	  by	  the	  
mean	  crude	  hospital	  charges	  amounting	  to	  $15	  249	  in	  patients	  that	  underwent	  
surgery	  compared	  with	  $7	  594	  in	  patients	  that	  did	  not	  have	  surgery	  during	  their	  
admission	  (P	  <	  0.001).72	  
	  
The	  influence	  of	  discharge	  destination	  on	  length	  of	  stay	  
	  
In	  a	  recent	  French	  study,	  Schnitzler	  et	  al	  reported	  that	  up	  to	  50%	  of	  patients	  
admitted	  with	  stroke	  require	  rehabilitation.73	  	  Luengo-­‐Fernadez	  et	  al	  reported	  that	  
although	  hospital	  admission	  is	  usually	  shorter	  than	  the	  admission	  to	  a	  rehabilitation	  
centre,	  the	  cost	  of	  a	  hospital	  admission	  bed	  cost	  per	  day	  (£331	  per	  day	  in	  a	  stroke	  
	   25	  
unit	  and	  £269	  per	  day	  in	  a	  general	  ward)	  exceeds	  that	  of	  rehabilitation	  centres	  
(£213	  per	  day).15	  	  For	  this	  reason,	  Lee	  et	  al	  suggested	  that	  it	  is	  more	  cost	  efficient	  to	  
arrange	  for	  timeous	  transfer	  to	  a	  rehabilitation	  centre	  in	  patients	  who	  require	  
rehabilitation.30	  
	  
The	  reasons	  for	  prolonged	  length	  of	  hospital	  stay	  in	  patients	  discharged	  to	  
rehabilitation	  centres	  or	  nursing	  homes	  are	  two	  fold.	  	  Firstly,	  LOS	  in	  hospital	  is	  
influenced	  by	  the	  availability	  of	  beds	  at	  rehabilitation	  centres	  and	  step	  down	  
facilities	  to	  which	  patients	  are	  discharged.22	  	  Secondly,	  stroke	  severity	  and	  
complications	  influence	  whether	  patients	  are	  discharged	  to	  institutions.28,31,74	  	  
Saxena	  et	  al	  reported	  that	  patients	  that	  are	  discharged	  to	  rehabilitation	  centres	  are	  
those	  that	  had	  more	  severe	  strokes	  and	  that	  experience	  greater	  functional	  
disability.31	  	  Furthermore,	  as	  reported	  by	  Indredavik	  et	  al,	  stroke	  severity	  
predisposes	  patients	  to	  developing	  complications,75	  which	  in	  itself	  not	  only	  prolongs	  
LOS,	  but	  it	  also	  delays	  the	  initiation	  of	  effective	  rehabilitation	  as	  reported	  by	  
Davenport	  et	  al.40	  
	  
Lim	  et	  al	  stated	  that	  one	  could	  achieve	  a	  shorter	  LOS	  by	  starting	  effective	  discharge	  
planning	  early	  in	  the	  admission.29	  	  Bryer	  et	  al,	  De	  Villiers	  et	  al	  and	  Langhorne	  et	  al	  
suggested	  that	  early	  assessment	  by	  a	  multidisciplinary	  team,	  comprising	  of	  social	  
workers,	  physiotherapists,	  occupational	  and	  speech	  therapists,	  results	  in	  shorter	  
LOS	  by	  facilitating	  the	  early	  application	  and	  efficient	  transfer	  to	  rehabilitation	  
centres.47,55,66	  
	  
In	  their	  Cochrane	  systematic	  review,	  the	  Early	  Supported	  Discharge	  Trialists	  have	  
reported	  that	  by	  developing	  an	  early	  discharge	  support	  group	  that	  would	  assist	  with	  
continued	  rehabilitation	  at	  home	  resulted	  in	  a	  9	  day	  shorter	  LOS	  after	  acute	  stroke	  
(P	  <	  0.001).76	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Conclusion	  
	  
Identification	  of	  gaps	  and	  need	  for	  further	  research	  
	  
Even	  though	  stroke	  is	  a	  leading	  cause	  of	  morbidity	  and	  mortality,	  very	  little	  is	  
known	  about	  the	  quality	  and	  cost	  of	  stroke	  care	  in	  South	  Africa.66	  	  Sposato	  et	  al	  
suggested	  that	  knowledge	  of	  the	  quality	  of	  stroke	  care	  is	  of	  critical	  importance	  in	  
forming	  interventions	  to	  improve	  stroke	  care.77	  	  With	  stroke	  prevalence	  and	  its	  
incurred	  costs	  that	  are	  predicted	  to	  continue	  to	  increase	  in	  future,	  the	  health	  sector	  
will	  be	  faced	  with	  increasing	  financial	  challenges	  in	  providing	  optimal	  care	  for	  
inpatients	  with	  acute	  stroke.9,77,78	  	  For	  this	  reason,	  De	  Villiers	  et	  al	  suggested	  further	  
study	  in	  cost	  analysis	  of	  stroke	  care	  in	  South	  Africa.66	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This	  study	  generated	  an	  extensive	  database,	  as	  elaborated	  in	  the	  research	  protocol.	  	  
However,	  to	  keep	  the	  manuscript	  focussed,	  the	  results	  of	  this	  study	  were	  divided	  
into	  two	  manuscripts	  in	  publishable	  format.	  
	  
Permission	  was	  obtained	  from	  the	  chairs	  of	  the	  Doctoral	  and	  Masters	  Committee	  
for	  Research	  and	  the	  Postgraduate	  Masters	  Committee	  of	  UCT	  to	  report	  and	  discuss	  
the	  results	  of	  this	  study	  in	  the	  format	  of	  two	  publications	  in	  Chapter	  2,	  instead	  of	  
the	  usual	  standard	  of	  one	  publication.	  
	  
The	  first	  article	  concentrates	  on	  the	  cost	  of	  acute	  stroke	  care,	  whereas	  the	  second	  
article	  focuses	  on	  the	  quality	  of	  stroke	  care	  in	  the	  general	  medical	  wards	  at	  Groote	  
Schuur	  Hospital.	  
	  
As	  stipulated	  in	  the	  University	  of	  Cape	  Town’s	  regulations	  for	  master’s	  degrees,	  
manuscripts	  are	  to	  be	  formatted	  to	  comply	  with	  the	  instructions	  to	  authors	  of	  a	  
journal	  appropriate	  to	  the	  subject	  matter	  of	  the	  dissertation.	  	  The	  author	  guidelines	  
for	  the	  journal	  “Stroke”	  were	  followed	  for	  these	  manuscripts.	  	  However,	  for	  the	  
purposes	  of	  readability	  of	  this	  dissertation,	  tables	  and	  graphs	  were	  placed	  in	  the	  
text	  rather	  than	  appended.	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Abstract	  
Abstract	  word	  count:	  	  250	  words	  
Background	  and	  purpose	  
Stroke	  remains	  the	  leading	  cause	  of	  death	  amongst	  South	  Africans	  older	  than	  60	  
years,	  yet	  little	  is	  known	  about	  the	  cost	  of	  stroke	  care	  in	  South	  Africa.	  	  The	  aim	  of	  
this	  study	  was	  to	  determine	  the	  cost	  of	  acute	  stroke	  care	  in	  general	  medical	  wards	  
in	  Cape	  Town	  and	  to	  identify	  factors	  associated	  with	  increased	  expense.	  	  	  
Methods	  
We	  conducted	  a	  retrospective	  folder	  review	  of	  all	  patients	  admitted	  with	  acute	  
stroke	  to	  general	  medical	  wards	  at	  Groote	  Schuur	  Hospital	  from	  1	  January	  to	  31	  
December	  2012.	  	  Patients	  younger	  than	  45	  years	  and	  those	  that	  received	  
thrombolysis	  were	  excluded.	  	  The	  hospital’s	  finance	  department	  provided	  the	  bed	  
costs,	  as	  for	  expenditure	  on	  consumables,	  pharmacy,	  laboratory	  and	  radiology	  for	  
each	  subject.	  	  
Results	  
The	  inpatient	  care	  of	  261	  patients	  was	  reviewed.	  	  The	  median	  cost	  of	  a	  stroke	  
admission	  in	  this	  study	  was	  R19,072.07	  (IQR	  R10,899.85	  to	  R27,789.43).	  	  The	  
strongest	  correlation	  with	  cost	  was	  with	  length	  of	  stay	  (LOS),	  r	  =	  0.9977.	  	  The	  
median	  LOS	  was	  6	  days	  (IQR	  3	  to	  9	  days).	  	  LOS	  was	  significantly	  prolonged	  in	  
patients	  with	  recurrent	  stroke	  (P	  =	  0.028),	  fever	  (P	  <	  0.001),	  urinary	  tract	  infections	  
(P	  <	  0.001),	  acute	  kidney	  injury	  (P	  <	  0.001),	  delayed	  assessment	  by	  allied	  health	  
professionals	  (P	  <	  0.01)	  and	  discharge	  to	  rehabilitation	  centres	  (P	  <	  0.001).	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Conclusions	  
Improving	  the	  quality	  of	  acute	  stroke	  care	  to	  reduce	  the	  number	  of	  complications,	  
early	  referral	  to	  allied	  health	  professionals	  and	  effective	  discharge	  planning	  would	  
result	  in	  shorter	  length	  of	  stay	  and	  therefore	  cost	  saving.	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Introduction	  
	  
Stroke	  remains	  the	  second	  leading	  cause	  of	  mortality	  and	  most	  frequent	  cause	  of	  
permanent	  disability	  in	  the	  world.1	  	  Internationally,	  stroke	  places	  a	  considerable	  
burden	  on	  acute	  and	  chronic	  health	  care	  services,	  representing	  between	  2%	  and	  7%	  
of	  total	  healthcare	  expenditure.2	  	  Even	  though	  stroke	  is	  the	  leading	  cause	  of	  death	  
in	  South	  Africans	  older	  than	  60	  years,	  accounting	  for	  17.7%	  of	  female	  and	  12.2%	  of	  
male	  deaths	  in	  this	  age	  group,	  very	  little	  is	  known	  about	  the	  cost	  of	  acute	  stroke	  
care	  in	  South	  Africa.3,4	  	  With	  stroke	  incidence	  that	  is	  predicted	  to	  continue	  to	  rise	  in	  
face	  of	  an	  increase	  in	  life	  expectancy	  and	  escalation	  in	  non-­‐communicable	  diseases	  
in	  urban	  and	  rural	  South	  Africa,	  the	  health	  sector	  will	  be	  faced	  with	  increasing	  
financial	  challenges	  in	  providing	  optimal	  care	  for	  inpatients	  with	  acute	  stroke.5-­‐9	  	  
Cost	  containment	  and	  rationalisation	  of	  health	  care	  resource	  allocation	  is	  therefore	  
of	  paramount	  importance	  if	  quality	  care	  is	  to	  be	  affordable	  for	  patients	  with	  acute	  
stroke.10	  	  
	  
This	  study	  was	  conducted	  to	  determine	  the	  cost	  of	  acute	  stroke	  care	  and	  factors	  
contributing	  to	  that	  cost.	  	  This	  study	  also	  aims	  to	  identify	  patient	  characteristics,	  
inpatient	  complications	  and	  management	  factors	  influencing	  the	  cost	  of	  stroke	  
care.	  	  	  The	  identification	  of	  modifiable	  factors	  associated	  with	  increased	  costs	  could	  






A	  retrospective	  folder	  review	  was	  conducted	  after	  approval	  by	  the	  Human	  Research	  
Ethics	  Committee	  of	  the	  Faculty	  of	  Health	  Sciences	  at	  the	  University	  of	  Cape	  Town.	  
Data	  was	  collected	  using	  a	  standardized	  template.	  	  All	  patient	  data	  in	  this	  study	  
remains	  anonymous.	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Study	  population	  and	  dates	  of	  enrolment	  
	  
Groote	  Schuur	  Hospital	  is	  an	  893	  bed	  tertiary	  academic	  hospital	  associated	  with	  the	  
University	  of	  Cape	  Town,	  which	  has	  121	  secondary	  level	  general	  medical	  ward	  beds	  
and	  a	  6	  bed	  specialist	  stroke	  unit.	  	  Stroke	  patients	  who	  are	  not	  admitted	  to	  the	  
stroke	  unit	  are	  managed	  in	  general	  medical	  wards.	  	  	  
	  
Patients	  were	  identified	  by	  reviewing	  emergency	  unit	  admission	  registers.	  	  All	  
patients	  admitted	  by	  the	  Department	  of	  Internal	  Medicine	  to	  the	  general	  medical	  
wards	  over	  a	  12	  month	  period	  (1	  January	  to	  31	  December	  2012)	  with	  a	  diagnosis	  of	  
acute	  stroke,	  as	  defined	  by	  the	  World	  Health	  Organization,	  were	  included	  in	  the	  
study.11	  
	  
	   Patients	  excluded	  from	  study	  
	  
Patients	  were	  excluded	  if,	  after	  folder	  review	  it	  was	  determined	  that	  acute	  stroke	  
was	  not	  the	  primary	  reason	  for	  admission,	  if	  they	  were	  younger	  than	  45	  years	  of	  
age	  on	  the	  day	  of	  admission,	  if	  they	  received	  thrombolysis	  or	  were	  admitted	  by	  a	  
neurologist	  to	  the	  stroke	  unit.	  	  Patients	  with	  subarachnoid	  or	  subdural	  
haemorrhage	  were	  not	  included	  into	  the	  study.	  	  	  
	  
	   Demography	  and	  clinical	  background	  of	  patients	  entered	  into	  study	  
	  
Data	  collected	  included	  the	  demographic	  details	  of	  subjects,	  a	  history	  of	  previous	  
stroke,	  preceding	  transient	  ischaemic	  attacks	  prior	  to	  admission	  and	  vascular	  risk	  
factors	  defined	  as	  smoking	  (current	  smoker	  or	  within	  the	  5	  years	  prior	  to	  
admission),	  hypertension	  (on	  the	  history,	  use	  of	  regular	  anti-­‐hypertensive	  
treatment	  or	  in-­‐hospital	  diagnosis),	  diabetes	  mellitus	  (on	  the	  history,	  regular	  use	  of	  
oral	  anti-­‐diabetic	  medication	  or	  subcutaneous	  insulin,	  or	  in-­‐hospital	  diagnosis),	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hypercholesterolaemia	  (on	  history	  or	  a	  total	  cholesterol	  level	  of	  more	  than	  5	  
mmol/L	  during	  the	  admission),	  atrial	  fibrillation	  (ECG),	  ischaemic	  heart	  disease	  
(history	  of	  angina	  or	  prior	  myocardial	  infarction),	  valvular	  heart	  disease	  
(echocardiography),	  HIV	  (positive	  serology)	  and	  neurosyphilis	  (cerebrospinal	  fluid	  
analysis).	  
	  
Stroke	  subtype	  and	  clinical	  presentation	  
	  
Computerised	  tomography	  (CT)	  scans	  of	  the	  brain	  were	  reviewed	  by	  a	  stroke	  
specialist	  and	  patients	  were	  classified	  as	  haemorrhagic	  or	  ischaemic	  stroke.	  	  The	  
latter	  were	  classified	  according	  to	  the	  Oxfordshire	  Community	  Stroke	  Project	  (OCSP)	  
clinical	  classification	  into	  total	  anterior	  circulation	  infarcts	  (TACI),	  partial	  anterior	  
circulation	  infarcts	  (PACI),	  lacunar	  infarcts	  (LACI)	  and	  posterior	  circulation	  infarcts	  
(POCI).12	  	  Clinical	  records	  were	  reviewed	  to	  identify	  patients	  with	  decreased	  level	  of	  
consciousness,	  aphasia	  (further	  classified	  into	  receptive	  and/or	  expressive	  aphasia),	  
dysphagia	  and	  hemiparesis	  of	  the	  arms	  and/or	  legs	  and	  its	  laterality.	  
	  
Special	  investigations	  done	  during	  admission	  
	  
Laboratory	  examinations	  done	  were	  identified	  from	  the	  hospitals	  electronic	  
reporting	  system	  using	  patients’	  hospital	  numbers.	  	  Investigations	  recorded	  
included	  full	  blood	  count,	  renal	  function	  (electrolytes,	  urea	  and	  creatinine),	  INR,	  
lipid	  profile,	  thyroid	  stimulating	  hormone	  (TSH),	  liver	  function	  tests,	  C-­‐reactive	  
protein	  (CRP),	  ELISA	  for	  human	  immunodeficiency	  virus	  (HIV),	  syphilis	  serology	  and	  
blood	  cultures.	  	  Urinalysis	  and	  cerebrospinal	  fluid	  analysis	  with	  its	  respective	  
microscopy,	  culture	  and	  sensitivities	  were	  also	  recorded.	  	  Radiological	  investigations	  
recorded	  included	  CT	  or	  MRI	  of	  the	  brain,	  angiogram	  of	  the	  intracranial	  vessels,	  
Doppler	  ultrasound	  of	  the	  carotid	  vessels,	  chest	  X-­‐rays	  and	  compression	  ultrasound	  
of	  the	  calves,	  CT	  angiogram	  of	  pulmonary	  vessels	  or	  ventilation/perfusion	  scan.	  	  
Cardiac	  investigations	  recorded	  included	  ECGs	  and	  echocardiograms.	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Inpatient	  treatment	  
Prescription	  charts	  were	  reviewed	  to	  identify	  the	  use	  of	  antiplatelet	  agents,	  
anticoagulants,	  antihypertensives,	  diabetic	  drugs,	  statins	  and	  antibiotics	  as	  well	  as	  
its	  route	  of	  administration	  and	  duration	  of	  therapy.	  
Involvement	  of	  allied	  health	  professionals	  
The	  time	  interval	  between	  admission	  and	  assessment	  by	  a	  speech	  therapist,	  
dietician,	  physiotherapist	  or	  occupational	  therapist	  was	  recorded.	  	  Patients	  were	  
categorised	  according	  to	  whether	  they	  were	  first	  seen	  within	  72	  hours	  of	  admission,	  
thereafter	  or	  not	  seen.	  
Complications	  during	  admission	  
The	  following	  complications	  were	  recorded:	  death,	  fever	  (defined	  as	  core	  body	  
temperature	  >	  37.5°C),	  pneumonia	  (diagnosed	  clinically	  or	  radiographically),	  urinary	  
tract	  infection	  (based	  on	  urinalysis	  results),	  drip	  site	  sepsis,	  hyperglycaemia	  (defined	  
as	  blood	  glucose	  >	  7mmol/L),	  acute	  kidney	  injury	  (defined	  by	  50%	  rise	  of	  creatinine	  
from	  baseline	  within	  7	  days	  or	  26.1μmol/L	  rise	  in	  creatinine	  within	  48	  hours),13	  
bedsores,	  deep	  vein	  thrombosis	  (ultrasonographic	  confirmation),	  pulmonary	  
embolism	  (confirmed	  on	  ventilation/perfusion	  scan	  or	  CT	  angiogram	  of	  pulmonary	  
vessels),	  gastro-­‐intestinal	  bleeds	  and	  seizures.
Discharge	  destination	  
Stroke	  survivors’	  discharge	  destinations	  from	  hospital	  were	  classified	  according	  to	  
whether	  they	  went	  home	  or	  to	  an	  inpatient	  rehabilitation	  centre.	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Length	  of	  stay	  
	  
The	  length	  of	  stay	  (LOS)	  was	  calculated	  in	  days	  from	  the	  day	  of	  admission	  to	  the	  day	  
of	  discharge	  or	  death.	  	  	  
	  
Cost	  of	  admission	  
	  
The	  hospital’s	  finance	  department	  provided	  the	  bed	  costs,	  as	  for	  expenditure	  on	  
consumables,	  pharmacy,	  laboratory	  and	  radiology	  for	  each	  subject.	  	  The	  cost	  of	  an	  
admission	  to	  a	  general	  medical	  ward	  was	  calculated	  by	  multiplying	  the	  total	  length	  
of	  stay	  in	  days	  with	  the	  sum	  of	  goods	  and	  services	  cost	  per	  patient	  day	  equivalent	  
(PDE)	  (R2250)	  and	  agency	  cost	  per	  PDE	  (R28),	  medicine	  cost	  per	  PDE	  (R300),	  
medical	  supplies	  per	  PDE	  (R233),	  which	  is	  a	  total	  of	  R2811	  per	  day.	  	  	  
	  
Chronic	  medication	  was	  included	  in	  ward	  cost,	  but	  acute	  medication	  such	  as	  
antibiotics	  were	  calculated	  based	  on	  the	  cost	  per	  drug	  per	  day	  multiplied	  by	  the	  
length	  of	  the	  treatment.	  	  The	  daily	  cost	  of	  parenterally	  administered	  antibiotics	  
given	  to	  patients	  in	  this	  study	  included	  ampicillin	  of	  R12.96,	  ceftriaxone	  of	  R4.55,	  
co-­‐amoxiclav	  of	  R39.60,	  ertapenem	  of	  R368.33,	  gentamycin	  of	  R11.61	  and	  penicillin	  
G	  of	  R44.64	  per	  day.	  	  Oral	  antiobiotics	  included	  amoxicillin	  of	  R0.83,	  co-­‐amoxiclav	  of	  
R2.98,	  ciprofloxacin	  of	  R0.88,	  flucloxacillin	  of	  R3.57	  and	  metronidazole	  of	  R0.56	  per	  
day.	  
	  
Each	  special	  investigation	  done	  during	  the	  admission	  was	  counted.	  	  The	  cost	  of	  each	  
investigation	  was	  multiplied	  by	  the	  number	  of	  times	  each	  test	  was	  done.	  	  
Radiological	  cost	  included	  chest	  X-­‐ray	  of	  R122,	  CT	  brain	  of	  R1628,	  MRI	  brain	  of	  
R1628,	  CT	  angiogram	  of	  intracranial	  vessels	  of	  R4096,	  carotid	  doppler	  of	  the	  carotid	  
arteries	  of	  R340	  and	  compression	  ultrasound	  of	  the	  calf	  of	  R340.	  	  An	  ECG	  was	  billed	  
at	  R151	  and	  echocardiogram	  would	  cost	  R340.	  	  Laboratory	  costs	  were	  based	  on	  the	  
cost	  of	  a	  full	  blood	  count	  of	  R50.22,	  urea,	  creatinine	  and	  electrolytes	  of	  R105.08,	  
INR	  of	  R40.95,	  total	  cholesterol	  of	  R39.12	  and	  lipid	  profile	  of	  R148.06,	  TSH	  of	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R220.89,	  CRP	  of	  R63.18,	  HIV	  ELISA	  test	  of	  R47.77,	  syphilis	  serology	  (RPR)	  of	  R29.19.	  	  
A	  blood	  culture	  would	  cost	  R104.61	  and	  urine	  microscopy	  and	  culture	  with	  




Coded	  data	  was	  entered	  into	  an	  Excel	  computerised	  database.	  	  Statistical	  analysis	  
was	  performed	  by	  using	  the	  statistical	  software	  R	  version	  3.0.2.	  	  Non-­‐parametric	  
Mann-­‐Whitney	  U	  (for	  dichotomous	  variables)	  or	  Kruskal-­‐Wallis	  (for	  categorical	  
variables)	  tests	  were	  used	  to	  identify	  whether	  demography,	  comorbidities,	  stroke	  
subtypes,	  clinical	  presentation,	  special	  investigations,	  medical	  complications	  and	  
management	  factors	  influenced	  length	  of	  stay.	  	  Only	  P	  values	  of	  less	  than	  0.05	  were	  




A	  total	  of	  344	  patients	  with	  an	  admission	  diagnosis	  of	  stroke	  were	  identified	  in	  
emergency	  unit	  registers,	  of	  which	  261	  were	  included	  in	  the	  study.	  	  Amongst	  the	  83	  
patients	  excluded,	  43	  had	  intracranial	  pathology	  other	  than	  acute	  stroke,	  9	  were	  
readmitted	  with	  complications	  of	  immobility	  from	  previous	  strokes,	  9	  were	  
admitted	  to	  the	  stroke	  unit,	  3	  were	  younger	  than	  45	  years	  of	  age	  and	  16	  patients	  
had	  incomplete	  patient	  records.	  
	  
The	  demography,	  type	  of	  stroke,	  clinical	  presentation	  and	  comorbidities	  of	  the	  
study	  sample	  are	  described	  in	  table	  1.	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Cost	  of	  admission	  
	  
The	  total	  expenditure	  on	  all	  stroke	  admissions	  in	  this	  study	  was	  R5,636,998.11,	  of	  
which	  R3,988,838.23	  (70.76%)	  was	  spent	  on	  the	  ward	  admission,	  R408,038.86	  
(7.23%)	  on	  medical	  supplies,	  R525,183.91	  (9.32%)	  on	  chronic	  medicine,	  R19,473.56	  
(0.35%)	  on	  antibiotics,	  R162,831.55	  (2.89%)	  on	  laboratory	  related	  costs	  and	  
R532,632.00	  (9.45%)	  on	  radiological	  costs.	  
	  
Figure	  1:	  	  this	  chart	  illustrates	  how	  the	  total	  cost	  of	  acute	  stroke	  care	  of	  all	  patients	  
(n	  =	  261)	  in	  this	  study	  was	  divided	  amongst	  ward	  cost,	  consumables,	  pharmacy	  cost,	  
laboratory	  cost	  and	  radiological	  cost.	  
	  
The	  median	  cost	  of	  stroke	  admissions	  was	  R19,072.07	  (range	  R5,136.85	  to	  
R100,343.62,	  IQR	  R10,899.85	  to	  R27,789.43).	  	  The	  greatest	  variation	  in	  cost	  was	  
observed	  with	  ward	  cost,	  with	  a	  median	  cost	  of	  R16,866.00	  (IQR	  R8,433.00	  to	  
R25,299.00).	  	  Median	  laboratory	  related	  cost	  was	  R505.37	  (IQR	  R387.76	  to	  R745.32)	  















Correlation	  between	  cost	  and	  length	  of	  stay	  
Stepwise	  multiple	  regression	  analysis	  revealed	  that	  length	  of	  stay	  (LOS)	  was	  the	  key	  
determinant	  of	  total	  cost	  of	  admission	  (P	  <	  0.001).	  Correlation	  between	  LOS	  and	  
total	  cost	  was	  0.9977	  with	  99.55%	  of	  the	  variation	  in	  total	  cost	  accounted	  for	  by	  
variation	  in	  the	  LOS,	  as	  demonstrated	  in	  figure	  2.	  
	  
Figure	  2:	  	  This	  scatter	  plot	  illustrates	  the	  correlation	  between	  length	  of	  stay	  as	  
measured	  in	  days	  and	  total	  cost	  of	  admission	  (n	  =	  261)	  (R2	  =	  99.55%).	  
R2	  is	  the	  percentage	  of	  total	  variance	  explained	  by	  the	  model.	  
	  
The	  median	  length	  of	  stay	  (LOS)	  was	  6	  days	  (range	  1	  to	  33	  days,	  IQR	  3	  –	  9	  days).	  	  	  	  
Non-­‐parametric	  tests	  established	  that	  demography,	  the	  different	  stroke	  types	  and	  
neurological	  deficits	  on	  presentation	  did	  not	  significantly	  influence	  LOS.	  	  The	  only	  
comorbidity	  associated	  with	  prolonged	  LOS	  was	  stroke	  recurrence	  (P	  =	  0.028).	  	  
Valvular	  heart	  disease	  (P	  =	  0.031)	  and	  HIV	  (P	  <	  0.001)	  displayed	  significance,	  but	  this	  























































Delayed	  assessment	  by	  allied	  health	  professionals,	  inpatient	  complications	  and	  
discharge	  to	  inpatient	  rehabilitation	  lead	  to	  a	  significant	  increase	  in	  LOS,	  as	  
demonstrated	  in	  table	  2.	  
Similarly,	  delays	  in	  special	  investigations	  were	  associated	  with	  a	  significant	  increase	  
in	  LOS	  (delays	  in	  angiogram,	  P	  =	  0.035;	  carotid	  artery	  Doppler	  ultrasound,	  P	  =	  0.021;	  
echocardiogram,	  P	  =	  0.007),	  however	  the	  sample	  size	  of	  patients	  that	  underwent	  
these	  tests	  in	  this	  study	  is	  not	  large	  enough	  to	  accurately	  make	  this	  inference	  (only	  
6	  patients	  (2.29%)	  underwent	  angiogram	  of	  the	  intra-­‐cranial	  vessels,	  11	  patients	  





! N&(%)& Median&LOS& P&value&
First&assessment&by&allied&health&professionals&*!
Speech!therapy! within!72!hours! 127!(48.66)! 7! <!0.001!
! after!72!hours! 26!(9.96)! 10! !
Dietary!assessment! within!72!hours! 94!(36.02)! 6.5! <!0.01!
! after!72!hours! 18!(6.9)! 10! !
Physiotherapy! within!72!hours! 150!(57.47)! 6! <!0.01!
! after!72!hours! 40!(15.33)! 9! !
Occupational!therapy! within!72!hours! 134!(51.34)! 6! <!0.001!
! after!72!hours! 39!(14.94)! 9! !
Complications&during&admission&*&
Death! yes! 53!(20.31)! 3! <!0.001!
! no! 208!(79.69)! 6! !
Fever! yes! 108!(41.38)! 7! <!0.001!
! no! 153!(58.62)! 5! !
Pneumonia! yes! 57!(21.84)! 5! 0.769!
! no! 210!(80.46)! 6! !
UTI! yes! 57!(21.84)! 7! <!0.001!
! no! 204!(78.16)! 5! !
Acute!kidney!injury! yes! 25!(9.58)! 10! <!0.001!
! no! 236!(90.42)! 5! !
Discharge&destination&†"
Home! ! 102!(40.23)! 4! <!0.001!
Rehabilitation!centre! ! 105!(39.08)! 8! !
Died! ! 54!(20.69)! 3! !
!
Non$parametric-analyses-were-performed-by-Mann-Whitney-U-(*)-or-Kruskal$Wallis-tests-(†)-as-indicated.-
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Table	  3	  demonstrates	  the	  influence	  of	  the	  number	  of	  inpatient	  complications	  on	  the	  




Death	  was	  statistically	  significant	  in	  shortening	  LOS.	  	  A	  logistic	  regression	  analysis	  
was	  performed	  to	  determine	  the	  factors	  that	  predicted	  for	  death	  in	  this	  study.	  	  




A	  sub-­‐analysis	  was	  performed	  amongst	  patients	  referred	  to	  inpatient	  rehabilitation	  
centres,	  which	  showed	  that	  patients	  assessed	  within	  72	  hours	  of	  admission	  by	  allied	  




! N&(%)& Median&LOS& P&value&
Number&of&inpatient&complications&
None! 93(35.63%)! 5! 0.059!
1!complication! 58!(22.22%)! 6! !
2!or!3!complications! 82!(31.42%)! 5.5! !





Predictor&of&death& Odds&ratio& 95%&Confidence&interval! P&value&
Lower&bound! Upper&bound!
TACI!12! 4.803! 2.403! 9.629! <!0.001!
Decreased!level!of!consciousness! 6.916! 3.607! 13.517! <!0.001!
Fever! 3.240! 1.745! 6.174! <!0.001!
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In	  corroboration	  with	  the	  above	  analysis,	  multivariate	  stepwise	  regression	  was	  used	  
to	  identify	  the	  key	  predictors	  for	  LOS.	  	  The	  results	  are	  shown	  in	  table	  6,	  wherein	  
fever,	  acute	  kidney	  injury	  and	  delayed	  management	  by	  allied	  health	  professionals	  
were	  associated	  with	  longer	  length	  of	  stay.	  	  This	  model	  explains	  38%	  of	  variance	  in	  
LOS	  (P	  value	  <	  0.001).	  
	  
	  




! N& %& Median&LOS& IQR& P&value&
Speech&therapy&*& 0.007&
Seen!within!72!hours!of!admission! 61! 79.22%! 8! 5!–!10! !
Seen!after!72!hours!of!admission! 16! 20.78%! 10.5! 8.5!–!15! !
Dietician&*& 0.084&
Seen!within!72!hours!of!admission! 43! 82.69%! 8! 5!–!9.5! !
Seen!after!72!hours!of!admission! 9! 17.31%! 10! 8!–!16! !
Physiotherapy&*& <!0.001&
Seen!within!72!hours!of!admission! 76! 79.16%! 7! 6!–!9! !
Seen!after!72!hours!of!admission! 20! 20.84%! 10.5! 8.5!–!15! !
Occupational&therapy&*& 0.059&
Seen!within!72!hours!of!admission! 62! 74.7%! 8! 6!–!9! !
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Discussion	  
	  
To	  our	  knowledge,	  this	  is	  the	  first	  study	  of	  the	  cost	  of	  acute	  stroke	  care	  in	  South	  
Africa.	  	  Inpatient	  treatment	  of	  acute	  stroke	  and	  its	  ensuing	  rehabilitation	  are	  
expensive.14	  	  Amongst	  all	  the	  predictors	  of	  inpatient	  cost,	  length	  of	  stay	  (LOS)	  has	  
the	  strongest	  association	  with	  the	  total	  cost	  of	  an	  admission,	  and	  is	  therefore	  used	  
as	  the	  key	  determinant	  of	  hospitalisation	  costs	  of	  patients	  with	  acute	  stroke.15-­‐17	  	  In	  
light	  of	  the	  health	  care	  resource	  constraints	  and	  growing	  demand	  for	  inpatient	  beds	  
that	  clinicians	  in	  developing	  countries	  are	  faced	  with,	  it	  is	  therefore	  very	  important	  
to	  identify	  the	  factors	  that	  prolong	  LOS	  and	  identify	  those	  that	  are	  modifiable	  in	  
order	  to	  make	  acute	  stroke	  care	  more	  cost-­‐efficient.15,18,19	  
	  
In	  our	  study,	  we	  investigated	  whether	  unmodifiable	  patient	  factors	  such	  
demography,	  stroke	  subtype	  and	  clinical	  presentation	  or	  modifiable	  factors	  such	  as	  
inpatient	  management,	  delays	  in	  special	  investigations,	  inpatient	  complications	  and	  
treatment	  thereof,	  and	  discharge	  destination	  played	  a	  role	  in	  determining	  the	  LOS	  
in	  patients	  with	  acute	  stroke.	  
	  
As	  was	  reported	  by	  previous	  studies	  by	  Chang	  et	  al,	  Jorgensen	  et	  al	  and	  Saxena	  et	  
al,15,17,20	  we	  found	  that	  age	  and	  gender	  did	  not	  have	  a	  significant	  influence	  on	  LOS	  
amongst	  patients	  admitted	  with	  stroke.	  	  Chow	  et	  al	  demonstrated	  that	  younger	  
patients	  were	  likely	  to	  have	  more	  expensive	  stroke	  care	  than	  their	  elder	  
counterparts,	  which	  could	  be	  explained	  by	  the	  more	  extensive	  set	  of	  investigations	  
that	  are	  usually	  done	  in	  the	  younger	  stroke	  population.21	  	  For	  this	  reason	  we	  
excluded	  patients	  younger	  than	  45	  years	  as	  we	  wanted	  to	  quantify	  the	  cost	  of	  the	  
average	  stroke	  patient	  admitted	  to	  general	  medical	  wards.	  	  	  
	  
In	  our	  study	  we	  found	  that	  patients	  presenting	  with	  a	  recurrent	  stroke	  had	  a	  
median	  LOS	  of	  7	  days	  as	  compared	  with	  a	  median	  LOS	  of	  5	  days	  in	  patients	  with	  first	  
time	  stroke	  (P	  =	  0.028),	  which	  is	  in	  accordance	  with	  a	  study	  by	  Huang	  et	  al	  that	  
showed	  that	  stroke	  reccurrence	  is	  associated	  with	  prolonged	  LOS.22	  	  This	  could	  be	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explained	  by	  the	  fact	  that	  patients	  with	  stroke	  recurrence	  have	  greater	  neurological	  
impairment	  than	  patients	  with	  a	  first	  time	  stroke.22	  	  Comparable	  to	  previous	  studies	  
by	  Chang	  et	  al	  and	  Saxena	  et	  al,15-­‐20	  comorbidities	  such	  as	  hypertension,	  diabetes,	  
dyslipidaemia	  and	  ischaemic	  heart	  disease	  did	  not	  influence	  LOS	  amongst	  patients	  
in	  our	  study.	  	  In	  this	  study	  patients	  with	  valvular	  heart	  disease	  and	  HIV	  had	  
statistically	  significant	  increases	  in	  LOS,	  but	  the	  sample	  sizes	  in	  these	  groups	  were	  
small	  and	  this	  finding	  should	  be	  interpreted	  with	  caution.	  	  In	  a	  study	  by	  Koton	  et	  al,	  
however,	  it	  was	  reported	  that	  valvular	  heart	  disease	  and	  heart	  failure	  were	  
associated	  with	  increased	  LOS.23	  	  	  
	  
Results	  from	  our	  study	  are	  in	  keeping	  with	  studies	  by	  Reed	  et	  al	  and	  Dodel	  et	  al	  
which	  showed	  that	  there	  is	  no	  statistically	  significant	  difference	  in	  LOS	  between	  
haemorrhagic	  and	  ischemic	  strokes.24,25	  	  Huang	  et	  al	  found	  patients	  with	  TACI	  to	  
have	  prolonged	  LOS.22	  	  In	  our	  study	  however,	  there	  was	  no	  statistically	  significant	  
difference	  in	  LOS	  between	  the	  infarct	  subtypes	  as	  classified	  by	  the	  TOAST	  criteria,12	  
which	  could	  be	  explained	  by	  the	  increased	  risk	  of	  death	  amongst	  the	  TACI	  group	  in	  
this	  study,	  as	  demonstrated	  in	  table	  4.	  
	  
Acute	  stroke	  patients	  are	  at	  risk	  of	  developing	  medical	  complications	  during	  their	  
hospital	  stay.27	  	  In	  line	  with	  the	  publication	  by	  Davenport	  et	  al,28	  two	  thirds	  of	  the	  
patients	  in	  our	  study	  had	  at	  least	  one	  medical	  complication	  during	  their	  admission.	  	  
Inpatient	  medical	  complications	  are	  not	  only	  considered	  to	  be	  a	  negative	  indicator	  
of	  quality	  of	  stroke	  care,	  as	  these	  complications	  are	  largely	  preventable,29,30	  but	  
complications	  were	  reported	  to	  increase	  the	  LOS	  and	  cost	  of	  care	  in	  studies	  by	  Lim	  
et	  al	  and	  Lee	  et	  al.18,19	  	  In	  this	  study,	  as	  in	  that	  by	  Kim	  et	  al,14	  LOS	  increased	  as	  the	  
number	  of	  complications	  increased	  (P	  =	  0.059).	  
	  
Death	  was	  associated	  with	  shorter	  length	  of	  stay	  in	  this	  study.	  	  Patients	  with	  TACI,	  
depressed	  level	  of	  consciousness	  at	  presentation,	  fever,	  pneumonia	  and	  multiple	  
complications	  had	  significantly	  increased	  mortality	  in	  this	  study	  (table	  4).	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This	  study	  showed	  that	  patients	  who	  were	  seen	  by	  allied	  health	  professionals	  within	  
72	  hours	  of	  admission	  had	  a	  significantly	  shorter	  LOS,	  which	  could	  be	  due	  to	  the	  
prevention	  of	  deconditioning	  as	  reported	  by	  Lim	  et	  al	  and	  by	  early	  mobilization	  
which	  reduced	  the	  risk	  of	  complications	  in	  a	  study	  by	  Ingeman	  et	  al.18,31	  	  
Complications	  contribute	  to	  deconditioning,	  which	  delays	  rehabilitation	  and	  hinders	  
successful	  functional	  recovery.18,27,28,30,32	  
	  
Lee	  et	  al	  suggested	  that	  is	  more	  cost	  efficient	  to	  transfer	  acute	  stroke	  patients	  to	  
rehabilitation	  centres	  as	  soon	  as	  possible,	  since	  the	  cost	  of	  a	  hospital	  admission	  
exceeds	  that	  of	  rehabilitation	  centres.19,33	  	  In	  this	  study	  patients	  transferred	  to	  
rehabilitation	  centres	  had	  significantly	  longer	  LOS	  than	  those	  discharged	  home.	  	  
Results	  from	  our	  study	  (table	  5)	  are	  in	  line	  with	  those	  of	  Bryer	  et	  al,	  De	  Villiers	  et	  al	  
and	  Langhorne	  et	  al	  who	  suggested	  that	  early	  assessment	  by	  a	  multidisciplinary	  
team,	  comprising	  of	  social	  workers,	  physiotherapists,	  occupational	  and	  speech	  
therapists,	  results	  in	  shorter	  LOS	  by	  facilitating	  the	  early	  application	  and	  efficient	  




We	  encountered	  limitations	  in	  conducting	  our	  study.	  	  Although	  from	  previous	  
studies	  we	  know	  that	  stroke	  severity	  is	  associated	  with	  prolonged	  LOS,15,36	  we	  could	  
not	  include	  stroke	  severity	  in	  the	  analysis	  of	  our	  data.	  	  As	  this	  study	  is	  a	  
retrospective	  folder	  review,	  we	  relied	  on	  the	  clinical	  notes	  of	  the	  enrolled	  patients	  
for	  data	  used	  in	  our	  study	  and	  the	  NHISS	  stroke	  scoring	  system	  was	  not	  consistently	  
recorded	  in	  the	  patients’	  notes.	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Conclusion	  
This	  is	  the	  first	  study	  evaluating	  the	  cost	  of	  acute	  stroke	  admissions	  in	  general	  
medical	  wards	  in	  South	  Africa.	  	  As	  expected,	  length	  of	  stay	  was	  the	  greatest	  
determinant	  of	  cost.	  	  This	  study	  has	  shown	  that	  length	  of	  stay	  was	  predominantly	  
influenced	  by	  modifiable	  factors,	  such	  as	  the	  occurrence	  of	  inpatient	  complications,	  
delay	  in	  special	  investigations,	  delayed	  assessment	  and	  management	  by	  allied	  
health	  professionals	  and	  discharge	  to	  rehabilitation	  centres.	  	  Improving	  the	  quality	  
of	  care	  to	  reduce	  the	  number	  of	  inpatient	  complications,	  reducing	  the	  waiting	  time	  
for	  special	  investigations,	  early	  referral	  to	  allied	  health	  professionals	  and	  effective	  
discharge	  planning	  in	  which	  transfer	  to	  rehabilitation	  centres	  is	  expedited	  would	  
result	  in	  shorter	  length	  of	  hospital	  stay	  and	  therefore	  cost	  saving.	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Abstract	  
Abstract	  word	  count:	  	  250	  words	  
Background	  and	  purpose	  
Organised	  stroke	  units	  with	  multi-­‐disciplinary	  care	  have	  superior	  outcomes	  than	  
conventional	  medical	  wards,	  but	  are	  not	  yet	  fully	  integrated	  in	  South	  Africa.	  	  The	  
aim	  of	  this	  study	  was	  to	  assess	  the	  quality	  of	  acute	  stroke	  care	  in	  general	  medical	  
wards	  and	  to	  identify	  areas	  where	  quality	  of	  care	  could	  be	  improved.	  
Methods	  
We	  conducted	  a	  retrospective	  folder	  review	  all	  patients	  admitted	  with	  acute	  stroke	  
to	  the	  general	  medical	  wards	  at	  Groote	  Schuur	  Hospital	  from	  1	  January	  to	  31	  
December	  2012.	  	  The	  positive	  indicators	  of	  quality	  of	  care	  included	  the	  
investigations	  and	  management	  as	  recommended	  by	  the	  South	  African	  Stroke	  
Guidelines.	  	  The	  negative	  indicators	  of	  quality	  of	  care	  were	  inpatient	  complications.	  
Results	  
Although	  neuroradiology	  was	  performed	  on	  95%	  of	  patients,	  carotid	  duplex	  Doppler	  
ultrasonography	  and	  echocardiography	  were	  not	  often	  done.	  	  Although	  all	  patients	  
with	  ischaemic	  stroke	  received	  inpatient	  antiplatelet	  or	  anti-­‐coagulation	  therapy,	  
not	  all	  risk	  factors	  were	  adequately	  addressed	  on	  discharge.	  	  Mortality	  was	  20%	  and	  
68%	  of	  patients	  experienced	  at	  least	  one	  medical	  complication.	  	  Fever	  and	  
pneumonia	  were	  predictors	  of	  death.	  	  Early	  mobilisation	  proved	  to	  be	  beneficial	  in	  
pneumonia	  reduction	  (P	  =	  0.002)	  and	  early	  nutritional	  support	  was	  beneficial	  in	  
reducing	  the	  incidence	  of	  acute	  kidney	  injury	  (P	  <	  0.001).	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Conclusions	  
There	  is	  a	  need	  for	  increased	  access	  to	  stroke	  unit	  beds,	  albeit	  dedicated	  stroke	  
beds	  in	  general	  medical	  wards,	  to	  ensure	  specialised	  nursing	  care	  and	  early	  
inpatient	  rehabilitation	  to	  reduce	  the	  number	  of	  inpatient	  complications	  and	  to	  
implement	  protocols	  to	  allow	  for	  better	  adherence	  to	  national	  guidelines.	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Introduction	  
	  
Stroke	  is	  the	  leading	  cause	  of	  disability	  around	  the	  world,	  and	  remains	  the	  second	  
most	  important	  reason	  for	  death	  internationally.1-­‐5	  	  South	  Africa	  is	  no	  exception,	  
with	  stroke	  being	  the	  most	  common	  reason	  for	  death	  amongst	  South	  Africans	  older	  
than	  60	  years.6	  	  It	  is	  estimated	  that	  50	  000	  of	  the	  75	  000	  annual	  strokes	  in	  South	  
Africa	  are	  not	  fatal.7	  	  Stroke	  survivors	  are	  at	  risk	  of	  long-­‐term	  disability	  and	  place	  a	  
considerable	  burden	  on	  health	  care	  services	  and	  health	  care	  budgets.7	  
	  
Even	  though	  major	  advances	  have	  been	  made	  in	  thrombolytic	  therapy	  of	  acute	  
ischaemic	  stroke,8	  much	  of	  acute	  stroke	  care	  still	  depends	  on	  rehabilitation	  and	  the	  
prevention	  of	  complications	  and	  stroke	  recurrence	  after	  the	  acute	  cerebrovascular	  
event.9	  	  High	  quality	  acute	  stroke	  care	  has	  been	  convincingly	  shown	  to	  be	  
associated	  with	  decreased	  mortality	  and	  morbidity,	  as	  well	  as	  with	  shorter	  length	  of	  
hospital	  stay.10-­‐12	  
	  
Organised	  stroke	  units	  with	  multi-­‐disciplinary	  care	  have	  superior	  outcomes	  than	  
conventional	  wards,13,14	  but	  there	  are	  few	  such	  units	  in	  South	  Africa.15,16	  	  Patients	  
managed	  in	  general	  medical	  wards	  are	  frequently	  not	  managed	  according	  to	  
National	  recommendations	  due	  to	  lack	  of	  protocols,	  bed	  pressure	  and	  staff	  
shortages.16	  	  Since	  little	  is	  known	  about	  the	  quality	  of	  stroke	  care	  in	  developing	  
countries,	  a	  better	  understanding	  of	  current	  practices	  would	  be	  of	  value	  in	  
facilitating	  interventions	  to	  improve	  the	  quality	  of	  stroke	  care.17	  
	  
We	  therefore	  conducted	  this	  study	  to	  review	  current	  practices	  in	  the	  general	  
medical	  wards	  at	  Groote	  Schuur	  Hospital	  and	  to	  identify	  areas	  where	  quality	  of	  care	  
could	  be	  improved.	  	  Groote	  Schuur	  Hospital	  is	  an	  893	  bed	  tertiary	  academic	  hospital	  
associated	  with	  the	  University	  of	  Cape	  Town,	  which	  has	  121	  secondary	  level	  general	  
medical	  ward	  beds	  and	  a	  6	  bed	  specialised	  stroke	  unit.	  	  When	  the	  hospital’s	  stroke	  
unit	  has	  reached	  capacity,	  patients	  with	  acute	  stroke	  are	  managed	  in	  the	  general	  
medical	  wards.	  





The	  Human	  Research	  Ethics	  Committee	  of	  the	  Faculty	  of	  Health	  Sciences	  at	  the	  
University	  of	  Cape	  Town	  approved	  this	  retrospective	  folder	  review.	  	  Data	  was	  
collected	  using	  a	  standardised	  template	  and	  remains	  anonymous.	  
	  
Study	  population	  and	  dates	  of	  enrolment	  
	  
All	  patients	  with	  a	  diagnosis	  of	  acute	  ischaemic	  or	  haemorrhagic	  stroke	  who	  were	  
admitted	  to	  the	  general	  medical	  wards	  at	  Groote	  Schuur	  Hospital	  from	  1	  January	  
2012	  to	  31	  December	  2012	  were	  considered	  for	  this	  study.	  
	  
	   Patients	  excluded	  from	  study	  
	  
Patients	  were	  excluded	  if	  they	  were	  under	  the	  age	  of	  45	  on	  the	  day	  of	  admission,	  
received	  thrombolytic	  therapy	  for	  acute	  stroke,	  were	  admitted	  to	  the	  specialised	  
stroke	  unit	  or	  had	  a	  discharge	  diagnosis	  other	  than	  acute	  stroke.	  
	  
	   Demography	  and	  clinical	  background	  of	  patients	  entered	  into	  study	  
	  
The	  patient’s	  age	  and	  gender	  were	  recorded,	  as	  were	  comorbidities,	  which	  included	  
previous	  stroke	  (from	  history	  of	  clinical	  notes),	  transient	  ischaemic	  attacks	  (TIAs)	  
prior	  to	  the	  index	  admission	  (from	  history),	  smoking	  (based	  on	  current	  or	  previous	  
history),	  hypertension	  (based	  on	  history	  or	  regular	  use	  of	  anti-­‐hypertensives),	  
diabetes	  mellitus	  (based	  on	  history,	  regular	  use	  of	  diabetic	  agents,	  hyperglycaemia	  
during	  admission),	  hyperlipidaemia	  (based	  on	  history,	  regular	  statin	  use,	  total	  
cholesterol	  >	  5	  mmol/dL	  on	  admission),	  atrial	  fibrillation	  (ECG),	  ischaemic	  heart	  
disease	  (based	  on	  history	  of	  angina	  or	  prior	  myocardial	  infarction),	  valvular	  heart	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disease	  (based	  on	  clinical	  notes	  or	  echocardiography),	  HIV	  (history,	  serology	  or	  





A	  stroke	  specialist	  reviewed	  all	  brain	  computer	  tomography	  (CT)	  and	  magnetic	  
resonance	  imaging	  (MRI)	  of	  included	  patients	  and	  classified	  patients	  as	  
haemorrhagic	  strokes	  or	  infarcts.	  	  Patients	  with	  infarcts	  were	  further	  classified	  
according	  to	  the	  Oxfordshire	  Community	  Stroke	  Project	  (OCSP)	  clinical	  classification	  
into	  total	  anterior	  circulation	  infarcts	  (TACI),	  partial	  anterior	  circulation	  infarcts	  




The	  following	  clinical	  parameters	  were	  recorded:	  decreased	  level	  of	  consciousness,	  
aphasia	  (further	  classified	  as	  receptive	  aphasia	  or	  expressive	  aphasia),	  dysphagia	  
and	  hemiparesis	  affecting	  the	  arm	  or	  leg	  and	  its	  laterality.	  	  
	  
Positive	  indicators	  of	  quality	  of	  care	  
	  
We	  identified	  positive	  indicators	  of	  quality	  of	  stroke	  care	  and	  grouped	  them	  under	  
investigations	  and	  management.	  
	  
The	  essential	  investigations	  of	  all	  stroke	  patients	  that	  were	  identified	  were	  CT	  or	  
MRI	  brain	  within	  24	  hours	  of	  admission,	  glucose	  on	  admission,	  full	  blood	  count,	  
renal	  function,	  CRP,	  ECG	  and	  chest	  X-­‐ray.19	  	  	  Additional	  investigations	  in	  selected	  
patients	  that	  were	  identified	  included	  a	  lipid	  profile,	  HIV	  testing,	  syphilis	  serology,	  
lumbar	  puncture,	  CT	  angiogram	  of	  intracranial	  vessels,	  Duplex	  Doppler	  
ultrasonography	  of	  carotid	  arteries	  and	  echocardiogram.19	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With	  regards	  to	  acute	  stroke	  management,	  it	  was	  recorded	  whether	  patients	  with	  
ischaemic	  stroke	  received	  aspirin	  or	  anticoagulation	  during	  their	  hospital	  stay.19	  	  It	  
was	  also	  recorded	  whether	  patients	  with	  infarcts	  were	  discharged	  on	  antiplatelet	  
therapy	  or	  warfarin	  if	  in	  atrial	  fibrillation.	  	  The	  management	  of	  risk	  factors	  at	  
discharge	  that	  were	  evaluated	  included	  blood	  pressure	  control,	  glucose	  control	  and	  
prescription	  of	  statin	  therapy.	  	  	  
	  
It	  was	  recorded	  whether	  patients	  underwent	  formal	  dysphagia	  screening	  within	  or	  
after	  72	  hours	  by	  speech	  therapy,	  and	  whether	  patients	  received	  nutritional	  
support	  from	  a	  dietician	  within	  or	  after	  72	  hours.	  	  It	  was	  furthermore	  recorded	  
whether	  patients	  received	  nasogastric	  feeding	  and	  intravenous	  fluids.	  	  Nursing	  
notes	  were	  reviewed	  to	  record	  whether	  patients	  received	  pressure	  care.	  	  
Prescription	  charts	  were	  evaluated	  to	  identify	  sub-­‐cutaneous	  heparin	  as	  part	  of	  
deep	  venous	  thrombosis	  (DVT)	  prophylaxis,	  regular	  oral	  diabetic	  treatment	  or	  sub-­‐
cutaneous	  insulin	  sliding	  scales	  in	  patients	  with	  diabetes,	  antibiotics	  with	  its	  route	  
of	  administration	  and	  paracetamol	  in	  the	  presence	  of	  fever.	  
	  
With	  regards	  to	  inpatient	  rehabilitation,	  the	  time	  interval	  between	  admission	  and	  
assessment	  by	  a	  physiotherapist	  and	  occupational	  therapist	  was	  recorded.	  	  Patients	  
were	  categorised	  according	  to	  whether	  they	  were	  first	  seen	  within	  72	  hours	  of	  
admission,	  thereafter	  or	  not	  seen.	  
	  
Negative	  indicators	  of	  quality	  of	  care	  
	  
The	  following	  inpatient	  complications	  were	  recorded:	  death,	  fever	  (temperature	  >	  
37.5°C),	  pneumonia	  (radiological	  confirmation	  or	  documented	  clinical	  findings),	  
urinary	  tract	  infection	  (UTI)	  (based	  on	  urinalysis),	  hyperglycaemia	  (blood	  glucose	  >	  
7mmol/L),	  bedsores	  (documented	  in	  notes),	  deep	  vein	  thrombosis	  (DVT)	  
(ultrasonographic	  confirmation),	  pulmonary	  embolism	  (PE)	  (confirmed	  by	  CT	  of	  the	  
pulmonary	  arteries	  or	  V/Q	  scanning),	  dehydration	  (recorded	  in	  notes),	  acute	  kidney	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injury	  (50%	  in	  rise	  of	  creatinine	  or	  26.1	  μmol/L	  rise	  in	  creatinine),20	  seizures,	  drip	  
site	  sepsis	  and	  gastro-­‐intestinal	  bleeds	  (recorded	  in	  notes).	  
Discharge	  destination	  
All	  stroke	  survivors	  in	  this	  study	  were	  classified	  whether	  they	  went	  home	  or	  to	  
inpatient	  rehabilitation	  centres	  directly	  after	  the	  acute	  hospital	  admission.	  
Statistical	  analysis	  
Coded	  data	  was	  entered	  into	  an	  Excel	  computerised	  database.	  	  Statistical	  analysis	  
was	  performed	  by	  using	  the	  software	  SPSS,	  version	  22.	  	  Multivariate	  logistic	  
regression	  was	  performed	  to	  assess	  which	  variables	  were	  associated	  with	  death,	  a	  
categorical	  variable.	  	  The	  strengths	  of	  association	  of	  the	  predictors	  were	  expressed	  
as	  the	  odds	  ratio	  (OR)	  and	  their	  95%	  CI.	  	  Chi-­‐square	  tests	  were	  used	  to	  analyse	  
categorical	  values,	  to	  compare	  the	  incidence	  of	  complications	  among	  patients	  seen	  
within	  72	  hours,	  after	  72	  hours	  or	  not	  seen	  by	  allied	  health	  professionals.	  	  P	  values	  
of	  less	  than	  0.05	  were	  considered	  statistically	  significant	  in	  the	  analysis.	  
Results	  
Review	  of	  emergency	  unit	  registers	  for	  patient	  referred	  for	  medical	  admission	  
identified	  344	  with	  an	  initial	  diagnosis	  of	  stroke	  of	  which	  261	  patients	  were	  included	  
in	  this	  study.	  	  Amongst	  the	  83	  patients	  excluded,	  43	  had	  intracranial	  pathology	  
other	  than	  acute	  stroke,	  9	  were	  readmitted	  with	  complications	  of	  previous	  strokes,	  
9	  were	  transferred	  to	  the	  stroke	  unit,	  3	  were	  younger	  than	  45	  years	  of	  age	  and	  16	  
patients	  had	  incomplete	  patient	  records.	  
The	  demographic	  details,	  type	  of	  stroke,	  clinical	  presentation	  and	  comorbidities	  of	  
patients	  in	  our	  study	  are	  summarised	  in	  table	  1.	  	  	  
66	  
The	  positive	  indicators	  of	  quality	  of	  care	  of	  patients	  in	  our	  study	  are	  summarised	  in	  
tables	  2	  and	  3.	  	  Table	  2	  indicates	  the	  number	  and	  percentage	  of	  patients	  in	  this	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work-­‐up,	  as	  recommended	  by	  the	  South	  African	  Stroke	  guidelines,	  whereas	  table	  3	  




Although	  90%	  of	  patients	  had	  their	  blood	  glucose	  measured	  on	  presentation	  (table	  
2),	  only	  half	  of	  stroke	  survivors	  in	  this	  study	  had	  their	  blood	  glucose	  measured	  on	  
the	  day	  of	  discharge.	  	  Amongst	  the	  group	  that	  had	  their	  glucose	  measured	  on	  
discharge,	  92.23%	  were	  diabetic.	  	  Amongst	  all	  patients	  discharged	  and	  glucose	  
measured,	  73.78%	  of	  patients	  had	  a	  serum	  glucose	  of	  less	  than	  10mmol/L.	  	  With	  
regards	  to	  diabetic	  treatment	  66	  (66.67%)	  patients	  received	  concomittant	  
subcutaneous	  insulin	  and	  oral	  diabetic	  treatment	  (table	  3).	  
	  
Amongst	  the	  stroke	  survivors	  in	  this	  study,	  49.3%	  of	  patients	  were	  discharged	  home	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The	  negative	  indicators	  of	  quality	  of	  care	  were	  inpatient	  complications	  and	  death,	  
which	  are	  summarised	  in	  table	  4.	  	  In	  this	  study,	  168	  (64%)	  patients	  developed	  at	  























Dietician! consulted!within!72!hours!of!admission! 94! 36.02%!




Physiotherapy!! within!72!hours!of!admission! 150! 57.47%!
! after!72!hours!of!admission! 40! 15.33%!
Occupational!therapy!& within!72!hours!of!admission! 134! 51.34%!
! after!72!hours!of!admission! 39! 14.94%!
Management&of&complications&
Paracetamol!given!in!the!presence!of!fever!||& 26!/!108!||! 24.07%!
Antibiotics!administered! orally! 25! 9.58%!
! intravenously! 38! 14.56%!
! intravenously!and!orally! 20! 7.66%!
Management&of&risk&factors&at&discharge&(excluding&54&patients&that&died)!
Blood!pressure!control!(SBP!<!140mmHg)! 141! 68.11%!
Glucose!control!#! serum!glucose!4!–!6.9mmol/L! 40!/!103!#! 38.83%!
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Amongst	  the	  63	  patients	  with	  a	  depressed	  level	  of	  consciousness,	  42	  (66.67%)	  
developed	  fever,	  20	  (31.74%)	  developed	  pneumonia,	  14	  (22.22%)	  developed	  
urinary	  tract	  infection,	  8	  (12.69%)	  developed	  acute	  kidney	  injury	  and	  30	  (47.61%)	  
patients	  died.	  	  Of	  the	  125	  patients	  who	  had	  dysphagia,	  77	  (61%)	  developed	  fever,	  
39	  (31.2%)	  developed	  pneumonia,	  17	  (13.6%)	  developed	  acute	  kidney	  injury	  and	  43	  
(34.4%)	  died.	  
	  
Table	  5	  illustrates	  the	  factors	  and	  their	  odds	  ratios	  that	  predicted	  death	  for	  patients	  






















Predictor&of&death& Odds&ratio& 95%&Confidence&interval! P&value&
Lower&bound! Upper&bound!
TACI!18! 4.803! 2.403! 9.629! <!0.001!
Decreased!level!of!consciousness! 6.916! 3.607! 13.517! <!0.001!
Fever! 3.240! 1.745! 6.174! <!0.001!
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The	  odds	  ratio	  for	  patients	  that	  received	  physiotherapy	  was	  0.324	  for	  developing	  
pneumonia,	  with	  a	  95%	  confidence	  interval	  of	  0.171	  to	  0.614	  (P	  <	  0.001),	  and	  0.209	  
for	  death	  with	  a	  95%	  confidence	  interval	  of	  0.111	  to	  0.396	  (P	  <	  0.001).	  	  Table	  6	  
demonstrates	  that	  pneumonia	  was	  less	  frequent	  in	  patients	  who	  received	  
physiotherapy	  and	  significantly	  reduced	  in	  the	  cohort	  that	  received	  physiotherapy	  
within	  72	  hours	  of	  admission	  (P	  =	  0.002).	  	  Speech	  therapy	  was	  not	  statistically	  




Amongst	  the	  25	  patients	  that	  developed	  acute	  kidney	  injury,	  17	  (68%)	  had	  
dysphagia	  and	  received	  nasogastric	  tube	  feeding.	  	  As	  demonstrated	  in	  table	  7,	  acute	  
kidney	  injury	  was	  significantly	  reduced	  in	  patients	  who	  received	  early	  nutritional	  
support,	  instituted	  by	  a	  dietician,	  as	  compared	  to	  those	  assessed	  by	  a	  dietician	  only	  














Pneumonia& Number! 20! 7! 24! 51!
%!within!cohort! 13.3%& 17.5%& 33.8%& 19.5%&
No&pneumonia& Number! 130! 33! 47! 210!
%!within!cohort! 86.7%& 82.5%& 66.2%& 80.5%&
Total! Number! 150! 40! 71! 261!














AKI& Number! 14! 5! 6! 25!
%!within!cohort! 14.9%& 27.8%& 4.0%& 9.6%&
No&AKI& Number! 80 13 143 236 
%!within!cohort! 85.1% 72.2% 96.0% 90.4% 
Total! Number! 94! 18! 149! 261!
%!within!cohort! 100.0%! 100.0%! 100.0%! 100.0%!
!
χ2!=!15.252;!!df!2;!!P!<!0.001!
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Discussion	  
	  
Stroke	  is	  a	  leading	  cause	  of	  mortality	  and	  morbidity	  in	  South	  Africa.6,7,16	  	  Although	  
class	  1	  level	  A	  evidence	  suggests	  that	  all	  stroke	  patients	  should	  be	  treated	  in	  
organised	  stroke	  units,19	  the	  majority	  of	  South	  African	  patients	  with	  stroke	  are	  
treated	  in	  general	  medical	  wards	  due	  to	  constraints	  in	  public	  health	  care	  
resources.16	  	  General	  medical	  wards	  often	  do	  not	  fulfil	  the	  criteria	  of	  high	  quality	  
stroke	  care	  due	  to	  the	  lack	  of	  implementation	  of	  protocols	  or	  adherence	  to	  national	  
stroke	  care	  guidelines.16	  
	  
The	  positive	  indicators	  of	  quality	  of	  care	  that	  were	  examined	  in	  this	  study	  included	  
the	  work-­‐up	  and	  management	  of	  acute	  stroke,	  as	  recommended	  by	  the	  South	  
African	  Stroke	  Guidelines.19	  	  Inpatient	  complications,	  which	  contribute	  to	  worse	  
outcome,	  are	  largely	  preventable	  and	  can	  be	  reduced	  by	  implementing	  higher	  
quality	  care.15,21-­‐23	  	  The	  incidence	  of	  complications	  can	  thus	  be	  used	  as	  negative	  
indicators	  of	  the	  quality	  of	  care.21,22	  
	  
Neuroimaging	  enables	  clinicians	  to	  differentiate	  between	  haemorrhagic	  and	  
ischaemic	  stroke	  as	  well	  as	  to	  exclude	  non	  vascular	  intra-­‐cranial	  pathology.19	  	  
Although	  87%	  of	  patients	  in	  this	  study	  had	  neuroimaging	  within	  24	  hours	  of	  
admission	  and	  7%	  thereafter,	  which	  is	  an	  indicator	  of	  good	  care,	  very	  few	  patients	  
had	  investigations	  such	  as	  echocardiography	  and	  carotid	  artery	  duplex	  Doppler,	  as	  
indicated	  in	  table	  2,	  and	  consequently	  were	  not	  adequately	  investigated	  for	  stroke	  
aetiology.	  	  Improving	  access	  to	  special	  investigations	  would	  thus	  be	  beneficial.	  	  
	  
All	  patients	  with	  cerebral	  infarcts	  that	  were	  not	  anti-­‐coagulated	  with	  warfarin,	  
received	  aspirin.	  	  However,	  only	  8.82%	  of	  patients	  with	  atrial	  fibrillation	  in	  this	  
study	  were	  anti-­‐coagulated	  as	  recommended.19	  	  Two	  international	  trials	  have	  
shown	  that	  that	  aspirin	  started	  within	  48	  hours	  of	  the	  acute	  ischaemic	  stroke	  has	  
beneficial	  effects.24-­‐25	  	  However,	  the	  IST	  trial	  failed	  to	  show	  similar	  benefits	  with	  
anti-­‐coagulation,	  but	  showed	  an	  increased	  risk	  of	  haemorrhage	  instead.19,26	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The	  South	  African	  Stroke	  Society	  recommends	  antipyretic	  treatment	  if	  the	  
temperature	  is	  greater	  than	  37.5°C,	  as	  experimental	  studies	  have	  shown	  that	  fever	  
increases	  infarct	  size.19	  	  Fever	  is	  a	  marker	  of	  infections	  and	  is	  as	  an	  independent	  
predictor	  of	  incomplete	  functional	  recovery	  and	  mortality	  after	  stroke.27	  	  In	  our	  
study	  fever	  was	  significantly	  associated	  with	  death,	  as	  demonstrated	  in	  table	  5.	  	  
Amongst	  the	  patients	  in	  our	  study	  that	  had	  fever,	  37%	  developed	  pneumonia	  and	  
41%	  had	  urinary	  tract	  infections.	  	  From	  this	  study	  it	  is	  apparent	  that	  antipyretic	  
treatment	  was	  often	  neglected,	  as	  demonstrated	  in	  table	  3,	  indicating	  a	  lack	  of	  
awareness	  amongst	  clinicians.	  
In	  our	  study,	  31.2%	  of	  patients	  with	  dysphagia	  developed	  pneumonia,	  which	  is	  in	  
line	  with	  previous	  studies	  showing	  that	  a	  third	  of	  patients	  with	  dysphagia	  will	  
develop	  pneumonia.28,29	  	  Additionally,	  our	  study	  found	  that	  pneumonia	  was	  
significantly	  associated	  with	  death,	  as	  presented	  in	  table	  5.	  	  Studies	  have	  shown	  
that	  pneumonia,	  accounting	  for	  a	  third	  of	  post	  stroke	  mortality,	  is	  the	  most	  
common	  non-­‐neurological	  cause	  of	  death	  following	  a	  stroke.29-­‐31	  	  In	  ensuring	  high	  
quality	  stroke	  care,	  all	  efforts	  should	  be	  made	  to	  prevent	  pneumonia.	  	  In	  our	  study	  
pneumonia	  occurred	  less	  frequently	  amongst	  patients	  who	  received	  physiotherapy,	  
with	  a	  further	  reduction	  if	  initiated	  within	  72	  hours	  of	  admission	  indicating	  that	  care	  
would	  be	  improved	  if	  all	  patients	  requiring	  physiotherapy	  received	  it	  as	  soon	  after	  
admission	  as	  possible.	  
Formal	  dysphagia	  screening	  performed	  by	  speech	  therapists	  has	  been	  shown	  to	  
significantly	  reduce	  the	  risk	  of	  pneumonia.28	  	  We	  were	  not	  able	  to	  determine	  
whether	  those	  patients	  who	  did	  have	  dysphagia	  screening	  were	  fed	  orally	  prior	  to	  
the	  assessment,	  which	  may	  have	  increased	  their	  risk	  of	  pneumonia	  and	  thus	  
accounting	  for	  our	  failure	  to	  demonstrate	  a	  benefit	  in	  reducing	  the	  incidence	  of	  
pneumonia.	  	  Although	  there	  is	  currently	  no	  evidence	  to	  suggest	  when	  a	  formal	  
dysphagia	  screen	  should	  be	  performed,	  care	  would	  be	  improved	  if	  formal	  dysphagia	  
assessment	  by	  a	  speech	  therapist	  was	  done	  before	  oral	  feeding.19	  	  In	  order	  to	  
maintain	  nutrition	  this	  should	  be	  done	  as	  soon	  as	  possible.19	  	  In	  this	  study	  there	  was	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a	  significant	  reduction	  in	  acute	  kidney	  injury	  in	  patients	  with	  dysphagia	  who	  
received	  nutritional	  support	  within	  72	  hours	  of	  admission,	  but	  only	  83%	  of	  patients	  
with	  dysphagia	  were	  seen	  by	  a	  dietician	  within	  that	  timeframe.	  	  
Urinary	  tract	  infections	  (UTI)	  are	  common	  in	  patients	  with	  acute	  stroke,	  particularly	  
severe	  stroke	  and	  are	  associated	  with	  poor	  functional	  recovery.27	  	  UTI	  was	  a	  
common	  complication	  in	  our	  study	  (table	  4)	  but	  was	  not	  a	  significant	  predictor	  of	  
death	  (table	  5).	  	  The	  incidence	  of	  both	  UTI	  and	  pneumonia	  was	  higher	  in	  this	  study	  
than	  in	  others,23	  indicating	  that	  stroke	  care	  could	  be	  improved.	  	  	  
Pressure	  care	  was	  implemented	  in	  two	  thirds	  of	  patients	  in	  this	  study	  (table	  3)	  and	  
bedsores	  were	  uncommon	  (table	  4).	  	  Venous	  thromboembolism	  is	  an	  uncommon	  
complication	  following	  acute	  stroke,	  but	  remains	  an	  important	  contributor	  to	  
mortality.23	  	  Deep	  vein	  thrombosis	  (DVT)	  has	  been	  reported	  to	  occur	  in	  up	  to	  75%	  of	  
patients	  not	  given	  thrombo-­‐prophylaxis.30	  	  Early	  mobilisation	  has	  been	  shown	  to	  
reduce	  the	  risk	  of	  DVT	  in	  patients	  with	  acute	  stroke	  fivefold.30	  	  It	  is	  thus	  surprising	  
that	  only	  two	  DVTs	  were	  diagnosed	  in	  our	  study	  despite	  only	  56%	  of	  patients	  with	  
infarcts	  receiving	  thrombo-­‐prophylaxis.	  	  Awareness	  of	  thrombo-­‐prophylaxis	  
recommendations	  and	  surveillance	  for	  DVTs	  should	  be	  increased.	  
Previous	  studies	  have	  shown	  that	  hyperglycaemia	  is	  associated	  with	  poor	  outcome	  
after	  stroke.9	  	  However,	  evidence	  to	  support	  tight	  glycaemic	  control	  with	  insulin	  
infusions	  after	  stroke	  remains	  limited.20	  	  The	  current	  recommendations	  by	  the	  
South	  African	  Stroke	  Society	  suggest	  treating	  hyperglycaemia	  with	  insulin	  if	  the	  
blood	  glucose	  is	  more	  than	  10	  mmol/L.20	  	  In	  this	  study	  hyperglycaemia	  occurred	  in	  
60%	  of	  diabetics	  indicating	  a	  need	  for	  more	  aggressive	  glycaemic	  control.	  	  	  
Sustained	  systolic	  blood	  pressures	  over	  140	  mmHg	  at	  the	  time	  of	  discharge	  were	  
observed	  in	  37%	  of	  hypertensive	  patients	  indicating	  sub	  optimal	  control.	  	  Better	  
adherence	  to	  secondary	  prevention	  recommendations	  would	  reduce	  the	  risk	  of	  
stroke	  recurrence.19
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This	  study	  highlights	  the	  high	  mortality	  and	  morbidity	  rate	  of	  patients	  with	  acute	  
stroke	  managed	  in	  general	  wards.	  	  The	  stroke	  unit	  model	  of	  care	  has	  been	  shown	  to	  
reduce	  complications	  and	  result	  in	  better	  functional	  outcomes	  following	  stroke.13-­‐15	  	  
Improved	  outcomes	  in	  stroke	  units	  are	  achieved	  by	  improved	  diagnostic	  accuracy,	  
appropriate	  monitoring	  and	  the	  prevention	  of	  complications	  resulting	  from	  efficient	  
management	  by	  a	  multidisciplinary	  team,	  specialised	  nursing	  care,	  early	  
rehabilitation	  and	  better	  discharge	  planning.9,15,32-­‐34	  	  Organised	  stroke	  care	  has	  
successfully	  been	  implemented	  and	  shown	  to	  improve	  outcomes	  in	  low	  resource	  





We	  encountered	  several	  limitations	  in	  this	  study.	  	  Due	  to	  the	  retrospective	  nature	  
of	  this	  study	  we	  relied	  on	  the	  quality	  of	  the	  clinicians’	  and	  nursing	  staff	  record	  
keeping	  for	  data	  collection.	  	  Furthermore,	  a	  clinical	  scoring	  system	  such	  as	  the	  
Rankin	  score	  was	  not	  consistently	  recorded	  in	  the	  notes	  and	  functional	  outcomes	  




This	  study	  indicates	  the	  need	  for	  organised	  stroke	  care	  with	  protocols	  for	  
management	  within	  the	  general	  medical	  wards.	  	  This	  would	  also	  facilitate	  more	  
timeous	  initiation	  of	  rehabilitation	  by	  the	  physiotherapist	  and	  occupational	  
therapist,	  as	  well	  as	  expedite	  early	  formal	  dysphagia	  screening	  by	  speech	  therapy	  
and	  nutritional	  support	  of	  patients	  with	  the	  help	  of	  dietetics.	  	  Early	  rehabilitation	  
prevents	  deconditioning	  after	  stroke	  and	  reduces	  the	  risk	  of	  developing	  inpatient	  
complications.35,36	  	  Our	  study	  clearly	  shows	  the	  benefit	  of	  early	  mobilisation	  by	  the	  
help	  of	  physiotherapy	  in	  reducing	  the	  incidence	  of	  pneumonia	  and	  early	  nutritional	  
support	  to	  reduce	  the	  incidence	  of	  acute	  kidney	  injury.	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AKI	  for	  acute	  kidney	  injury,	  CT	  for	  computerized	  tomography,	  DVT	  for	  deep	  vein	  
thrombosis,	  IQR	  for	  interquartile	  range,	  LACI	  for	  lacunar	  infarct,	  LOC	  for	  level	  of	  
consciousness,	  LOS	  for	  length	  of	  stay,	  MRI	  for	  magnetic	  resonance	  imaging,	  OR,	  for	  
odds	  ration,	  PACI	  for	  partial	  anterior	  circulation	  infarct,	  PE	  for	  pulmonary	  embolism,	  
POCI	  for	  posterior	  circulation	  infarct,	  TIA	  for	  transient	  ischaemic	  attack,	  TACI	  for	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Background	  
Although	  South	  Africa	  is	  at	  present	  overwhelmed	  by	  infectious	  diseases	  such	  as	  HIV	  
and	  TB,	  there	  has	  also	  been	  a	  substantial	  increase	  in	  non-­‐communicable	  diseases	  
amongst	  South	  Africans	  over	  the	  past	  15	  years.1,2	  	  The	  WHO	  suggests	  that	  South	  
Africa	  has	  a	  two	  to	  three	  times	  higher	  incidence	  of	  non-­‐communicable	  diseases	  
than	  that	  is	  found	  in	  the	  developed	  world.1	  	  	  This	  burden	  of	  disease	  is	  the	  result	  of	  
the	  increase	  of	  cardiovascular	  risk	  factors	  present	  in	  urban	  and	  rural	  South	  Africa,	  
and	  is	  predicted	  to	  increase	  considerably	  if	  the	  appropriate	  action	  is	  not	  taken.1,3,4
Cerebrovascular	  accidents	  remain	  the	  second	  leading	  cause	  of	  mortality	  and	  most	  
frequent	  cause	  of	  permanent	  disability	  in	  the	  world.5	  	  In	  South	  Africa,	  stroke	  
accounts	  for	  17.7%	  of	  female	  and	  12.2%	  of	  male	  deaths	  in	  persons	  of	  60	  years	  of	  
age	  and	  older,	  making	  it	  the	  leading	  cause	  of	  death	  in	  this	  age	  group.6	  	  In	  a	  report	  
published	  by	  the	  Western	  Cape	  Department	  of	  Health	  and	  the	  City	  of	  Cape	  Town	  in	  
2008,	  it	  was	  estimated	  that	  the	  stroke	  mortality	  in	  females	  ranged	  from	  108.1	  to	  
131.5	  deaths	  per	  100000	  in	  Mitchell’s	  Plain	  and	  Khayelitsha	  respectively,	  whereas	  in	  
males	  the	  deaths	  per	  100000	  ranged	  from	  125.8	  in	  Khayelitsha	  to	  136.6	  in	  
Mitchell’s	  Plain.7	  	  This	  illustrates	  the	  burden	  that	  cerebrovascular	  accidents	  have	  on	  
the	  acute	  and	  chronic	  health	  care	  facilities.	  
Even	  though	  stroke	  is	  a	  leading	  cause	  of	  morbidity	  and	  mortality,	  very	  little	  is	  
known	  about	  the	  quality	  of	  stroke	  care	  and	  its	  incurred	  cost	  in	  South	  Africa.8	  	  
Knowledge	  of	  the	  quality	  of	  stroke	  care	  that	  our	  patients	  are	  currently	  receiving	  is	  
of	  critical	  importance	  in	  order	  to	  improve	  current	  practices	  and	  plan	  future	  
protocols.8,9,10	  	  Widespread	  implementation	  of	  optimal	  stroke	  care	  continues	  to	  
pose	  enormous	  challenges	  on	  health	  care	  systems.10	  	  Furthermore,	  with	  stroke	  
prevalence	  that	  is	  predicted	  to	  continue	  to	  increase	  in	  the	  near	  future,	  the	  health	  
sector	  will	  be	  faced	  with	  even	  more	  financial	  difficulties	  to	  maintain	  optimal	  care	  
for	  inpatients	  with	  acute	  stroke.1,9,10	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Aim	  
	  
The	  aim	  of	  this	  project	  is	  to	  establish	  the	  quality	  and	  cost	  of	  acute	  stroke	  care	  in	  the	  





The	  objective	  of	  this	  study	  is	  to	  establish	  the	  quality	  of	  care	  offered	  to	  patients	  
admitted	  with	  an	  acute	  cerebrovascular	  attack	  to	  general	  medical	  wards	  at	  Groote	  
Schuur	  Hospital	  and	  to	  identify	  specific	  management	  practices	  that	  could	  be	  
improved.	  	  Data	  generated	  by	  this	  study	  will	  be	  useful	  in	  informing	  
recommendations	  for	  stroke	  management	  and	  the	  development	  of	  protocols	  for	  
acute	  stroke	  care	  in	  this	  setting.	  	  	  	  The	  study	  will	  also	  establish	  the	  cost	  of	  stroke	  
care	  and	  examine	  to	  which	  extent	  patient	  demographics	  (age	  and	  gender),	  clinical	  
factors	  (i.e.	  comorbidities,	  neurological	  deficits	  of	  the	  stroke,	  complications	  during	  
the	  admission)	  and	  management	  factors	  influence	  the	  cost	  of	  stroke	  care.	  	  This	  
would	  identify	  areas	  where	  rationalisation	  of	  resources	  could	  lead	  to	  cost	  savings	  






This	  study	  is	  a	  retrospective	  audit	  of	  all	  acute	  stroke	  patients	  admitted	  to	  the	  




The	  study	  sites	  for	  our	  project	  will	  include	  the	  general	  medicine	  wards	  at	  Groote	  
Schuur	  Hospital.	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Study	  population	  and	  sampling	  
	  
We	  intend	  to	  include	  all	  patients	  that	  were	  admitted	  with	  acute	  ischaemic	  or	  
haemorrhagic	  stroke	  to	  the	  general	  medical	  wards.	  
	  
Patients	  that	  will	  not	  be	  included	  in	  the	  study	  are	  
• Patients	  in	  which	  acute	  stroke	  is	  not	  the	  primary	  reason	  for	  admission,	  or	  
developed	  stroke	  in	  hospital	  whilst	  being	  admitted	  for	  another	  reason	  
• Patients	  under	  the	  age	  of	  45	  on	  the	  day	  of	  admission	  
• Patients	  that	  received	  thrombolytic	  therapy	  for	  acute	  stroke	  
• Patients	  that	  were	  transferred	  to	  the	  stroke	  unit	  
• Patients	  that	  suffered	  from	  sub-­‐arachnoid	  haemorrhage	  
	  
The	  reason	  for	  the	  above	  exclusions	  is	  that	  these	  patients	  have	  additional	  
investigations	  as	  part	  of	  work-­‐up,	  prolonged	  hospital	  stays,	  a	  different	  set	  of	  
complications,	  all	  which	  may	  skew	  the	  analysis	  of	  the	  data	  that	  we	  wish	  to	  collect.	  
	  
Patients	  will	  be	  identified	  from	  admission	  registers	  in	  the	  emergency	  unit	  of	  Groote	  
Schuur	  Hospital.	  	  In-­‐patient	  medical	  records	  by	  medical	  doctors,	  nursing	  staff	  and	  
members	  of	  allied	  health	  will	  be	  reviewed	  and	  data	  will	  be	  extracted.	  	  Investigations	  
done	  will	  be	  identified	  using	  the	  National	  Health	  Laboratory	  Service	  (NHLS)	  and	  




Data	  collection	  to	  establish	  quality	  and	  cost	  of	  acute	  stroke	  care	  will	  include:	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1.2.	  	  Risk	  factors	  for	  cerebrovascular	  attack	  (CVA)	  
	  
a. previous	  CVA	  (from	  history	  of	  clinical	  notes)	  
b. transient	  ischaemic	  attacks	  (TIAs)	  prior	  to	  admission	  (from	  history)	  
c. smoking	  (based	  on	  current	  or	  previous	  history)	  
d. hypertension	  (based	  on	  history,	  notes	  or	  regular	  use	  of	  anti-­‐hypertensives)	  
e. diabetes	  mellitus	  (based	  on	  history,	  regular	  use	  of	  diabetic	  agents,	  
hyperglycaemia)	  
f. hyperlipidaemia	  (based	  on	  history,	  regular	  statin	  use,	  total	  cholesterol	  >	  5	  
mmol/dL)	  
g. atrial	  fibrillation	  (from	  history	  or	  ECG)	  
h. ischaemic	  heart	  disease	  (based	  on	  history	  of	  angina	  or	  myocardial	  infarction)	  
i. valvular	  heart	  disease	  (based	  on	  history	  or	  clinical	  notes)	  
j. HIV	  (history,	  serology	  or	  regular	  use	  of	  anti-­‐retroviral	  therapy)	  
k. neurosyphilis	  (based	  on	  cerebrospinal	  fluid	  analysis)	  
	  
1.3.	  Stroke	  subtype	  
	  
a. infarct	  	  
I. classified	  by	  TOAST	  criteria	  (by	  expert	  review	  of	  CT	  brain)	  
i. total	  anterior	  circulation	  infarct	  
ii. partial	  anterior	  circulation	  infarct	  
iii. lacunar	  infarct	  
iv. posterior	  infarct	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1.4.	  	  Clinical	  presentation	  
	  
a. decreased	  level	  of	  consciousness	  
b. aphasia	  
i. receptive	  aphasia	  
ii. expressive	  aphasia	  
c. dysphagia	  
d. hemiparesis	  
i. right	  or	  left	  arm	  
ii. right	  or	  left	  leg	  
	  
1.5.	  	  Special	  investigations	  done	  during	  admission	  (and	  quantify	  how	  many)	  
	  
a. Blood	  pressure	  measured	  (on	  admission	  and	  discharge)	  
b. Glucose	  measured	  (on	  admission	  and	  discharge)	  
c. Full	  blood	  count	  
d. Renal	  function	  
e. INR	  
f. Lipid	  profile	  
g. TSH	  
h. Liver	  function	  tests	  
i. CRP	  
j. Human	  Immunodeficiency	  Virus	  (HIV)	  
k. Venereal	  Disease	  Research	  Laboratory	  test	  (VDRL)	  
l. Blood	  culture	  
m. Chest	  X-­‐ray	  (CXR)	  
n. Electrocardiogram	  (ECG)	  
o. Computerised	  Tomography	  (CT)	  of	  the	  brain	  
p. MRI	  of	  the	  brain	  
q. Angiogram	  of	  the	  intracranial	  vessels	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r. Doppler	  ultrasound	  of	  the	  carotid	  arteries	  
s. Echocardiogram	  
t. Urinalysis	  (Dipstix)	  
u. Urine	  microscopy,	  culture	  and	  sensitivities	  
v. Lumbar	  puncture	  
	  





d. Urinary	  tract	  infection	  (UTI)	  
e. Hyperglycaemia	  
f. Bedsores	  
g. Deep	  vein	  thrombosis	  (DVT)	  /	  pulmonary	  embolism	  (PE)	  
h. Dehydration	  
i. Acute	  kidney	  injury	  (50%	  in	  rise	  of	  creatinine	  or	  26.1	  μmol/L	  rise	  in	  
creatinine)11	  
j. Seizures	  
k. Drip	  site	  sepsis	  
l. Gastro-­‐intestinal	  bleeds	  
	  
1.7.	  	  Management	  
	  
a. Time	  between	  admission	  and	  CT	  brain	  
b. Aspirin	  given	  
c. Warfarin	  given	  
d. Heparin	  prophylaxis	  given	  
e. Nasogastric	  tube	  (NGT)	  feeding	  
f. Intravenous	  fluids	  administered	  
g. Fever	  managed	  
h. Antibiotics	  given	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i. Pressure	  care	  done	  
j. Regular	  diabetic	  medication	  given	  
k. Insulin	  sliding	  scale	  prescribed	  
	  
1.8.	  	  How	  soon	  patients	  were	  assessed	  by	  allied	  health	  professionals	  during	  
admission	  
	  
a. Speech	  therapy	  
b. Physiotherapy	  
c. Occupational	  therapy	  
d. Dietician	  
	  
1.9.	  	  Management	  of	  risk	  factors	  at	  discharge	  
	  
a. Blood	  pressure	  control	  at	  discharge	  
b. Glucose	  control	  at	  discharge	  
c. Discharged	  on	  antiplatelet	  therapy	  	  
d. Discharged	  on	  warfarin	  if	  in	  AF	  
e. Discharged	  on	  a	  statin	  if	  increased	  cholesterol	  
	  
1.10.	  	  Discharge	  destination	  
	  
a. Home	  
b. Rehabilitation	  centre	  
	  
The	  length	  of	  stay	  will	  be	  calculated	  from	  the	  day	  of	  admission	  until	  the	  day	  of	  
discharge,	  counted	  in	  days.	  
	  
The	  cost	  of	  each	  stroke	  included	  in	  the	  study	  will	  be	  determined	  by	  accessing	  the	  
Groote	  Schuur	  Hospital	  financial	  records	  through	  the	  hospital	  finance	  department	  
and	  case	  management	  to	  determine	  the	  bed	  cost,	  as	  well	  as	  the	  radiology,	  
laboratory	  and	  pharmacy	  bills	  for	  each	  subject	  as	  identified	  by	  their	  folder	  number.	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Statistical	  analysis	  
Coded	  data	  will	  be	  entered	  into	  an	  Excel	  computerised	  database.	  
Statistical	  Analysis	  will	  be	  performed	  using	  the	  statistical	  software	  R	  version	  3.0.2.	  	  
Univariate	  analysis	  using	  non-­‐parametric	  tests	  and	  multivariate	  regression	  analysis	  
will	  be	  used	  to	  identify	  risk	  factors,	  stroke	  characteristics,	  medical	  complications	  
and	  management	  associated	  with	  increased	  length	  of	  stay	  and	  cost	  of	  admission.	  
Univariate	  logistic	  regressions	  will	  be	  used	  to	  identify	  the	  risk	  factors,	  stroke	  
characteristics	  and	  inpatient	  complications	  associated	  with	  increased	  risk	  of	  death	  
during	  admission.	  
Budget	  
No	  budget	  is	  required	  for	  this	  retrospective	  study.	  
Timeline	  
February	  2012	  –	  July	  2013	   complete	  project	  design	  
data	  collection	  from	  medical	  folders	  
August	  2013	   	  data	  collection	  on	  financial	  records	  
September	  –	  December	  2013	  	   data	  processing	  
February	  –	  March	  2014	   data	  analysis	  
report	  writing	  
preparation	  for	  journal	  articles	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Benefits	  of	  this	  clinical	  audit	  
	  
Analysis	  of	  data	  obtained	  from	  this	  audit	  will	  identify	  areas	  of	  stroke	  care	  where	  the	  
quality	  of	  care	  could	  be	  improved	  and	  inform	  the	  development	  of	  guidelines	  and	  
protocols	  of	  care.	  
In	  establishing	  the	  cost	  of	  stroke	  care	  and	  by	  identifying	  those	  factors	  that	  increase	  
the	  cost	  of	  stroke	  care,	  we	  may	  be	  able	  to	  identify	  areas	  where	  resource	  utilisation	  




There	  are	  no	  ethical	  conflicts	  in	  this	  study,	  since	  this	  project	  is	  a	  retrospective	  audit	  
of	  patient	  information,	  which	  will	  be	  kept	  anonymous.	  	  Furthermore,	  this	  
retrospective	  study	  would	  not	  interfere	  with	  the	  current	  practice	  and	  stroke	  care	  
patients	  are	  receiving.	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Data	  collection	  sheet	  
	  
	  







Patient'number'in'study' $ GSH$Folder$number$ $ Gender$ M$ F$
Name$ $ Date$of$birth$ $ Prev$CVA$ Y$ N$
Risk$factors$ Smoking$ HPT$ DM$ !$chol$ TIA$ A$fib$ IHD$ VHD$ HIV$ Syphilis$
Admission$date$ $ BP$ $$$$$$$$$$$$$$$$$/$ Glucose$ $
Investigations$
(indicate$number)$
Blood$ FBC$ U&E$ INR$ Chol$ TSH$ LFT$ CRP$ HIV$ RPR$ B/C$
CXR$ ECG$ CT$brain$ MRI$ Carotid$ Echo$ Angiogram$ Dipstix$ UQMCS$ LP$
Other' $
Time$to$CTB$ $ Type$ Haemorrhage$ Infarct$ Unknown$ TOAST$ TACI$ PACI$ LACI$ POCI$
Infarct$subtype$ Lacunar$ Atherosclerosis$ Embolic$ Vasculitis$ Other:'
Deficit$
(on$admission)$
" level$of$consciousness$ Receptive$aphasia$ Expressive$aphasia$ Dysphagia$
Right$hemi$arm$ Right$hemi$leg$ Left$hemi$arm$ Left$hemi$leg$
Complications$ Death$ Fever$ Pneumonia$ UTI$ Bedsores$ Hyperglycemia$
DVT$ PE$ Dehydration$ Acute$kidney$injury$(creat$up$50%$or$26umol/L)$
Drip$site$sepsis$ Seizures$ Upper$GI$bleed$ Number$of$complications$
Prevention$ Aspirin$$ Warfarin$ Heparin$prophylaxis$ NGT$if$dysphagia$ IV$fluids$
Fever$managed$ Antibiotics$ Pressure$care$ Regular$DM$meds$ Sliding$scale$
Assessed$by$
Allied$health$
Speech$ <$72$hrs$ >$72$hrs$ none$ Dietician$ <$72$hrs$ >$72$hrs$ none$
Physio$ <$72$hrs$ >$72$hrs$ none$ O.T.$ <$72$hrs$ >$72$hrs$ none$
Discharge$date$ $ $$BP$ $$$$$$$$$$$$$$$$$/$ Glucose$$ $
Discharge$to$ Rehab$ Home$ $ Reason$for$delay$ $
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$ Date$ $ $ $ Treatment$whilst$admitted$
FBC$ WCC$ 4$–$10$ $ $ $ $
HB$ 14.3$–$18.3$ $ $ $ $
MCV$ 79$–$96$ $ $ $ $
PLTS$ 137$–$373$ $ $ $ $
DIFF$ Neutro$ 2.0$–$7.5$ $ $ $ $
Mono$ 0.18$–$0.8$ $ $ $ $
Lymph$ 1.0$–$4.0$ $ $ $ $
Eosinophils$ 0$–$0.45$ $ $ $ $
CLOT$ INR$ $ $ $ $ $
PTT$patient$ $ $ $ $ $
PTT$control$ $ $ $ $ $
RENAL$ Na+$ 135$–$147$ $ $ $ $
K+$ 3.3$–$5.3$ $ $ $ $
Urea$ 2.6$–$7.0$ $ $ $ $
Creatinine$ 60$–$120$ $ $ $ $
GFR$ >$120$ $ $ $ $
LIVER$ Bili$total$ 0$–$21$ $ $ $ Treatment$on$discharge$
Bili$conj$ 0$Q$6$ $ $ $ $
Total$prot$ 60$–$85$ $ $ $ $
Albumin$ 35$–$52$ $ $ $ $
ALP$ 40$–$120$ $ $ $ $
GGT$ 0$–$60$ $ $ $ $
ALT$ 5$–$40$ $ $ $ $
AST$ 5$Q$40$ $ $ $ $
INFLAM$ ESR$ 0$Q$15$ $ $ $ $
CRP$ 0$Q$10$ $ $ $ $
THYR$ TSH$ 0.27$–$4.2$ $ $ $ $
T4$ 12$Q$22$ $ $ $ $
T3$ $ $ $ $ $
LIPIDS$
$
Total$chol$ <5.0$ $ $ $ $
Trigs$ <3.0$ $ $ $ $
HDL$ >1.0$ $ $ $ Additional$comments$
LDL$ <1.7$ $ $ $ $




CSF$ Polymorphs$ $ $ $ $
Lymphocytes$ $ $ $ $
Erythrocytes$ $ $ $ $
Protein$ $ $ $ $
Glucose$ $ $ $ $
Bacteria$ $ $ $ $
Culture$ $ $ $ $
FTA$/$TPHA$ $ $ $ $
CLAT$ $ $ $ $
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Results	  and	  data	  analyses	  
	  
	  
The	  abbreviation	  LOS	  for	  “length	  of	  stay”	  is	  often	  used	  in	  the	  appendix.	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Age	  was	  not	  statistically	  significant	  in	  influencing	  length	  of	  stay	  in	  this	  study	  (refer	  
to	  table	  1)	   	  
Univariate*analysis*of*LOS*as*influenced*by*demographic*data!
!
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Age!(P!value!0.9191)!by!KruskalQWallis!test!
45!–!59! 85! 32.57%! 7.164! 6! 1!–!20!
60!–!74! 111! 42.53%! 6.477! 6! 1!–!19!
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Age!(P!value!0.9191)!by!KruskalQWallis!test!
45!–!59! 85! 32.57%! 7.164! 6! 1!–!20!
60!–!74! 111! 42.53%! 6.477! 6! 1!–!19!









































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Age!(P!value!0.9191)!by!KruskalQWallis!test!
45!–!59! 85! 32.57%! 7.164! 6! 1!–!20!
60!–!74! 111! 42.53%! 6.477! 6! 1!–!19!
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Gender	  was	  not	  statistically	  significant	  in	  influencing	  length	  of	  stay	  in	  this	  study	  
(refer	  to	  table	  2).	  
!
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Gender*(P!value!0.285)!by!MannQWhitney!U!test!
Male! 121! 46.36%! 6.165! 6! 1!Q!16!
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Gender*(P!value!0.285)!by!MannQWhitney!U!test!
Male! 121! 46.36%! 6.165! 6! 1!Q!16!




































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Gender*(P!value!0.285)!by!MannQWhitney!U!test!
Male! 121! 46.36%! 6.165! 6! 1!Q!16!



































	   97	  
Figure	  7:	  Incidence	  of	  comorbidities	  in	  this	  study	  
	  
	  
	   	  *
*
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The	  only	  comorbidities	  that	  were	  statistically	  significant	  in	  influencing	  LOS	  were	  
previous	  stroke,	  valvular	  heart	  disease	  and	  HIV.	  
	  
However,	  the	  sample	  sizes	  of	  valvular	  heart	  disease	  and	  HIV	  were	  very	  small,	  and	  




! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Previous*Stroke!(P!value!0.028)!MannQWhitney!U!test!
Yes! 94! 36.02%! 7.319! 7! 1!–!19!
No! 167! 63.98%! 6.365! 5! 1!–!19!
Transient*ischaemic*attack*(TIA)*prior*to*admission*(P!value!0.953)!MannQWhitney!U!test!
Yes! 23! 8.81%! 6.478! 6! 1!–!16.15!
No! 238! 91.19%! 6.731! 6! 1!–!19!
Smoking*(P!value!0.072)!MannQWhitney!U!test!
Yes! 94! 36.02%! 6.138! 5! 1!–!19.675!
No! 167! 63.98%! 7.029! 6! 1!–!19!
Hypertension!(P!value!0.589)!MannQWhitney!U!test!
Yes! 223! 85.44%! 6.713! 6! 1!–!19!
No! 38! 14.56%! 6.684! 5! 1!–!19.075!
Diabetes*mellitus!(P!value!0.910)!MannQWhitney!U!test!
Yes! 99! 37.93%! 6.585! 6! 1!–!19!
No! 162! 62.07%! 6.783! 5.5! 1!–!17.65!
Hypercholesterolaemia*(P!value!0.687)!MannQWhitney!U!test!
Yes! 128! 49.04%! 6.718! 5.5! 1!–!19!
No! 133! 50.96%! 6.699! 6! 1!–!19!
Atrial*fibrillation!(P!value!0.263)!MannQWhitney!U!test!
Yes! 34! 13.03%! 7.147! 6.5! 1.65!–!16.525!
No! 227! 86.97%! 6.643! 6! 1!–!19!
Ischaemic*heart*disease*(P!value!0.678)!MannQWhitney!U!test!
Yes! 52! 19.92%! 6.423! 5! 1.275!–!16!
No! 209! 80.08%! 6.779! 6! 1!–!19!
Valvular*Heart*Disease***(P!value!0.031)*MannQWhitney!U!test!
Yes! 9! 3.45%! 9.333! 9! 2.8!–!15.6!
No! 252! 96.55%! 6.615! 6! 1!–!19!
HIV***(P!value!0.001)!MannQWhitney!U!test!
Yes! 5! 1.92%! 19! 19! 8.9!–!29.9!
No! 256! 98.08%! 6.648! 6! 1!–!19!
Neurosyphilis***(P!value!0.096)!MannQWhitney!U!test!
Yes! 3! 1.15%! 12! 10! 6.2!–!19.5!
No! 258! 98.85%! 6.647! 6! 1!–!19!
*
*!small!sample!size,!results!to!be!interpreted!with!caution! !
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Smoking	  (P	  =	  0.072)	  
	  
	  
Transient	  ischaemic	  attack	  prior	  to	  
admission	  (P	  =	  0.953)	  
	  
	  






























































































































































































































































































































Table	  4:	  	  Stepwise	  regression	  analysis	  of	  LOS	  with	  comorbidities	  *
Stepwise*regression*analysis*of*LOS*against*different*comorbidities*
*
Predictor* Number* %* Beta* P!value*
Previous!stroke! 94! 36.02%! 0.184! 0.022!
Smoking! 94! 36.02%! Q!0.154! 0.055!








Figure	  9:	  	  Stroke	  subtypes	  in	  this	  study	  
Table	  5:	  Univariate	  analysis	  of	  LOS	  amongst	  different	  stroke	  types	  
Figure	  10:	  	  LOS	  as	  influenced	  by	  the	  different	  stroke	  subtypes	  
The	  difference	  in	  stroke	  subtype	  was	  not	  statistically	  significant	  in	  influencing	  LOS	  in	  
this	  study	  (refer	  to	  table	  5).	  
Univariate*analysis*of*LOS*amongst*different*stroke*types*
!
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Type*of*stroke!(P!value!0.567)!by!KruskalQWallis!test!
Ischaemic! 216! 82.76%! 6.671! 6! 1!–!19!




6!! 2.30%! 8.666! 7! 2.5!–!18!
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6!! 2.30%! 8.666! 7! 2.5!–!18!

























































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Type*of*stroke!(P!value!0.567)!by!KruskalQWallis!test!
Isc ic! 216! 82.76%! 6.671! 6! 1!–!19!




6!! 2.30%! 8.666! 7! 2.5!–!18!
























































Figure	  11:	  Infarct	  subgroups	  as	  classified	  by	  OCSP	  clinical	  classification	  
Table	  6:	  Univariate	  analysis	  of	  LOS	  amongst	  infarcts	  as	  classified	  by	  OCSP	  
clinical	  classification	  
Figure	  12:	  LOS	  as	  influenced	  by	  infarct	  subtypes	  classified	  by	  OCSP	  clinical	  
classification	  
The	  different	  infarcts	  classified	  according	  to	  the	  TOAST	  criteria	  were	  not	  statistically	  
significant	  in	  influencing	  LOS	  in	  this	  study	  (refer	  to	  table	  6).	  
!
!
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Infarcts*classified*by*TOAST*criteria!(P!value!0.151)!by!KruskalQWallis!test!
TACI! 46! 20.72%! 6.195! 4.5! 1!–!19.875!
PACI! 110! 49.55%! 7.345! 7! 1!–!19!
LACI! 51! 22.97%! 6.058! 5! 1!–!15!
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TACI! 46! 20.72%! 6.195! 4.5! 1!–!19.875!
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LACI! 51! 22.97%! 6.058! 5! 1!–!15!











































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Infarcts*classified*by*TOAST*criteria!(P!value!0.151)!by!KruskalQWallis!test!
TACI! 46! 20.72%! 6.195! 4.5! 1!–!19.875!
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Figure	  13:	  Infarct	  subgroups	  as	  classified	  by	  underlying	  pathogenesis	  
	  
Table	  7:	  Univariate	  analysis	  of	  LOS	  amongst	  infarcts	  as	  classified	  according	  
to	  pathogenesis	  
Figure	  14:	  LOS	  as	  influenced	  by	  infarct	  subtypes	  classified	  by	  pathogenesis	  
The	  different	  infarcts	  classified	  according	  to	  pathogenesis	  were	  not	  statistically	  
significant	  in	  influencing	  LOS	  in	  this	  study	  (refer	  to	  table	  7).	  
!
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Pathogenesis*of*infarction!(P!value!0.438)!by!KruskalQWallis!test!
Lacunar! 51! 22.97%! 6.058! 5! 1!–!15!
Atherosclerosis! 115! 51.80%! 6.939! 6! 1!–!19.15!
CardioQembolic! 49! 22.07%! 6.387! 5! 1!–!16!
Vasculitis!*! 6! 2.70%! 11.833! 12.5! 1.625!–!19.875!





















































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Pathogenesis*of*infarction!(P!value!0.438)!by!KruskalQWallis!test!
Lacunar! 51! 22.97%! 6.058! 5! 1!–!15!
Atherosclerosis! 115! 51.80%! 6.939! 6! 1!–!19.15!
CardioQembolic! 49! 22.07%! 6.387! 5! 1!–!16!
Vasculitis!*! 6! 2.70%! 11.833! 12.5! 1.625!–!19.875!





















































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Pathogenesis*of*infarction!(P!value!0.438)!by!KruskalQWallis!test!
Lacunar! 51! 22.97%! 6.058! 5! 1!–!15!
Atherosclerosis! 115! 51.80%! 6.939! 6! 1!–!19.15!
CardioQembolic! 49! 22.07%! 6.387! 5! 1!–!16!
Vasculitis!*! 6! 2.70%! 11.833! 12.5! 1.625!–!19.875!





















































Figure	  15:	  	  Incidence	  of	  neurological	  deficits	  on	  admission	  
	  	  
Table	  8:	  Univariate	  analysis	  of	  LOS	  as	  influenced	  by	  clinical	  presentation	  /	  
neurological	  deficit	  on	  admission	  








Predictor* Number* %* Beta* P!value*
Expressive!aphasia! 75! 28.74%! 0.194! 0.062!
















































































































































































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Decreased*level*of*consciousness*(P!value!0.194)!MannQWhitney!U!test!
Yes! 63! 24.14%! 6.380! 4! 1!–!19!
No! 198! 75.86%! 6.813! 6! 1!–!19!
Receptive*aphasia*(P!value!0.627)!MannQWhitney!U!test!
Yes! 34! 13.03%! 7.176! 6! 1!–!21.45!
No! 227! 86.97%! 6.638! 6! 1!–!19!
Expressive*aphasia*(P!value!0.616)!MannQWhitney!U!test!
Yes! 75! 28.74 ! 7.360! 6! 1!–!25.9!
No! 186! 71.26%! 6.446! 6! 1!–!16.375!
Dysphagia*(P!value!0.886)!MannQWhitney!U!test!
Yes! 125! 47.89%! 6.696! 6! 1!–!19!
No! 136! 52.11%! 6.720! 6! 1!–!19!
Paresi *of*right*arm!(P!v lue!0.162)!MannQWhitney!U!test!
Yes! 146! 55.94%! 6.534! 5! 1!–!19.37!
No! 115! 44.06%! 6.930! 6! 1!–!16.15!
Paresis*of*right*leg!(P!value!0.145)!MannQWhitney!U!test!
Yes! 148! 56.70%! 6.51! 5! 1!–!19.325!
No! 113! 43.30%! 6.964! 6! 1!–!16.2!
Paresis*of*left*arm!(P!value!0.281)!MannQWhitney!U!test!
Yes! 108! 41.38%! 6.861! 6! 1!–!16.325!
No! 153! 58.62%! 6.601! 5! 1!–!19.2!
Paresis*of*left*leg!(P!value!0.289)!MannQWhitney!U!test!
Yes! 109! 41.76%! 6.853! 6! 1!–!16.3!
No! 152! 58.24%! 6.605! 5! 1!–!19.225!
!
!
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Clinical	  presentation	  was	  not	  statistically	  significant	  in	  influencing	  LOS	  in	  this	  study	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Systolic	  blood	  pressure	  on	  admission	  was	  not	  statistically	  significant	  in	  influencing	  











Predictor* Number* %* Beta* P!value*
Expressive!aphasia! 75! 28.74%! 0.194! 0.062!
















































































































































































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Blood*pressure*on*admission*(P!value!0.118)!by!KruskalQWallis!test!
SBP!<!120! 37! 14.18%! 8.567! 8! 1.9!–!19.6!
SBP!120!–!129! 28! 10.73%! 7.071! 5! 1!–!23.55!
SPB!130!–!139! 31! 11.88%! 5.387! 5! 1.5!–!12.5!
SBP!140!–!159! 50! 19.16%! 6.6! 6! 1!–!14.78!
SBP!160!–!179! 42! 16.09%! 7.024! 5! 1!–!19.98!



















! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Blood*pressure*on*admission*(P!value!0.118)!by!KruskalQWallis!test!
SBP!<!120! 37! 14.18%! 8.567! 8! 1.9!–!19.6!
SBP!120!–!129! 28! 10.73%! 7.071! 5! 1!–!23.55!
SPB!130!–!139! 31! 11.88%! 5.387! 5! 1.5!–!12.5!
SBP!140!–!159! 50! 19.16%! 6.6! 6! 1!–!14.78!
SBP!160!–!179! 42! 16.09%! 7.024! 5! 1!–!19.98!
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Table	  11:	  	  Univariate	  analysis	  of	  LOS	  associated	  with	  blood	  glucose	  as	  




Blood	  glucose	  on	  admission	  was	  not	  statistically	  significant	  in	  influencing	  LOS	  in	  this	  
study.	  
	  
	  	   	  
*
*
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Glucose*measured*on*admission*(P!value!0.454)!by!KruskalQWallis!test!
Not!tested! 26! 10%! 7.615! 6! 1!–!20!
Glucose!<!4! 2! 0.77%! 5.5! 5.5! 4.075!–!6.925!
Glucose!4!Q!7! 103! 39.46%! 6.592! 5! 1!–!19!
Glucose!7!Q!10! 82! 31.42%! 7.341! 6! 1!–!19!
Glucose!>!10! 47! 18.01%! 5.438! 5! 1!–!11.825!
















! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Glucose*measured*on*admission*(P!value!0.454)!by!KruskalQWallis!test!
Not!tested! 26! 10%! 7.615! 6! 1!–!20!
Glucose!<!4! 2! 0.77%! 5.5! 5.5! 4.075!–!6.925!
Glucose!4!Q!7! 103! 39.46%! 6.592! 5! 1!–!19!
Glucose!7!Q!10! 82! 31.42%! 7.341! 6! 1!–!19!
Glucose!>!10! 47! 18.01%! 5.438! 5! 1!–!11.825!
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Table	  12:	  Univariate	  analysis	  of	  LOS	  associated	  with	  laboratory	  related	  





	   	  
*
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Full*blood*count*measured*(P!value!<!0.001)!by!KruskalQWallis!test!
Not!tested! 2! 0.77%! 6.5! 6.5! 4.125!–!8.875!
1!test! 166! 63.60%! 5.771! 5! 1!–!16.875!
2!tests! 63! 24.14%! 7.063! 6! 1!–!19.45!
>!2!tests! 30! 11.49%! 11.167! 10! 3.45!–!26.65!
Total!tested! 259! 99.23%! ! ! !
Renal*function*measured*(P!value!<!0.001)!by!KruskalQWallis!test*
Not!tested! 1! 0.38%! 9! 9! 9!
1!test! 135! 51.72%! 5.215! 4! 1!–!15.65!
2!tests! 74! 28.35%! 7.108! 6! 1!–!19.175!
>!2!tests! 51! 19.54%! 10.039! 9! 2.25!–!23.5!
Total!tested! 260! 99,62%! ! ! !
INR*measured*(P!value!0.042)!by!KruskalQWallis!test*
Not!tested! 205! 78.44%! 6.492! 6! 1!–!19!
1!test! 48! 18.39%! 6.583! 5! 1!–!18.475!
2!tests! 2! 0.77%! 9.5! 9.5! 3.325!–!15.675!
>!2!tests! 6! 2.30%! 14.167! 11! 8!–!29.125!
Total!tested! 56! 21.46%! ! ! !
Lipid*profile*measured*(P!value!0.127)!by!KruskalQWallis!test*
Not!tested! 71! 26.93%! 7.056! 7! 1!–!17.5!
1!test! 177! 67.82%! 6.452! 5! 1!–!19!
2!tests! 12! 4.60%! 8.75! 9.5! 1.55!–!17.07!
>!2!tests! 1! 0.38%! 3! 3! 3!
Total!tested! 190! 73.07%! ! ! !
TSH*measured*(P!value!0.715)!by!Mann!Whitney!U!test*
Not!tested! 177! 67.82%! 6.841! 6! 1!–!19.6!
Tested! 84! 32.18%! 6.429! 6! 1!–!15.85!
Liver*function*test*measured*(P!value!0.093)!by!KruskalQWallis!test*
Not!tested! 210! 80.46%! 6.567! 6! 1!–!19!
1!test! 48! 19.39%! 6.875! 6! 19!
2!tests! 2! 0.77%! 13! 13! 12.05!–!13.95!
>!2!tests! 1! 0.38%! 16! 16! 16!
Total!tested! 51! 19.54%! ! ! !
CRP*measured*(P!value!0.154)!by!KruskalQWallis!test*
Not!tested! 249! 94.40%! 6.57! 6! 1!–!19!
1!test! 11! 4.21%! 8.727! 6! 2.25!–!22.25!
2!tests! 0! 0! 0! 0! 0!
>!2!tests! 1! 0.38%! 19! 19! 19!






Not!tested! 232! 88.89%! 6.582! 6! 1!–!19!
Tested! 29! 11.11%! 7.724! 7! 1!–!23.3!
VDRL*tested*(P!value!0.462)!by!KruskalQWallis!test*
Not!tested! 187! 71,65%! 6.254! 5! 1!–!19!
1!test! 73! 27.97%! 7.178! 6! 1!–!19.2!
2!tests! 1! 0.38%! 7! 7! 7!
>!2!tests! 0! 0! 0! 0! 0!
Total!tested! 74! 28.35%! ! ! !
Blood*culture*done*(P!value!<!0.001)!by!KruskalQWallis!test*
Not!tested! 208! 79.69%! 6.091! 5! 1!–!18.25!
1!test! 39! 14.94%! 8.436! 8! 1.95!–!19.05!
2!tests! 8! 3.07%! 9.375! 8! 3.350!–!22.375!
>!2!tests! 6! 2.30%! 13.333! 15! 5.5!–!19.5!
Total!tested! 53! 20.31%! ! ! !
Urinalysis*(dipstix)*analysed*(P!value!0.095)!by!Mann!Whitney!U!test*
Not!tested! 1! 0.38%! 2! 2! 2!
Tested! 260! 99.62%! 6.645! 6! 1!–!19!
Urine*MCS*done*(P!value!of!0.621)!by!Mann!Whitney!U!test*
Not!tested! 219! 83.91%! 6.562! 6! 1!–!19!
Tested! 42! 16.09%! 7.778! 6! 1.88!–!20.5!
Lumbar*puncture*and*CSF*analysis*(P!value!0.020)!by!Mann!Whitney!U!test*
Not!tested! 251! 96.17%! 6.566! 6! 1!–!19!
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Table	  13:	  Univariate	  analysis	  of	  LOS	  associated	  with	  radiological	  and	  cardiac	  




Delays	  in	  CT	  angiogram	  and	  echocardiogram	  were	  associated	  with	  prolonged	  LOS,	  
however,	  the	  sample	  sizes	  in	  these	  groups	  were	  to	  small	  to	  accurately	  interpret	  the	  
results.	  
	  
	   	  
*
*
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
CT*brain*(P!value!0.759)!by!KruskalQWallis!test*
Not!done! 13! 4.98%! 7.385! 6! 1.3!–!17.5!
Done!once! 237! 90.80%! 6.620! 6! 1!–!19!
Done!twice! 10! 3.83%! 7.7! 6.5! 2!–!19.1!
Done!>!twice! 1! 0.38%! 9! 9! 9!
Total!done! 248! 95.02%! ! ! !
MRI*brain***(P!value!0.053)!by!Mann!Whitney!U!test*
Not!done! 259! 99.23%! 6.649! 6! 1!–!19!
Done! 2! 0.77%! 14.5! 14.5! 10.23!–!18.78!
Total!done! 2! 0.77%! ! ! !
Angiogram*of*intracranial*vessels***(P!value!0.035)!by!Mann!Whitney!U!test*
Not!done! 255! 97.71%! 6.494! 6! 1!–!19!
Done!once! 6! 2.29%! 15.833! 10.5! 2!–!32.75!
Total!done! 6! 2.29%! ! ! !
Doppler*of*carotid*arteries*(P!value!0.021)!by!Mann!Whitney!U!test*
Not!done! 250! 95.79%! 6.448! 6! 1!–!19!
Done!once! 11! 4.21%! 12.636! 9! 3.25!–!32.5!
Total!done! 11! 4.21%! ! ! !
Chest*Xaray*(P!value!0.011)!by!KruskalQWallis!test*
Not!done! 17! 6.51%! 5.118! 3! 1!–!17!
Done!once! 222! 85.06%! 6.550! 6! 1!–!19!
Done!twice! 16! 6.13%! 9.8! 9! 5.4!–!15.4!
Done!>!twice! 6! 2.30%! 16! 16! 16!
Total!done! 244! 93.49%! ! ! !
Compression*ultrasound*of*calves***(P!value!0.185)!by!Mann!Whitney!U!test*
Not!done! 259! 99.23%! 6.687! 6! 1!–!19!
Done!once! 2! 0.77%! 9.5! 9.5! 8.08!–!10.93!
Total!done! 2! 0.77%! ! ! !
*
ECG*(P!value!0.486)!by!KruskalQWallis!test*
Not!done! 33! 12.64%! 6.484! 5! 1!–!20.2!
Done!once! 207! 79.31%! 6.633! 6! 1!–!19!
Done!twice! 16! 6.13%! 7.688! 7! 2.38!–!17.87!
Done!>!twice! 5! 1.92%! 8.2! 5! 4!–!18.8!
Total!done! 228! 87.36%! ! ! !
Echocardiogram***(P!value!0.007)!by!Mann!Whitney!U!test*
Not!done! 245! 93.87%! 6.4! 5! 1!–!19!
Done!once! 16! 6.13%! 11.438! 8.5! 2.75!–!32.25!
Total!done! 16! 6.13%! ! ! !
*
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Time	  to	  CT	  brain	  was	  not	  statistically	  significant	  in	  influencing	  LOS	  in	  this	  study	  




! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Time*to*CT*or*MRI*of*brain*(P!value!0.230)!by!KruskalQWallis!test!
<!24!hours! 228! 87,36%! 6.570! 5.5! 1!–!19!
>!24!hours! 20! 7,66%! 7.85! 8! 1.475!–!16.675!
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Figure	  24:	  Medical	  management	  of	  patients	  in	  this	  study	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Figure	  25:	  Percentage	  of	  patients	  managed	  by	  allied	  health	  professionals,	  
and	  when	  first	  assessed	  
	  
	  
	   	  
!
!




















































































































































































































































































































































































































































































Table	  15:	  	  Univariate	  analysis	  of	  LOS	  as	  influenced	  by	  when	  patients	  were	  

































































































































































































	   118	  
Figure	  26:	  Mean	  LOS	  as	  influenced	  by	  when	  patients	  were	  first	  assessed	  by	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Inpatient	  complications	  that	  were	  significant	  in	  prolonging	  LOS	  were	  fever,	  UTI	  and	  
acute	  kidney	  injury.	  	  Drip	  site	  sepsis	  had	  a	  small	  sample	  size	  and	  the	  results	  should	  




! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Death*during*admission*(P!value!<!0.001)!by!Mann!Whitney!U!test!
Yes! 53! 20.31%! 4.320! 3! 1!–!11.7!
No! 208! 79.69%! 7.317! 6! 1!–!19!
Fever*(P!value!0.001)!by!Mann!Whitney!U!test!
Yes! 108! 41.38%! 7.851! 7! 1.675!–!19.325!
No! 153! 58.62%! 5.901! 5! 1!–!16!
Pneumonia*(P!value!0.769)!by!Mann!Whitney!U!test!
Yes! 51! 19.54%! 7.117! 5! 1!–!19.5!
No! 210! 80.46%! 6.609! 6! 1!–!19!
UTI*(P!value!<!0.001)!by!Mann!Whitney!U!test!
Yes! 57! 21.84%! 8.122! 7! 2!–!16!
No! 204! 78.16%! 6.313! 5! 1!–!19!
Drip*site*Sepsis***(P!value!0.037)!by!Mann!Whitney!U!test!
Yes! 2! 0.77%! 15.5! 15.5! 11.225!–!19.775!
No! 259! 99.23%! 6.640! 6! 1!–!19!
Hyperglycaemia*(P!value!0.258)!by!Mann!Whitney!U!test!
Yes! 59! 22.61%! 7.016! 6! 1.45!–!17.65!
No! 202! 77.39%! 6.618! 5! 1!–!19!
Dehydration***(P!value!0.629)!by!Mann!Whitney!U!test!
Yes! 7! 2.68%! 7.285! 7! 2!–!13.7!
No! 254! 97.32%! 6.692! 6! 1!–!19!
Acute*kidney*injury*(P!value!<!0.001)!by!Mann!Whitney!U!test!
Yes! 25! 9.58%! 9.480! 10! 3.6!–!17.2!
No! 236! 90.42%! 6.415! 5! 1!–!19!
DVT*/*PE***(P!value!0.185)!by!Mann!Whitney!U!test!
Yes! 2! 0.77%! 9.5! 9.5! 8.075!–!10.925!
No! 259! 99.23%! 6.687! 6! 1!–!19!
Bedsores***(P!value!0.242)!by!Mann!Whitney!U!test!
Yes! 8! 3.07%! 8.375! 7! 2.35!–!17.6!
No! 253! 96.93%! 6.656! 6! 1!–!19!
GI*Bleed***(P!value!0.594)!by!Mann!Whitney!U!test!
Yes! 4! 1.53%! 10! 10! 1.225!–!18.775!
No! 257! 98.47%! 6.657! 6! 1!–!19!
Seizures***(P!value!0.116)!by!Mann!Whitney!U!test!
Yes! 2! 0.77%! 10! 10! 10!–!10!
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On	  stepwise	  regression	  analysis,	  inpatient	  complications	  that	  were	  significant	  in	  
prolonging	  LOS	  were	  fever	  and	  acute	  kidney	  injury.	  
	  
Death	  was	  significant	  in	  shortening	  LOS.	  
	   	  
*
*
! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Number*of*complications*(P!value!0.059)!by!KruskalQWallis!testing!
0! 93! 35.63%! 6.247! 5! 1!–!16.7!
1! 58! 22.22%! 6.310! 6! 1!–!17.725!
2Q3! 82! 31.42%! 6.890! 5.5! 1!–!19!

































Figure	  29:	  	  The	  number	  of	  inpatient	  complications	  that	  patients	  developed	  
Table	  18:	  	  Univariate	  analysis	  of	  LOS	  as	  influenced	  by	  the	  number	  of	  





! Number* Percentage* Mean*LOS* Median*LOS*
Number*of*complications*(P!value!0.22)!by!KruskalQWallis!testing*
0! 93! 35.63%! 6.247! 5!
1! 58! 22.22%! 6.310! 6!
2! 48! 18.39%! 7.166! 5.5!
3! 34! 13.03%! 6.500! 5.5!
4! 20! 7.66%! 8.3! 8!
5! 6! 2.30%! 7.666! 8!
6! 1! 0.38%! 11! 11!





























































! Number* Percentage* Mean*LOS* Median*LOS*
Number*of*complications*(P!value!0.22)!by!KruskalQWallis!testing*
0! 93! 35.63%! 6.247! 5!
1! 58! 22.22%! 6.310! 6!
2! 48! 18.39%! 7.166! 5.5!
3! 34! 13.03%! 6.500! 5.5!
4! 20! 7.66%! 8.3! 8!
5! 6! 2.30%! 7.666! 8!
6! 1! 0.38%! 11! 11!



























































Figure	  30:	  Mean	  LOS	  increased	  as	  the	  number	  of	  inpatient	  complications	  
increased	  
Table	  19:	  	  Univariate	  analysis	  of	  LOS	  as	  influenced	  by	  the	  number	  of	  





! Number* Percentage* Mean*LOS* Median*LOS*
Number*of*complications*(P!value!0.22)!by!KruskalQWallis!testing*
0! 93! 35.63%! 6.247! 5!
1! 58! 22.22%! 6.310! 6!
2! 48! 18.39%! 7.166! 5.5!
3! 34! 13.03%! 6.500! 5.5!
4! 20! 7.66%! 8.3! 8!
5! 6! 2.30%! 7.666! 8!
6! 1! 0.38%! 11! 11!




























































! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Number*of*complications*(P!value!0.059)!by!KruskalQWallis!testing!
0! 93! 35.63%! 6.247! 5! 1!–!16.7!
1! 58! 22.22%! 6.310! 6! 1!–!17.725!
2Q3! 82! 31.42%! 6.890! 5.5! 1!–!19!

































Table	  20:	  Incidence	  of	  complications	  amongst	  ischaemic	  and	  haemorrhagic	  
stroke	  
	  
Table	  21:	  	  Incidence	  of	  complications	  amongst	  patients	  with	  depressed	  level	  
of	  consciousness	  








! Number! %! Number! %!
Death! 43! 19.9! 5! 19.2!
Fever! 81! 37.5! 14! 53.84!
Pneumonia! 41! 18.89! 7! 26.92!
UTI! 35! 16.2! 3! 11.53!
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Table	  23:	  	  Chi	  squared	  test	  (χ2)	  comparing	  occurrence	  of	  pneumonia	  
amongst	  patients	  that	  received	  early,	  late	  and	  no	  physiotherapy	  
Table	  24:	  Chi	  squared	  test	  (χ2)	  comparing	  occurrence	  of	  bedsores	  amongst	  
patients	  that	  were	  seen	  by	  the	  occupational	  therapist	  within	  72	  hours	  of	  
admission	  with	  those	  managed	  only	  after	  72	  hours	  
Table	  25:	  	  Chi	  squared	  test	  (χ2)	  comparing	  occurrence	  of	  acute	  kidney	  injury	  
(AKI)	  amongst	  patients	  that	  were	  assessed	  by	  the	  dietician	  within	  72	  hours	  

















Pneumonia* Number! 20! 7! 24! 51!
%!within!cohort! 13.3%* 17.5%* 33.8%* 19.5%*
No*pneumonia* Number! 130! 33! 47! 210!
%!within!cohort! 86.7%* 82.5%* 66.2%* 80.5%*
Total! Number! 150! 40! 71! 261!














Bedsores* Number! 2! 5! 8!
%!within!cohort! 1.5%* 12.8%* 3.1%*
No*bedsores! Number! 132 34 253
%!within!cohort! 98.5% 87.2% 96.9%
Total! Number! 134! 39! 261!
















AKI* Number! 14! 5! 6! 25!
%!within!cohort! 14.9%* 27.8%* 4.0%* 9.6%*
No*AKI* Number! 80 13 143 236
%!within!cohort! 85.1% 72.2% 96.0% 90.4%
Total! Number! 94! 18! 149! 261!
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Table	  26:	  	  Logistic	  regression	  analysis	  of	  the	  risk	  of	  death	  
Predictor)of)death) Odds)ratio) 95%)Confidence)interval! P)value)
Lower)bound! Upper)bound!
TACI!! 4.803! 2.403! 9.629! <!0.001!
Decreased!level!of!consciousness! 6.916! 3.607! 13.517! <!0.001!
Fever! 3.240! 1.745! 6.174! <!0.001!







Figure	  31:	  Discharge	  destinations	  in	  this	  study	  
Table	  27:	  Univariate	  analysis	  of	  LOS	  as	  influenced	  by	  discharge	  destination	  
	  
Figure	  32:	  LOS	  as	  influenced	  by	  discharge	  destination	  




! Number* Percentage* Mean*LOS* Median*LOS* 2.5*–*97.5%*quartiles*
Discharge*destination*(P!value!<!0.001)!by!KruskalQWallis!testing!
Home! 102! 40.23%! 5.676! 4! 1!–!16.475!
Rehabilitation! 105! 39.08%! 8.971! 8! 3!–!20!
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Table	  28:	  Median	  LOS	  of	  group	  that	  was	  referred	  to	  inpatient	  rehabilitation	  




Figure	  33:	  Median	  LOS	  of	  patients	  referred	  to	  inpatient	  rehabilitation	  







! Number* Percentage* Median*LOS* IQR*
Speech*therapy*by!Mann!Whitney!U!test!(P!value!0.007)*
Seen!within!72!hours!of!admission! 61! 79.22%! 8! 5!–!10!
Seen!after!72!hours!of!admission! 16! 20.78%! 10.5! 8.5!–!15!
Dietician*by!Mann!Whitney!U!test!(P!value!0.084)*
Seen!within!72!hours!of!admission! 43! 82.69%! 8! 5!–!9.5!
Seen!after!72!hours!of!admission! 9! 17.31%! 10! 8!–!16!
Physiotherapy*by!Mann!Whitney!U!test!(P!value!<!0.001)*
Seen!within!72!hours!of!admission! 76! 79.16%! 7! 6!–!9!
Seen!after!72!hours!of!admission! 20! 20.84%! 10.5! 8.5!–!15!
Occupational*therapy*by!Mann!Whitney!U!test!(P!value!0.059)*
Seen!within!72!hours!of!admission! 62! 74.7%! 8! 6!–!9!








! Number* Percentage* Median*LOS* IQR*
Speech*therapy*by!Mann!Whitney!U!test!(P!value!0.007)*
Seen!within!72!hours!of!admission! 61! 79.22%! 8! 5!–!10!
Seen!after!72!hours!of!admission! 1 ! 20.78%! 10.5! 8.5!–!15!
Dietician*by Mann!Whitney!U!test!(P!value! .084)*
Seen!with n!72!hours!of!admission! 43! 82.69%! 8! 5!–!9.5!
Seen!after!72 hours!of admission! 9! 17 31%! 10! 8!–!16!
Physiotherapy*by!Mann!Whitney!U!test!(P!value!<!0.001)*
Seen!within!72!hours!of!admission! 76! 79.16%! 7! 6!–!9!
Seen!after!72!hours!of!admission! 20! 20.84%! 10.5! 8.5!–!15!
Occupational*therapy*by!Mann!Whitney!U!test!(P!value!0.059)*
Seen!within!72!hours!of!admission! 62! 74.7%! 8! 6!–!9!
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Table	  31:	  	  Glucose	  control	  of	  diabetic	  patients	  at	  discharge	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Table	  32:	  	  Patients	  with	  ischaemic	  stroke	  discharged	  on	  antiplatelet	  therapy	  
	  
	  









Figure	  38:	  	  Patients	  with	  ischaemic	  stroke	  discharged	  on	  warfarin	  
	  




























































































































































! Infarcts* Haemorrhagic*stroke* All*patients*
Given! 171! 14! 185!(70.88%)!










! Infarcts* Haemorrhagic*stroke* All*patients*
Given! 96!(86.5%)! 6!(5.4%)! 102!(91.9%)!
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  figures	  to	  those	  that	  
enhance	  the	  study.	  
—TOP—	  
Online	  Manuscript	  Submission	  
To	  submit	  your	  manuscript	  online,	  please	  visit	  the	  journal's	  online	  manuscript	  submission	  site	  (http://stroke.ahajournals.org),	  
and	  follow	  the	  instructions	  for	  creating	  an	  author	  account	  and	  submitting	  a	  manuscript.	  Access	  can	  also	  be	  gained	  by	  visiting	  
Stroke	  online	  at	  http://stroke.ahajournals.org	  and	  selecting	  the	  Online	  Submissions	  button.	  If	  you	  have	  any	  questions	  about	  
the	  online	  submission	  process,	  contact	  the	  Editorial	  Office	  by	  e-­‐mail	  at	  stroke@strokeahajournal.org	  or	  by	  telephone	  at	  617-­‐
542-­‐5100.	  
Initial	  Review	  Process	  
Submitted	  manuscripts	  will	  be	  evaluated	  initially	  by	  the	  editor-­‐in-­‐chief	  and	  an	  associate	  editor.	  A	  rapid	  initial	  decision	  of	  
whether	  to	  have	  a	  manuscript	  formally	  reviewed	  by	  two	  or	  more	  reviewers	  with	  appropriate	  expertise	  or	  rejected	  without	  a	  
formal	  review	  will	  be	  determined	  by	  the	  senior	  editor	  and	  a	  second	  reviewer	  (assistant	  editor,	  section	  editor,	  member	  of	  the	  
editorial	  board,	  or	  invited	  reviewer	  with	  topic-­‐related	  expertise)	  based	  on	  the	  quality,	  originality,	  scientific	  rigor	  and	  data	  
presentation/analysis	  of	  the	  manuscript.	  It	  is	  anticipated	  that	  approximately	  50%	  of	  the	  submitted	  manuscripts	  will	  undergo	  
formal	  review	  and	  50%	  will	  be	  rejected	  without	  evaluation	  by	  external	  reviewers.	  This	  policy	  reflects	  the	  stringent	  
requirements	  for	  the	  acceptance	  of	  manuscripts	  submitted	  to	  Stroke.	  
—TOP—	  
Instructions	  for	  New	  Submissions	  
The	  following	  items	  should	  be	  uploaded	  with	  the	  manuscripts	  file(s):	  
• A	  cover	  letter	  that	  includes	  the	  following	  statement:	  “All	  authors	  have	  read	  and	  approved	  the	  submitted	  manuscript,	  the	  
manuscript	  has	  not	  been	  submitted	  elsewhere	  nor	  published	  elsewhere	  in	  whole	  or	  in	  part,	  except	  as	  an	  abstract	  
(if	  relevant).”	  The	  cover	  letter	  may	  include	  the	  names	  of	  up	  to	  3	  potential	  reviewers	  whom	  the	  authors	  would	  like	  
to	  suggest,	  especially	  members	  of	  the	  editorial	  board.	  The	  authors	  may	  also	  include	  the	  names	  of	  up	  to	  3	  reviewers	  
whom	  they	  would	  like	  to	  not	  evaluate	  their	  submission.	  The	  editor	  ultimately	  decides	  who	  reviews	  the	  manuscript.	  
• Authorship	  Responsibility	  and	  Copyright	  Transfer	  Agreement	  Forms	  are	  now	  ONLINE	  ONLY.	  Forms	  will	  be	  required	  PRIOR	  
to	  resubmission,	  or	  if	  the	  manuscript	  has	  only	  one	  version	  (e.g.,	  a	  letter	  to	  the	  editor)	  after	  acceptance.	  Each	  
author	  will	  be	  sent	  an	  email	  containing	  a	  link	  to	  the	  form	  as	  an	  appropriate	  time.	  
• Acknowledgement	  release	  signatures,	  if	  applicable.	  Please	  see	  the	  Acknowledgment	  Permission	  Form	  .	  (Note:	  The	  lead	  
author	  is	  responsible	  for	  collecting	  these	  and	  indicating	  such	  on	  the	  Copyright	  Transfer	  Agreement.)	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• One	  copy	  of	  any	  in-­‐press	  article	  that	  is	  cited	  in	  the	  references,	  if	  applicable.	  
• One	  copy	  of	  any	  abstracts	  published	  or	  submitted	  for	  publication,	  if	  applicable.
—TOP—	  
Manuscript	  Formatting	  
• Only	  Microsoft	  Word	  files	  will	  be	  accepted	  for	  review.
• Manuscripts	  must	  be	  double-­‐spaced,	  including	  references,	  figure	  legends,	  and	  tables.	  
• We	  recommend	  using	  Times	  New	  Roman	  12-­‐point	  font.
• Leave	  1-­‐inch	  margins	  on	  all	  sides.	  Number	  every	  page,	  beginning	  with	  the	  abstract	  page,	  including	  tables,	  figure	  legends,
and	  figures.	  
• Cite	  each	  figure	  and	  table	  in	  text	  in	  numerical	  order.
• Manuscripts	  should	  be	  presented	  in	  the	  following	  sequence:
1. Title	  page
2. Abstract
3. Text,	  including	  Introduction,	  Methods,	  Results,	  Discussion	  and	  Summary/Conclusions	  
4. Acknowledgments






• Cite	  each	  reference	  in	  text	  in	  numerical	  order	  and	  list	  in	  the	  References	  section.	  In	  text,	  reference	  numbers	  may	  be
repeated	  but	  not	  omitted.	  Do	  not	  duplicate	  references	  either	  in	  text	  or	  in	  the	  reference	  list.	  
• Use	  SI	  units	  of	  measure	  in	  all	  manuscripts.	  For	  example,	  molar	  (M)	  should	  be	  changed	  to	  mol/L;	  mg/dL	  to	  mmol/L;	  and	  cm	  
to	  mm.	  Units	  of	  measure	  previously	  reported	  as	  percentages	  (e.g.,	  hematocrit)	  are	  expressed	  as	  a	  decimal	  fraction.	  
Measurements	  currently	  not	  converted	  to	  SI	  units	  in	  biomedical	  applications	  are	  blood	  and	  oxygen	  pressures,	  
enzyme	  activity,	  H+	  concentration,	  temperature,	  and	  volume.	  The	  SI	  unit	  should	  be	  used	  in	  text,	  followed	  by	  the	  
conventionally	  used	  measurement	  in	  parentheses.	  Conversions	  should	  be	  made	  by	  the	  author	  before	  the	  
manuscript	  is	  submitted	  for	  peer	  review.	  
• Consult	  the	  AMA	  Manual	  of	  Style:	  A	  Guide	  for	  Authors	  and	  Editors,	  10th	  ed,	  Oxford:	  Oxford	  University	  Press;	  2007,	  for
style.	  
• Please	  provide	  sex-­‐specific	  and/or	  racial/ethnic-­‐specific	  data,	  when	  appropriate,	  in	  describing	  outcomes	  of	  epidemiologic	  
analyses	  or	  clinical	  trials;	  or	  specifically	  state	  that	  no	  sex-­‐based	  or	  racial/ethnic-­‐based	  differences	  were	  present.	  
See	  the	  Uniform	  Requirements	  for	  Manuscripts	  Submitted	  to	  Biomedical	  Journals	  for	  more	  details.	  
• Please	  review	  the	  correct	  usage	  "sex"	  and	  "gender."	  "Gender"	  is	  a	  social	  construct	  and	  "sex"	  describes	  a	  biological	  status.
Please	  use	  the	  terms	  appropriately.	  	  
• Consult	  current	  issues	  for	  additional	  guidance	  on	  format.
—TOP—	  
Title	  Page	  
The	  title	  page	  (first	  page)	  must	  include:	  
• Full	  title	  of	  the	  article,	  limited	  to	  120	  characters.
• Authors'	  names,	  highest	  academic	  degree	  earned	  by	  each,	  authors'	  affiliations,	  name	  and	  complete	  address	  for
correspondence,	  and	  address	  for	  reprints	  if	  different	  from	  address	  for	  correspondence.	  Please	  also	  include	  any	  
study	  group	  or	  collaborative	  in	  the	  author	  list,	  i.e.,	  "	  .	  .	  .Last	  Author,	  on	  behalf	  of	  the	  Stroke	  Study	  Group."	  
• Fax	  number,	  telephone	  number,	  and	  e-­‐mail	  address	  for	  the	  corresponding	  author.
• Cover	  title	  (total	  characters	  must	  not	  exceed	  50,	  including	  spaces)	  to	  be	  typeset	  on	  the	  top	  of	  the	  journal	  page.
• Itemized	  list	  of	  the	  tables	  and	  figures
• 3	  to	  7	  key	  words	  for	  use	  as	  indexing	  terms
• Subject	  Codes	  for	  use	  as	  search	  terms	  across	  Highwire	  Press	  online	  journals	  Article	  Collections	  database.	  Please	  select
from	  the	  Journal	  Subject	  Codes	  List.	  
• Specify	  the	  number	  of	  words	  on	  your	  title	  page.	  Word	  count	  should	  include	  all	  parts	  of	  the	  manuscript	  (i.e.,	  title	  page,
abstract,	  main	  body	  of	  text,	  acknowledgments,	  sources	  of	  funding,	  disclosures,	  references,	  figure	  legends,	  tables,	  
and	  appendices	  intended	  for	  print	  publication).	  Over-­‐length	  manuscripts	  will	  NOT	  be	  accepted	  for	  publication	  
without	  an	  additional	  page	  charge.	  See	  the	  Costs	  to	  Authors	  below.	  
—TOP—	  
Abstract	  
• Do	  not	  cite	  references	  in	  the	  abstract.
• Limit	  use	  of	  acronyms	  and	  abbreviations.
• Be	  concise	  (250	  words,	  maximum).
• The	  abstract	  should	  have	  the	  following	  headings:	  
1. Background	  and	  Purpose	  (description	  of	  rationale	  for	  study)
2. Methods	  (brief	  description	  of	  methods)
3. Results	  (presentation	  of	  significant	  results)
4. Conclusions	  (succinct	  statement	  of	  data	  interpretation)
5. When	  applicable,	  include	  a	  fifth	  heading:	  "Clinical	  Trial	  Registration	  Information."	  Please	  list	  the	  URL,	  as	  well	  as	  
the	  Unique	  Identifier,	  for	  the	  publicly	  accessible	  website	  on	  which	  the	  trial	  is	  registered.	  If	  the	  trial	  is	  not	  
registered,	  please	  indicate	  the	  reason	  in	  the	  heading.	  Example	  1:	  Clinical	  Trial	  Registration-­‐URL:	  
http://www.clinicaltrials.gov.	  Unique	  identifier:	  NCT00123456.	  Example	  2:	  Clinical	  Trial	  Registration-­‐
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URL:	  http://www.controlled-­‐trials.com.	  Unique	  identifier:	  ISRCTN70000879.	  Example	  3:	  Clinical	  Trial	  
Registration-­‐URL:	  http://www.chictr.org.	  Unique	  identifier:	  ChiCTR-­‐RCH-­‐14004884.	  Example	  4:	  Clinical	  
Trial	  Registration-­‐This	  trial	  was	  not	  registered	  because	  enrollment	  began	  prior	  to	  July	  1,	  2005.	  
—TOP—	  
Text	  
• Follow	  the	  instructions	  in	  “Manuscript	  Formatting.”	  
• The	  following	  are	  typical	  main	  headings:	  Materials	  and	  Methods,	  Results,	  Discussion,	  and	  Summary.
• Abbreviations	  must	  be	  defined	  at	  first	  mention	  in	  the	  text,	  tables,	  and	  figures.
• Introduction:	  This	  section	  should	  briefly	  introduce	  the	  context	  of	  the	  results	  to	  be	  presented	  and	  should	  duplicate	  what	  is
contained	  elsewhere	  in	  the	  manuscript	  
• Methods:
A. For	  any	  apparatuses	  used	  in	  Methods,	  the	  complete	  names	  of	  manufacturers	  must	  be	  supplied.	  
B. For	  human	  subjects	  or	  patients,	  describe	  their	  characteristics.
C. For	  animals	  used	  in	  experiments,	  state	  the	  species,	  strain,	  number	  used,	  and	  other	  pertinent	  descriptive
characteristics.	  
D. When	  describing	  surgical	  procedures	  on	  animals,	  identify	  the	  preanesthetic	  and	  anesthetic	  agents	  used,	  and
state	  the	  amount	  or	  concentration	  and	  the	  route	  and	  frequency	  of	  administration	  for	  each.	  The	  use	  of	  
paralytic	  agents,	  such	  as	  curare	  or	  succinylcholine,	  is	  not	  an	  acceptable	  substitute	  for	  anesthetics.	  
E. For	  other	  invasive	  procedures	  on	  animals,	  report	  the	  analgesic	  or	  tranquilizing	  drugs	  used.	  If	  none	  were	  used,
provide	  justification	  for	  such	  exclusion.	  
F. Manuscripts	  that	  describe	  studies	  on	  humans	  must	  indicate	  that	  the	  study	  was	  approved	  by	  an	  institutional
review	  committee	  and	  that	  the	  subjects	  gave	  informed	  consent.	  
G. Manuscripts	  involving	  animals	  must	  indicate	  that	  the	  study	  was	  approved	  by	  an	  institutional	  animal	  care	  and
use	  committee.	  
H. Reports	  of	  studies	  on	  both	  animals	  and	  humans	  must	  indicate	  that	  the	  procedures	  followed	  were	  in	  accordance
with	  institutional	  guidelines.	  
I. All	  drugs	  should	  be	  referred	  to	  by	  their	  generic	  names	  rather	  than	  trade	  names.	  The	  generic	  chemical
identification	  of	  all	  investigational	  drugs	  must	  be	  provided.	  
J. A	  statistical	  subsection	  must	  be	  provided	  at	  the	  end	  of	  the	  Methods	  section	  describing	  the	  statistical
methodology	  employed	  for	  the	  data	  presented	  in	  the	  manuscript.	  
K. The	  Methods	  section	  should	  provide	  essential	  information	  related	  to	  the	  conduct	  of	  the	  study	  presented	  in	  the	  
manuscript.	  For	  methodology	  previously	  published	  by	  the	  authors,	  the	  prior	  publication	  should	  be	  
referenced	  and	  a	  copy	  of	  the	  paper	  provided	  to	  the	  reviewers,	  if	  necessary.	  
L. The	  Methods	  section	  should	  only	  contain	  material	  that	  is	  absolutely	  necessary	  for	  comprehension	  of	  the	  results
section.	  Additional	  (more	  detailed)	  methods	  can	  be	  provided	  as	  a	  data	  supplement.	  
M. Prevention	  of	  bias	  is	  important	  for	  experimental	  stroke	  research	  (see	  Macleod	  et	  al,	  Stroke.	  2009;40:e50–e52).
For	  studies	  where	  the	  primary	  objective	  is	  the	  preclinical	  testing	  of	  therapies,	  the	  following	  checklist	  
items	  must	  be	  adhered	  to:	  
1. Animals:	  Species,	  strains	  and	  sources	  must	  be	  defined.	  For	  genetically	  modified	  animals,	  wildtype	  
controls	  including	  background	  and	  back-­‐crossing	  must	  be	  defined.	  
2. Statistics	  and	  sample	  size:	  Specific	  statistical	  methods	  must	  be	  defined,	  including	  parametric	  versus	  
nonparametric	  and	  multigroup	  analyses,	  and	  sample	  size	  powering	  based	  on	  expected	  
variances	  and	  differences	  between	  groups.	  
3. Inclusions	  and	  exclusions:	  Specific	  criteria	  for	  inclusions	  and	  exclusions	  must	  be	  specified.	  For	  
example,	  only	  animals	  where	  blood	  flow	  reductions	  fall	  below	  a	  certain	  threshold	  are	  
included.	  Or	  only	  animals	  with	  a	  certain	  degree	  of	  neurological	  deficits	  are	  included.	  Once	  
animals	  are	  randomized	  (see	  below),	  all	  excluded	  animals	  must	  be	  reported,	  including	  
explicit	  presentation	  of	  mortality	  rates.	  
4. Randomization,	  allocation	  concealment	  and	  blinding:	  All	  animals	  must	  be	  randomized.	  Investigators	  
responsible	  for	  surgical	  procedures	  or	  drug	  treatments	  must	  be	  blinded.	  End	  point	  
assessments	  must	  be	  performed	  by	  investigators	  blinded	  to	  the	  groups	  for	  which	  each	  
animal	  is	  assigned.	  
• Results:	  This	  section	  should	  succinctly	  report	  the	  results	  of	  experimental	  studies	  and	  clinical	  research	  or	  clinical
series/observations.	  
• Guidelines	  for	  Human	  Phenotype–Genotype	  Association	  or	  Linkage	  Studies:
A. Reporting	  issues
1. Report	  process	  for	  selecting	  genes	  and	  SNPs.	  
2. Report	  Hardy-­‐Weinberg	  statistics	  or	  P	  values	  and	  method	  of	  calculating	  same.	  





4. Describe	  genotyping	  methods.	  If	  numerous	  primers	  have	  been	  used,	  please	  include	  them	  in	  an	  
online	  supplement.	  
B. False-­‐positive	  and	  false-­‐negative	  concerns.	  Given	  well-­‐described	  problems	  with	  both	  false-­‐positive	  and	  false-­‐
negative	  associations,	  phenotype–genotype	  association	  studies	  should	  meet	  some	  or	  all	  of	  the	  criteria	  
below:	  
1. Phenotype	  is	  clearly	  defined,	  is	  heritable,	  and	  if	  a	  quantitative	  phenotype	  is	  reported,	  reproducibility	  
data	  are	  provided.	  
2. The	  sample	  size	  is	  adequate	  to	  detect	  a	  SNP	  or	  haplotype	  with	  a	  modest	  effect.	  For	  genotype-­‐trait	  
	   138	  
associations,	  provide	  an	  estimate	  of	  the	  effect	  size	  that	  could	  be	  detected	  with	  power	  0.80	  
or	  higher	  with	  the	  allele	  frequency	  and	  sample	  size	  reported.	  
3. Since	  multiple	  statistical	  testing	  methods	  are	  frequently	  used	  in	  genotyping-­‐phenotyping	  studies,	  
please	  include	  specifics	  of	  the	  primary	  model(s)	  tested.	  Nonessential	  secondary	  models	  may	  
be	  published	  as	  electronic	  data	  supplements.	  Clinically	  relevant	  confounders	  should	  be	  
included	  in	  multivariable	  models	  or	  residuals.	  
C. Review	  criteria	  for	  human	  linkage	  studies.	  Manuscripts	  should	  include	  the	  following:	  
1. Identifying	  plausible	  candidate	  genes	  under	  the	  linkage	  peak.	  
2. Follow-­‐up	  fine	  mapping	  to	  narrow	  the	  region	  of	  linkage,	  and/or	  genotyping	  some	  of	  the	  candidate	  
genes	  under	  the	  linkage	  peak.	  
3. Replication	  data	  from	  another	  sample.	  
• Guidelines	  for	  Genomic	  and	  Proteomic	  Studies:	  
A. Preparation	  of	  Data	  Submitted:	  Data	  should	  follow	  the	  MIAME	  checklist	  (for	  more	  information	  see	  
http://www.mged.org/Workgroups/MIAME/miame_checklist.html).	  
B. Accessibility	  of	  Data:	  Authors	  of	  papers	  that	  include	  genomic,	  proteomic,	  or	  other	  high-­‐throughput	  data	  are	  
required	  to	  make	  their	  data	  easily	  accessible	  for	  the	  reviewers	  and	  the	  editors	  during	  the	  review	  
process.	  
1. You	  may	  submit	  your	  data	  to	  the	  NCBI	  gene	  expression	  and	  hybridization	  array	  data	  repository	  
(GEO,	  http://www.ncbi.nlm.nih.gov/geo/	  )	  and	  provide	  the	  GEO	  accession	  number;	  or,	  
2. You	  may	  provide	  a	  link	  to	  a	  secure	  or	  publicly	  accessible	  Web	  site	  which	  hosts	  the	  data.	  Prior	  to	  
publication,	  the	  data	  must	  be	  submitted	  and	  an	  accession	  number	  obtained.	  Access	  to	  the	  
information	  in	  the	  database	  must	  be	  available	  at	  the	  time	  of	  publication.	  GEO	  has	  a	  Web-­‐
based	  submission	  route,	  suitable	  for	  a	  small	  number	  of	  samples,	  or	  a	  batch	  submission	  tool	  
(called	  SOFT).	  GEO	  is	  accessible	  from	  http://www.ncbi.nlm.nih.gov/geo/	  The	  submission	  FAQ	  
is	  available	  at	  (http://www.ncbi.nlm.nih.gov/projects/geo/info/faq.htm	  l	  )	  
• Guidelines	  for	  Proteins	  and	  Nucleic	  Acid	  Sequences:	  
A. Newly	  reported	  nucleotide	  or	  protein	  sequences	  must	  be	  deposited	  in	  GenBank	  or	  EMBL	  databases,	  and	  an	  
accession	  number	  must	  be	  obtained.	  Access	  to	  the	  information	  in	  the	  database	  must	  be	  available	  at	  the	  
time	  of	  publication.	  Authors	  are	  responsible	  for	  arranging	  release	  of	  data	  at	  the	  time	  of	  publication.	  The	  
authors	  must	  also	  provide	  a	  statement	  in	  the	  manuscript	  that	  this	  sequence	  has	  been	  scanned	  against	  
the	  database	  and	  all	  sequences	  with	  significant	  relatedness	  to	  the	  new	  sequence	  identified	  (and	  their	  
accession	  numbers	  included	  in	  the	  text	  of	  the	  manuscript).	  
1. GenBank	  GenBank	  Submissions	  National	  Center	  for	  Biotechnology	  Information	  8600	  Rockville	  Pike,	  
Building	  38A	  Room	  8N-­‐805	  Bethesda,	  MD	  20894	  Tel:	  (301)	  496-­‐2475	  On	  the	  web	  at:	  
http://www.ncbi.nlm.nih.gov/Genbank/index.html	  
2. EMBL	  Nucleotide	  Sequence	  Submissions	  European	  Bioinformatics	  Institute	  Hinxton	  Hall	  Hinxton,	  
Cambridge	  CB10	  1SD,	  UK	  Tel.:	  44-­‐1223-­‐494401;	  Fax:	  44-­‐1223-­‐494472	  e-­‐mail:	  
support@ebi.ac.uk	  On	  the	  web	  at:	  http://www.ebi.ac.uk	  
3. DNA	  Data	  Bank	  of	  Japan	  Center	  for	  Information	  Biology	  National	  Institute	  of	  Genetics	  Mishima,	  
Shizuoka,	  411,	  Japan	  Tel.:	  81-­‐559-­‐81-­‐6853;	  Fax:	  81-­‐559-­‐81-­‐6849	  On	  the	  web	  at:	  
http://www.ddbj.nig.ac.jp	  
B. Submission	  to	  any	  data	  bank	  is	  sufficient	  to	  ensure	  entry	  in	  all.	  
• Discussion:	  This	  section	  should	  not	  reiterate	  the	  results	  but	  put	  the	  results	  in	  appropriate	  context	  regarding	  relevant	  
literature	  and	  the	  importance	  of	  new	  observations	  contained	  in	  the	  manuscript.	  
• Summary/Conclusions:	  A	  brief	  paragraph	  summarizing	  the	  results	  and	  their	  importance	  may	  be	  included	  but	  is	  not	  
required.	  
—TOP—	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representing	  such	  corporations.	  The	  corresponding	  author	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  Conflict	  of	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  information	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  before	  submitting	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  manuscript	  online.	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  Wong	  YT,	  Khan	  S,	  eds.	  Book	  Title.	  
3rd	  Ed.	  New	  York,	  NY:	  Publisher	  Name;	  2009:456–464.	  
• Example	  of	  a	  website	  reference:	  CDC	  Chronic	  Disease	  Indicators:	  Indicator	  Definition.	  Hospitalization	  for	  cerebrovascular	  
accident	  or	  stroke.	  National	  Center	  for	  Chronic	  Disease	  Prevention	  and	  Health	  Promotion	  web	  site.	  
http://apps.nccd.cdc.gov/cdi/IndDefinition.aspx?IndicatorDefinitionID=83.	  Accessed	  November	  23,	  2010.	  
• Web	  sites	  generally	  follow	  this	  format:	  Author	  names	  (if	  any).	  Title	  of	  information	  or	  page.	  Name	  of	  website.	  URL.	  
Publication	  date	  (if	  any).	  Access	  date.	  




• Provide	  figure	  legends	  on	  a	  separate	  page	  of	  the	  manuscript.	  
• Permission	  is	  required	  for	  all	  images	  that	  are	  reused	  or	  adapted	  from	  another	  source.	  To	  obtain	  permission,	  please	  follow	  
the	  instructions	  provided	  by	  the	  copyright	  holder	  or	  listed	  in	  the	  license	  agreement.	  This	  includes	  Creative	  
Commons	  material;	  please	  refer	  to	  http://creativecommons.org/licenses/	  for	  more	  information	  about	  properly	  
crediting	  Creative	  Commons	  sources.	  Follow	  the	  copyright	  holder	  or	  licensor's	  requirements	  for	  credit	  attributions	  
and	  provide	  them	  in	  the	  figure	  legend.	  If	  no	  language	  is	  provided	  in	  the	  permission	  letter,	  use	  the	  following	  
sample:	  Reprinted	  from	  Butler	  et	  al,19	  with	  permission	  from	  Smith	  Publishing.	  Copyright	  2005,	  American	  Society	  of	  
Medical	  Research.	  	  
—TOP—	  
Tables	  
• Each	  table	  must	  be	  typed	  on	  a	  separate	  sheet	  and	  double-­‐spaced,	  if	  possible.	  The	  table	  number	  should	  be	  Arabic,	  followed	  
by	  a	  period	  and	  a	  brief	  informative	  title.	  
• Use	  the	  same	  size	  type	  as	  in	  text.	  
• Tables	  should	  be	  cell-­‐based	  (i.e.,	  constructed	  using	  Microsoft	  Word	  tables	  or	  Excel).	  Do	  not	  use	  tabs	  or	  hard	  returns.	  Do	  
not	  supply	  tables	  as	  graphics.	  
• Tables	  should	  be	  used	  to	  present	  comparisons	  of	  large	  amounts	  of	  data	  at	  a	  glance.	  Tables	  with	  only	  1	  or	  2	  rows	  of	  data	  
should	  be	  incorporated	  into	  the	  text.	  
• Tables	  should	  be	  as	  compact	  as	  possible.	  Avoid	  unnecessary	  rows	  and	  columns.	  
• Use	  indenting	  within	  the	  stub	  column	  to	  indicate	  subgroups.	  Do	  not	  use	  bold,	  shading,	  rules,	  etc.	  
• Tables	  should	  not	  contain	  vertically	  merged	  cells;	  horizontally	  merged	  cells	  are	  permitted	  when	  necessary	  in	  the	  heading	  
row.	  
• Internal	  headings	  are	  not	  permitted	  outside	  of	  the	  stub	  column.	  If	  internal	  headings	  are	  required,	  the	  table	  should	  be	  split	  
into	  2	  tables.	  	  
• No	  internal	  shading	  is	  permitted.	  
• Units	  of	  measure	  should	  be	  in	  the	  heading	  row	  or	  stub	  column	  rather	  than	  the	  body	  of	  the	  table	  whenever	  possible.	  
• Indicate	  footnotes	  in	  the	  table	  in	  this	  order:	  *,	  †,	  ‡,	  §,	  |	  |,	  #,	  *	  *	  .	  Follow	  AMA	  9th	  edition	  for	  footnote	  styles.	  
• A	  permission	  is	  required	  for	  all	  tables	  that	  are	  reused	  or	  adapted	  from	  another	  source.	  To	  obtain	  permission,	  please	  follow	  
the	  instructions	  provided	  by	  the	  copyright	  holder	  or	  listed	  in	  the	  license	  agreement.	  Follow	  the	  copyright	  holder	  or	  
licensor's	  requirements	  for	  credit	  attributions	  and	  provide	  them	  in	  the	  table	  footnote.	  If	  no	  language	  is	  provided	  in	  
the	  permission	  letter,	  use	  the	  following	  sample:	  Reprinted	  from	  Butler	  et	  al,19	  with	  permission	  from	  Smith	  




• The	  combined	  total	  number	  of	  figures	  and	  tables	  is	  limited	  to	  6.	  Each	  figure	  may	  contain	  up	  to	  4	  panels	  (i.e.,	  parts	  A	  to	  D)	  
and	  must	  conform	  to	  the	  requirements	  for	  figures	  described	  below.	  
• Authors	  should	  be	  pleased	  with	  the	  figure	  submission	  quality	  before	  submission.	  We	  recommend	  that	  you	  print	  the	  figure
at	  its	  final	  publication	  size	  to	  check	  the	  quality.	  
• Figures	  should	  be	  submitted	  as	  high-­‐resolution	  TIFF	  or	  EPS	  files.	  PowerPoint	  files	  can	  be	  accepted	  but	  is	  a	  less	  preferred
file	  format,	  as	  elements	  within	  the	  figure	  (such	  as	  axis	  labels)	  may	  shift	  location	  or	  drop	  out	  during	  conversion.	  
JPEG,	  Word,	  and	  Excel	  files	  should	  not	  be	  used.	  See	  Artwork	  and	  Table	  Guidelines	  (PDF)	  for	  instructions	  for	  
creating	  high-­‐quality	  digital	  art	  in	  various	  software	  applications.	  
• Color	  figures	  should	  be	  in	  RGB	  (red/green/blue)	  mode.	  If	  a	  figure	  is	  supplied	  in	  CMYK	  (cyan/magenta/yellow/black)	  mode,
there	  may	  be	  a	  shift	  in	  the	  appearance	  of	  colors,	  especially	  fluorescents.	  Figures	  that	  will	  appear	  in	  black	  and	  white	  
should	  be	  submitted	  in	  black	  and	  white.	  
• Figures	  should	  be	  supplied	  at	  the	  highest	  resolution	  possible	  for	  optimal	  clarity.	  Color	  figures	  should	  be	  at	  least	  300	  dpi;
halftones,	  600	  dpi;	  and	  line	  art,	  1200	  dpi.	  
• Figures	  should	  be	  submitted	  at	  the	  final	  publication	  size.	  Please	  note	  that	  most	  figures	  will	  be	  sized	  at	  1	  column	  wide.
Dimensions	  for	  figures	  are:	  
◦ 1	  column:	  3.25	  inches	  wide
◦ 2	  columns:	  6.80	  inches	  wide
• For	  line	  and	  bar	  graphs	  and	  pie	  charts,	  ensure	  that	  the	  colors/lines/symbols	  used	  for	  the	  different	  sets	  of	  data	  are	  easily	  
distinguishable.	  
• Graphs	  and	  charts	  should	  have	  a	  white	  background.	  Do	  not	  use	  dark	  PowerPoint	  backgrounds.
• Labels	  for	  panels	  should	  be	  uppercase	  letters	  (A,	  B,	  C,	  D)	  in	  boldface	  Arial	  or	  Helvetica.
• Multipart	  figures	  may	  have	  no	  more	  than	  4	  panels	  (i.e.,	  A,	  B,	  C,	  D).
• Multipart	  figures	  may	  be	  set	  at	  2	  columns	  across	  the	  page	  and	  should	  be	  laid	  out	  horizontally	  if	  appropriate.
• Use	  the	  same	  font	  (typeface)	  throughout	  the	  figure.	  Sans	  serif	  fonts,	  such	  as	  Arial	  and	  Helvetica,	  work	  best.	  
• Use	  the	  largest	  font	  size	  possible	  without	  distorting	  the	  figures.	  Text	  should	  be	  no	  smaller	  than	  6	  points.
• Whenever	  possible,	  all	  text	  within	  a	  figure	  should	  be	  the	  same	  size.	  If	  this	  is	  not	  possible,	  the	  font	  size	  should	  vary	  by	  no
more	  than	  2	  points.	  
• Label	  units	  of	  measure	  consistently	  with	  the	  text	  and	  legend.	  Follow	  the	  AMA	  for	  unit	  abbreviations.	  
• Incorporate	  figure	  keys	  into	  the	  legend	  rather	  than	  including	  them	  as	  part	  of	  the	  figure	  whenever	  possible.	  Titles	  should	  be
included	  in	  the	  figure	  legends.	  
• Any	  abbreviations	  or	  symbols	  used	  in	  the	  figures	  must	  be	  defined	  in	  the	  figure	  or	  figure	  legend.
• Follow	  AMA	  9th	  edition	  for	  footnote	  style	  in	  legends.
• If	  the	  figure	  is	  reprinted/adapted	  from	  another	  source,	  please	  provide	  a	  permission	  letter	  and	  include	  the	  source	  in	  the
legend	  as	  noted	  above.	  	  
• Supply	  a	  scale	  bar	  with	  photomicrographs.	  
• Authors	  are	  responsible	  for	  the	  cost	  of	  printing	  color	  illustrations.	  Authors	  are	  also	  responsible	  for	  obtaining	  from	  the
copyright	  holder	  permission	  to	  reproduce	  previously	  published	  artwork.	  Authors	  can	  check	  guidelines	  online	  at	  
http://submit-­‐stroke.aha-­‐journals.org/	  under	  Artwork	  and	  Table	  Guidelines	  (PDF).	  
• See	  AMA,	  10th	  edition,	  Section	  4.2	  for	  more	  information	  on	  figures.
—TOP—	  
Online	  Supplements	  
This	  optional	  section	  provides	  an	  opportunity	  for	  authors	  to	  present	  supporting	  materials	  to	  the	  manuscript.	  The	  manuscript	  
appears	  both	  in	  the	  print	  version	  and	  online,	  whereas	  Online	  Supplements	  are	  independent	  from	  the	  manuscript	  and	  appear	  
only	  online	  in	  the	  format	  submitted	  by	  the	  authors.	  Online	  Supplements	  undergo	  peer	  review	  and	  therefore	  must	  be	  
submitted	  simultaneously	  with	  original	  submissions.	  
Any	  collaborators	  who	  need	  to	  be	  cross-­‐referenced	  in	  PubMed	  should	  be	  listed	  either	  as	  authors	  or,	  for	  study	  groups,	  in	  the	  
main	  manuscript	  file	  as	  an	  Appendix.	  This	  information	  is	  included	  in	  the	  word	  count.	  If	  contributers	  do	  not	  need	  to	  be	  listed	  as	  
authors	  or	  cross-­‐referenced	  in	  PubMed,	  then	  they	  may	  be	  included	  in	  a	  PDF	  Data	  Supplement	  to	  the	  manuscript.	  
Online	  Supplements	  may	  consist	  of	  any	  of	  the	  following,	  in	  any	  combination:	  the	  expanded	  materials	  and	  methods;	  additional	  
figures	  and	  supporting	  information;	  additional	  tables	  and	  supporting	  information;	  and,	  video	  files.	  
The	  guidelines	  below	  should	  be	  used	  for	  online	  supplements:	  
• Material	  to	  be	  published	  as	  an	  online	  only	  supplement	  should	  be	  uploaded	  online	  as	  a	  single	  PDF.	  An	  exception	  to	  this
would	  be	  if	  the	  online	  supplement	  is	  a	  video	  file.	  
• The	  online	  supplement	  should	  have	  a	  title	  page	  with	  the	  label	  of	  ONLINE	  SUPPLEMENT	  above	  the	  title.	  The	  supplemental
material	  to	  be	  included	  in	  this	  PDF	  is	  as	  follows:	  Supplemental	  Methods,	  Supplemental	  Tables,	  Supplemental	  
Figures	  and	  Figure	  Legends,	  and	  Supplemental	  References.	  If	  applicable,	  the	  legends	  for	  the	  Video	  files	  should	  also	  
be	  included	  in	  this	  PDF.	  
• The	  online	  supplement	  should	  be	  single-­‐spaced.
• If	  citations	  are	  made	  in	  the	  Online	  Supplement,	  the	  Online	  Supplement	  must	  contain	  its	  own	  independent	  Reference
Section	  with	  references	  numbered	  sequentially,	  beginning	  with	  reference	  1,	  even	  if	  some	  of	  these	  references	  
duplicate	  those	  in	  the	  print	  version.	  
• Number	  supplementary	  figures	  and	  tables	  as	  Figure	  I,	  Figure	  II,	  Table	  I,	  Table	  II,	  etc.
• Place	  the	  supplemental	  figure	  legend	  underneath	  the	  corresponding	  figure.	  
• When	  referring	  to	  online-­‐only	  material	  in	  the	  print	  version	  of	  the	  manuscript,	  use	  the	  phrase	  "please	  see
141	  
http://stroke.ahajournals.org."	  
• Data	  Supplements	  appear	  only	  online	  and	  will	  not	  appear	  in	  reprints	  of	  the	  article.	  The	  Editorial	  Office	  is	  not	  responsible	  
for	  converting	  files	  to	  a	  suitable	  format.	  
—TOP—	  
Instructions	  for	  Revised	  Submissions	  
• In	  the	  top	  right-­‐hand	  corner,	  indicate	  the	  manuscript	  number	  followed	  by	  R1	  to	  denote	  a	  first	  revision.	  
• Please	  provide	  a	  copy	  of	  the	  revised	  text	  with	  changes	  marked	  in	  the	  text	  using	  either	  track	  changes	  or	  highlighting.
• In	  your	  written	  response	  to	  the	  reviewers'	  comments,	  give	  the	  page	  number(s),	  paragraph(s),	  and	  line	  number(s)	  where
each	  revision	  was	  made.	  
• Respond	  to	  each	  referee's	  comments,	  indicating	  precisely	  the	  changes	  made	  in	  response	  to	  the	  critiques.	  Also	  give	  reasons
for	  suggested	  changes	  that	  were	  not	  implemented,	  and	  identify	  additional	  changes	  made.	  
• Revisions	  not	  received	  within	  60	  days	  from	  the	  date	  of	  the	  decision	  letter	  will	  be	  administratively	  withdrawn.	  For	  further
consideration	  the	  manuscript	  must	  be	  resubmitted	  de	  novo.	  At	  the	  editors'	  discretion,	  and	  in	  cases	  where	  
substantial	  new	  data	  are	  required,	  extensions	  may	  be	  granted	  for	  revisions.	  In	  such	  cases,	  every	  effort	  will	  be	  made	  
to	  retain	  the	  original	  reviewers.	  
—TOP—	  
Journal	  Policies	  
Compliance	  With	  NIH	  and	  Other	  Research	  Funding	  Agency	  Accessibility	  Requirements	  
Several	  research	  funding	  agencies	  now	  require	  or	  request	  authors	  to	  submit	  the	  post-­‐print	  (the	  article	  after	  peer	  review	  and	  
acceptance	  but	  not	  the	  final	  published	  article)	  to	  a	  repository	  that	  is	  accessible	  online	  by	  all	  without	  charge.	  Within	  medical	  
research,	  3	  funding	  agencies	  in	  particular	  have	  announced	  such	  policies:	  
1. The	  US	  National	  Institutes	  of	  Health	  (NIH)	  requires	  authors	  to	  deposit	  post-­‐prints	  of	  articles,	  which	  have	  received	  NIH
funding,	  in	  its	  repository	  PubMed	  Central	  (PMC).	  This	  deposit	  should	  be	  done	  within	  the	  12	  months	  after	  
publication	  of	  the	  final	  article	  in	  the	  journal.	  
2. The	  Howard	  Hughes	  Medical	  Institute	  (HHMI)	  requires,	  as	  a	  condition	  of	  research	  grants,	  deposit	  in	  PMC,	  but	  within	  6	  
months	  after	  publication	  of	  the	  final	  article.	  
3. The	  Wellcome	  Trust	  requires,	  as	  a	  condition	  of	  research	  grants,	  deposit	  in	  UK	  PMC	  within	  6	  months	  after	  publication	  of	  the
final	  article.	  
As	  a	  service	  to	  authors,	  the	  Publisher	  (Wolters	  Kluwer	  Health/Lippincott	  Williams	  &	  Wilkins)	  of	  the	  AHA	  journals	  will	  identify	  
to	  PMC	  articles	  that	  require	  depositing.	  The	  Copyright	  Transfer	  Agreement	  provides	  the	  primary	  mechanism	  for	  identifying	  
such	  articles.	  The	  AHA	  also	  requests	  that,	  during	  the	  submission	  process	  in	  eJournal	  Press,	  funding	  is	  indicated.	  
WKH/LWW	  will	  transmit	  the	  post-­‐print	  of	  an	  article,	  which	  is	  based	  on	  research	  funded	  in	  whole	  or	  in	  part	  by	  1	  or	  more	  of	  
these	  3	  agencies,	  to	  PMC.	  
On	  NIH	  request,	  it	  remains	  the	  legal	  responsibility	  of	  the	  author(s)	  to	  confirm	  with	  the	  NIH	  the	  provenance	  of	  their	  manuscript	  
for	  purposes	  of	  deposit.	  
• Author(s)	  will	  not	  deposit	  their	  articles	  themselves.
• Author(s)	  will	  not	  alter	  the	  post-­‐print	  already	  transmitted	  to	  NIH.	  
• Author(s)	  will	  not	  authorize	  the	  display	  of	  the	  post-­‐print	  prior	  to:	  
◦ 12	  months	  after	  publication	  of	  the	  final	  article,	  in	  the	  case	  of	  NIH,
◦ 6	  months	  after	  publication	  of	  the	  final	  article,	  in	  the	  case	  of	  HHMI	  and	  the	  Wellcome	  Trust
For	  more	  information,	  please	  visit	  PMC.	  
—TOP—	  
Guidelines	  for	  Clinical	  Trials	  
• In	  accordance	  with	  the	  Clinical	  Trial	  Registration	  Statement	  from	  the	  International	  Committee	  of	  Medical	  Journal	  Editors
(ICMJE	  )	  (Circulation.	  2005;111:1337–1338),	  all	  clinical	  trials	  submitted	  for	  publication	  in	  Stroke	  must	  be	  registered	  
in	  a	  public	  trials	  registry	  at	  or	  before	  the	  onset	  of	  participant	  enrollment.	  This	  requirement	  applies	  to	  all	  clinical	  
trials	  that	  begin	  enrollment	  after	  July	  1,	  2005.	  
• Research	  is	  considered	  to	  be	  a	  clinical	  trial	  if	  it	  involves	  prospective	  assignment	  of	  human	  subjects	  to	  an	  intervention	  or	  
comparison	  group	  to	  study	  the	  relation	  between	  a	  health-­‐related	  intervention	  and	  a	  health	  outcome.	  Health-­‐
related	  interventions	  include	  any	  intervention	  used	  to	  modify	  a	  biomedical	  or	  health-­‐related	  outcome	  (for	  
example,	  drugs,	  surgical	  procedures,	  devices,	  behavioral	  treatments,	  dietary	  interventions,	  and	  process-­‐of-­‐care	  
changes).	  Health	  outcomes	  include	  any	  biomedical	  or	  health-­‐related	  measures	  obtained	  in	  patients	  or	  participants,	  
including	  pharmacokinetic	  measures	  and	  adverse	  events.	  As	  previously,	  purely	  observational	  studies	  (those	  in	  
which	  the	  assignment	  of	  the	  medical	  intervention	  is	  not	  at	  the	  discretion	  of	  the	  investigator)	  will	  not	  require	  
registration.	  Those	  who	  are	  uncertain	  whether	  their	  trial	  meets	  the	  expanded	  ICMJE	  definition	  should	  err	  on	  the	  
side	  of	  registration	  if	  they	  wish	  to	  seek	  publication.	  
• The	  registry	  must	  be	  accessible	  to	  the	  public	  at	  no	  charge,	  searchable,	  open	  to	  all	  prospective	  registrants,	  and	  managed	  by
a	  not-­‐for-­‐profit	  organization.	  The	  registry	  must	  include	  the	  following	  information:	  a	  unique	  identifying	  number,	  a	  
statement	  of	  the	  intervention(s),	  study	  hypothesis,	  definition	  of	  primary	  and	  secondary	  outcome	  measurements,	  
eligibility	  criteria,	  target	  number	  of	  subjects,	  funding	  source,	  contact	  information	  for	  the	  principal	  investigator,	  and	  
key	  dates	  (registration	  date,	  start	  date,	  and	  completion	  date).	  The	  registries	  listed	  below	  are	  approved	  by	  the	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1. United	  States	  National	  Library	  of	  Medicine
2. International	  Standard	  Randomized	  Controlled	  Trial	  Number	  (ISRCTN)
3. University	  Hospital	  Medical	  Information	  Network	  (UMIN)
4. Australian	  Clinical	  Trials	  Registry	  (ACTR)
5. Netherlands	  Trial	  Register
• Clinical	  trials	  may	  be	  listed	  with	  Other	  registries,	  but	  these	  registries	  must	  meet	  the	  above-­‐mentioned	  requirements.
• The	  authors	  will	  be	  requested	  to	  provide	  the	  exact	  URL	  and	  unique	  identification	  number	  for	  the	  trial	  registration	  at	  the
time	  of	  submission.	  This	  information	  will	  be	  published	  in	  a	  footnote	  on	  the	  first	  page	  of	  the	  article.	  
• Clinical	  trial	  reports	  should	  also	  comply	  with	  the	  Consolidated	  Standards	  of	  Reporting	  Trials	  (CONSORT)	  and	  include	  a	  flow
diagram	  presenting	  the	  enrollment,	  intervention	  allocation,	  follow-­‐up,	  and	  data	  analysis	  with	  number	  of	  subjects	  
for	  each.	  Please	  also	  refer	  specifically	  to	  the	  CONSORT	  Checklist	  of	  items	  to	  include	  when	  reporting	  a	  randomized	  
clinical	  trial.	  
• Results	  posted	  in	  the	  same	  clinical	  trials	  registry	  in	  which	  the	  primary	  registration	  resides	  will	  not	  be	  considered	  prior	  
publication	  if	  they	  are	  presented	  in	  the	  form	  of	  a	  brief	  abstract	  (500	  words	  or	  fewer)	  or	  a	  table.	  
—TOP—	  
Embargo	  Policy	  
• All	  content	  information	  of	  an	  accepted	  paper	  is	  strictly	  confidential	  and	  cannot	  appear	  in	  the	  media	  (in	  print	  or	  electronic
form)	  before	  its	  embargo	  date	  and	  time.	  Authors/researchers,	  their	  respective	  public	  relations	  representatives	  and	  
funding	  sponsors	  may	  not	  distribute	  or	  promote	  their	  work	  to	  the	  media	  prior	  to	  embargo.	  
• In	  the	  event	  that	  the	  American	  Heart	  Association/American	  Stroke	  Association	  selects	  the	  manuscript	  for	  promotion	  in	  a
news	  release,	  news	  conference,	  video	  news	  release	  or	  podcast,	  AHA/ASA	  staff	  will	  contact	  the	  author/researcher	  
to	  inform	  him/her	  of	  the	  pending	  news	  materials	  and	  to	  notify	  him/her	  that	  he/she	  may	  give	  reporters	  pre-­‐
embargo	  interviews	  based	  upon	  the	  media	  requests	  generated	  by	  the	  AHA/ASA	  news	  materials.	  
Authors/researchers	  must	  ensure	  that	  the	  reporter	  understands	  and	  will	  adhere	  to	  the	  embargo	  time.	  
• If	  an	  embargo	  break	  is	  the	  result	  of	  any	  action	  by	  an	  author/researcher,	  he/she	  risks	  withdrawal	  of	  publication	  of	  his/her
manuscript.	  Violations	  of	  the	  embargo	  policy	  may	  also	  jeopardize	  future	  acceptance	  of	  manuscripts	  to	  be	  
published	  in	  AHA/ASA	  scientific	  journals.	  
• Generally,	  embargoes	  on	  journal	  articles	  lift	  the	  day	  and	  the	  time	  the	  article	  is	  published,	  either	  on-­‐line	  or	  in	  print
(whichever	  comes	  first)	  by	  the	  American	  Heart	  Association/American	  Stroke	  Association.	  
• Questions	  about	  media	  embargoes	  should	  be	  directed	  to	  Bridgette	  McNeill,	  Senior	  Communications	  Manager,	  Corporate
&	  Media	  Communications,	  AHA	  National	  Center,	  7272	  Greenville	  Avenue,	  Dallas,	  TX	  75231-­‐4596;	  Tel:	  214-­‐706-­‐
1135;	  Email:	  bridgette.mcneill@heart.org.	  
• Although	  the	  Editorial	  Office	  will	  endeavor	  to	  notify	  authors	  of	  the	  anticipated	  publication	  date/time,	  neither	  the	  Editorial
Office	  nor	  the	  AHA/ASA	  will	  be	  responsible	  for	  any	  consequences	  of	  early	  online	  posting	  with	  regard	  to	  the	  
intellectual	  property	  rights.	  To	  safeguard	  their	  intellectual	  property,	  authors	  should	  ensure	  that	  appropriate	  
reports	  of	  invention	  and	  patent	  applications	  have	  been	  filed	  before	  the	  manuscript	  is	  accepted.	  
—TOP—	  
Permissions	  
• Requests	  for	  permission	  to	  reproduce	  figures,	  tables,	  or	  portions	  of	  articles	  originally	  published	  in	  Stroke	  can	  be	  obtained
via	  Rightslink	  (a	  service	  of	  the	  Copyright	  Clearance	  Center),	  not	  the	  Editorial	  Office.	  All	  permission	  requests	  are	  
now	  processed	  via	  the	  Rightslink	  online	  system.	  Steps	  for	  obtaining	  permission	  include:	  
1. On	  Stroke's	  home	  page,	  either	  search	  for	  the	  article	  using	  the	  Search	  feature	  or	  locate	  a	  copy	  of	  the	  article	  in	  
the	  online	  archives	  for	  which	  you	  are	  requesting	  permission.	  
2. Next,	  select	  the	  Full	  Text	  or	  PDF	  version	  of	  the	  article.
3. Then,	  locate	  the	  "Request	  Permissions"	  link	  in	  the	  menu	  on	  the	  right	  side	  of	  the	  Web	  page	  (under	  "Services").	  A	  
new	  Web	  browser	  will	  open,	  which	  is	  Rightslink.	  
4. Follow	  the	  step-­‐by-­‐step	  instructions	  in	  Rightslink	  for	  requesting	  permission	  by:	  
a. Selecting	  the	  way	  the	  content	  will	  be	  used.	  
b. Creating	  an	  account,	  if	  one	  does	  not	  exist	  already.	  
c. Accepting	  the	  terms	  and	  conditions	  for	  reuse.	  
d. Determining	  method	  of	  payment.	  
5. Further	  information	  can	  be	  found	  in	  the	  Permissions	  and	  Rights	  Instructions
6. Note:	  For	  AHA	  Scientific	  Statements	  and	  Guidelines,	  permission	  to	  reprint,	  modify,	  alter,	  enhance,	  copy,	  or
distribute	  this	  content	  must	  be	  obtained	  from	  the	  American	  Heart	  Association.	  Instructions	  are	  located	  
at	  http://www.americanheart.org/presenter.jhtml?id	  entifier=4431	  A	  link	  to	  the	  "Permission	  Request	  
Form"	  appears	  on	  the	  right	  side	  of	  the	  Web	  page,	  in	  the	  "Related	  Items"	  box.	  
—TOP—	  
Costs	  to	  Authors	  
Authors	  are	  charged:	  
• $70	  per	  published	  page	  of	  an	  article	  to	  defray	  costs	  of	  publication	  (information	  is	  sent	  with	  author's	  proof).
• Authors	  of	  papers	  exceeding	  4,500	  words	  (1,800	  words	  for	  Brief	  Reports,	  1500	  words	  for	  Case	  Studies,	  and	  750	  words	  for
Letters/Responses	  to	  the	  Editor)	  will	  be	  charged	  a	  minimum	  fee	  of	  $425	  per	  additional	  1,000	  words.	  The	  usual	  $70	  
page	  charge	  will	  also	  apply.	  Word	  count	  will	  be	  calculated	  by	  the	  editorial	  office,	  using	  the	  Microsoft	  Word	  tool.	  
Title	  page,	  abstract,	  main	  body	  of	  text,	  acknowledgments,	  sources	  of	  funding,	  disclosures,	  references,	  figure	  
legends,	  tables,	  and	  appendices	  intended	  for	  print	  publication	  are	  included	  in	  the	  total	  word	  count.	  
• Color	  charges	  per	  color	  page	  equals	  $653.00.	  This	  is	  in	  addition	  to	  the	  page	  charges.	  Estimate	  of	  cost	  will	  be	  provided	  for
author's	  approval	  by	  the	  publisher.	  
143	  
• Expense	  for	  replacing	  poor-­‐quality	  art.
• Expense	  for	  reprints	  (price	  lists	  are	  sent	  with	  author's	  proof).
• $50	  per	  published	  page	  for	  excessive	  author	  alterations.
• $100	  per	  published	  page	  for	  printing	  a	  correction	  (erratum	  after	  online	  or	  print	  publication	  of	  the	  article)	  that	  results	  from	  
an	  author's	  error.	  
No	  page	  charges	  to	  authors	  from	  the	  following	  countries:	  Armenia,	  Afghanistan,	  Bangladesh,	  Benin,	  Bhutan,	  Bolivia,	  Burkina	  
Faso,	  Burundi,	  Cabo	  Verde,	  Cambodia,	  Cameroon,	  Central	  African	  Republic,	  Chad,	  Comoros,	  Congo,	  Cote	  d'Ivoire,	  Djibouti,	  
Arab	  Rep.	  Egypt,	  El	  Salvador,	  Eritrea,	  Ethiopia,	  The	  Gambia,	  Georgia,	  Ghana,	  Guatemala,	  Guinea,	  Guinea-­‐Bissau,	  Guyana,	  Haiti,	  
Honduras,	  India,	  Indonesia,	  Kenya,	  Kiribati,	  Kosovo,	  Kyrgyz	  Republic,	  Lao	  PDR,	  Lesotho,	  Liberia,	  Madagascar,	  Malawi,	  Mali,	  
Mauritania,	  Fed.	  Sts.	  Micronesia,	  Moldova,	  Mongolia,	  Morocco,	  Mozambique,	  Nepal,	  Nicaragua,	  Niger,	  Nigeria,	  Pakistan,	  
Papua	  New	  Guinea,	  Paraguay,	  Philippines,	  Rwanda,	  Samoa,	  Sao	  Tome	  and	  Principe,	  Senegal,	  Sierra	  Leone,	  Solomon	  Islands,	  
Somalia,	  Sri	  Lanka,	  Swaziland,	  Tajikistan,	  Tanzania,	  Timor-­‐Leste,	  Togo,	  Uganda,	  Ukraine,	  Uzbekistan,	  Vanuatu,	  Vietnam,	  West	  
Bank	  and	  Gaza,	  Yemen,	  Rep.,	  Zambia,	  and	  Zimbabwe.	  
—TOP—	  
Redundant	  Publication	  
Manuscripts	  submitted	  to	  Stroke	  should	  conform	  to	  “Uniform	  Requirements	  for	  Manuscripts	  Submitted	  to	  Biomedical	  
Journals”	  except	  as	  indicated	  otherwise	  in	  the	  instructions	  below.	  
Manuscripts	  submitted	  to	  Stroke	  should	  not	  contain	  material	  previously	  published	  in	  other	  publications,	  except	  as	  an	  abstract,	  
and	  must	  not	  be	  currently	  under	  consideration	  for	  publication	  in	  another	  journal.	  The	  editors	  of	  Stroke	  agree	  with	  the	  
principles	  of	  the	  HEART	  Group	  regarding	  redundant	  publication	  (Circulation.	  1997;96:1.	  Cardiovascular	  News:	  “HEART	  Group	  
Notification	  Regarding	  Redundant	  Publication”).	  Redundant	  publication	  is	  publication	  of	  a	  paper	  that	  overlaps	  substantially	  
with	  one	  already	  published.	  When	  submitting	  a	  paper,	  authors	  should	  make	  a	  full	  statement	  to	  the	  editor	  about	  all	  
submissions	  and	  previous	  reports	  that	  might	  be	  regarded	  as	  redundant	  publication	  of	  the	  same	  or	  similar	  work.	  The	  authors	  
should	  alert	  the	  editor	  if	  the	  work	  includes	  subjects	  about	  whom	  a	  previous	  report	  has	  been	  published.	  Copies	  of	  such	  
material	  should	  be	  included	  with	  the	  submitted	  paper	  to	  help	  the	  editor	  decide	  how	  to	  handle	  the	  matter.	  If	  redundant	  
publication	  is	  attempted	  without	  such	  notification,	  authors	  should	  expect	  editorial	  action	  to	  be	  taken;	  at	  the	  least,	  rejection	  of	  
the	  manuscript.	  
—TOP—	  
Editorial	  Conflict-­‐of-­‐Interest	  Policy	  
Original	  Contributions	  submitted	  by	  the	  editor-­‐in-­‐chief	  and	  any	  of	  the	  associate	  editors	  are	  handled	  by	  a	  Consulting	  Editor	  or	  
by	  another	  editor,	  who	  makes	  all	  decisions	  about	  the	  manuscript	  (including	  choice	  of	  referees	  and	  ultimate	  acceptance	  or	  
rejection).	  The	  entire	  process	  is	  handled	  confidentially.	  All	  manuscripts	  submitted	  from	  the	  Editor's	  home	  institution	  are	  also	  
handled	  entirely	  by	  a	  Consulting	  Editor	  or	  by	  another	  editor	  from	  a	  different	  institution.	  The	  Editor	  (in	  Chief)	  and/or	  Associate	  
Editors	  may	  additionally,	  from	  time	  to	  time,	  refer	  a	  manuscript	  to	  a	  Consulting	  Editor	  to	  avoid	  a	  real	  or	  reasonably	  perceived	  
conflict	  of	  interest.	  
—TOP—	  
Expedited	  Publication	  
The	  editors	  invite	  submission	  of	  manuscripts	  that	  have	  major	  importance	  to	  the	  scientific	  community.	  To	  be	  considered	  for	  
expedited	  publication,	  an	  article	  must	  be	  unique	  and	  contain	  information	  that	  could	  make	  a	  significant	  difference	  in	  medical	  
practice	  or	  constitute	  an	  important	  advance	  in	  basic	  knowledge.	  The	  authors	  must	  clearly	  state	  reasons	  for	  the	  request	  in	  the	  
cover	  letter.	  If	  the	  editors	  agree	  that	  an	  article	  should	  be	  an	  expedited	  publication,	  they	  will	  arrange	  an	  accelerated	  review	  
and,	  if	  accepted,	  accelerated	  publication.	  
—TOP—	  
Preliminary	  Reports	  
The	  editors	  discourage	  submission	  of	  preliminary	  reports	  that	  describe	  a	  standardized	  design	  and	  progress	  to	  date.	  The	  
editors	  will	  not	  consider	  publication	  of	  such	  studies	  unless	  the	  article	  describes	  new	  and	  innovative	  methodology	  and/or	  
reports	  data	  that	  might	  be	  used	  independently	  by	  other	  groups	  in	  planning	  similar	  studies.	  If	  a	  preliminary	  report	  is	  
submitted,	  authors	  should	  specify	  inclusion	  of	  material	  that	  meets	  the	  guidelines	  of	  this	  policy.	  
—TOP—	  
Disclaimer	  
Statements,	  opinions,	  and	  results	  of	  studies	  published	  in	  Stroke	  are	  those	  of	  the	  authors	  and	  do	  not	  reflect	  the	  policy	  or	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  required	  by	  the	  University	  of	  Cape	  Town’s	  regulations	  for	  master’s	  degrees,	  the	  
dissertation	  was	  submitted	  to	  TurnItIn	  for	  a	  similarity	  check.	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This	  audit	  was	  initially	  planned	  to	  include	  all	  patients	  admitted	  with	  acute	  stroke	  to	  
the	  general	  medical	  wards	  at	  Groote	  Schuur	  Hospital	  and	  GF	  Jooste	  Hospital,	  under	  
the	  title	  “Audit	  of	  the	  quality	  and	  cost	  of	  acute	  inpatient	  stroke	  care	  at	  district	  and	  
secondary	  level	  hospitals	  in	  the	  Cape	  Metro”.	  
However,	  GF	  Jooste	  Hospital	  was	  decommissioned	  in	  2013,	  which	  made	  access	  to	  
medical	  folders	  for	  review	  difficult.	  	  After	  consideration	  with	  my	  supervisor,	  it	  was	  
felt	  that	  the	  261	  consecutive	  patients	  enrolled	  from	  the	  medical	  wards	  at	  Groote	  
Schuur	  Hospital	  would	  suffice	  for	  the	  purposes	  of	  a	  master’s	  degree.	  	  The	  protocol	  
was	  amended	  and	  the	  title	  was	  changed	  to	  “Audit	  of	  the	  quality	  and	  cost	  of	  acute	  
inpatient	  stroke	  care	  in	  the	  general	  medical	  wards	  at	  Groote	  Schuur	  Hospital”.	  	  
Approval	  was	  obtained	  from	  the	  Faculty	  of	  Health	  Sciences	  Human	  Research	  Ethics	  
Committee	  after	  changing	  the	  title	  and	  amending	  the	  protocol	  accordingly,	  which	  
was	  followed	  by	  approval	  by	  the	  Dissertations	  /	  Doctoral	  &	  Masters	  Committee	  of	  
the	  Faculty	  of	  Health	  Sciences	  at	  the	  University	  of	  Cape	  Town.	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PROJECT TITLE: AUDIT OF THE QUALITY AND COST OF ACUTE STROKE CARE AT DISTRICT
AND SECONDARY LEVEL HOSPITALS IN THE CAPE METROPOLE.
Thank you for responding to the issues raised by the Faculty of Health Sciences Human Research
Ethics Committee in your letter dated 9th March 2012.
It is a pleasure to inform you that the HREC has formally approved the above-mentioned study.
Approval is granted for one year till the 3oth March 2013.
Please submit a progress form, using the standardised Annual Report Form (FHSO16), if the study
continues beyond the approval period. Please submit a Standard Closure form (FHSO10) if the study
is completed within the approval period.
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal
investigator.
PIease quote the HREC. REF in all your correspondence.
Yours sincerely
//zd
PROFESSOR M BLOCKMANW n ernrcslt Federal \/de Assurance Number: FWAOOOO1637.
Institutional Review Board (IRB) number: IR800001938
This serves to confirm that the University of Cape Town Human Research Ethics Committee complies
to the Ethics Standards for Clinical Research with a new drug in patients, based on the Medical
Research Council (MRC-SA), Food and Drug Administration (FDA-USA), International Convention on
Harmonisation Good Clinical Practice (ICH GCP) and Declaration of Helsinki guidelines.
The Human Research Ethics Committee granting this approval is in compliance with the ICH
Harmonised Tripartite Guidelines E6: Note for Guidance on Good Clinical Practice (CPMP/ICHlL35l95)
and FDA Code Federal Regulation Part 50, 56 and 312.
s.thomas
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From: Jackie Cogill jackie.cogill@uct.ac.za
Subject: Viljoen : Confirmation of Approval of Study Proposal
Date: 29 August 2012 at 10:36 AM
To: charleviljoen@gmail.com, Charle Viljoen ca.viljoen@uct.ac.za
Cc: Linda De Villiers Linda.DeVilliers@uct.ac.za, Lorraine McDonald lorraine.mcdonald@uct.ac.za
Dear Dr Viljoen
Candidature Approval  (VLJCHA007)
Degree MMed in Medicine
Title Audit of the quality and cost of acute inpatient stroke care
at district and secondary level hospitals in the Cape Metro
Department Medicine
Supervisor Dr L De Villiers 
Ethics Approval 061/2012
I am pleased to advise that the Chair of the Dissertations/Doctoral &
Masters Committee has approved your candidature for the above degree on behalf of the






Room'N2.19, 'Wernher'&'Beit'North,'Health'Sciences'Campus,'Anzio'Rd,'Observatory,'7925'! +'27 21'406'6750! !+!27
86'5565'5778! Office Hours: 08h00-16h00 Unavailable Hours:  10h00-11h00 & 13h00-13h30
UNIVERSITY OF CAPE TOWN 
This e-mail is subject to the UCT ICT policies and e-mail disclaimer published on our website at
http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from +27 21 650 9111. This e-mail is intended
only for the person(s) to whom it is addressed. If the e-mail has reached you in error, please notify the author. If
you are not the intended recipient of the e-mail you may not use, disclose, copy, redirect or print the content. If this
e-mail is not related to the business of UCT it is sent by the sender in the sender's individual capacity.
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lnstitute of Ageing in Africa




PTOJCCT TitIEI AUDIT OF THE qUALITY AND COST OF ACUTE STROKE CARE AT DISTRICT AND SECONDARY LEVEL HOSPITALS IN
THE CAPE METROPOLE
Thank you for your letter to the Human Research Ethics Committee dated 26 June 2013.
It is a pleasure to inform you that the Ethics Committee has approved the amendment subject to the following:-
1. Permission to access GSH financial records must be obtained from Groote Schuur Hospital, and a copy of
this approval must be submitted to the HREC.
2. An annual progress report must be submitted if the study continues beyond the approval period.
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal investigator.




CHAIRPERSON, HSF HUMAN ETHICS
sAriefdien
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T}NIVTRSITY $F CAPE T
FHSOl
LTY OF HEALTH SCIENCES
Human Research Ethics Committee
/ Renewal
Record Reviews/Audits/Collection of Biolooical Specimens/Re
HREC office use only (FWA00001637; 1RB00001938)
This serves as notification of annual approval, including any documentation described below.
d Rppi-cved Annualprogress report Approved until/next renewal date *.a. acju
tr Not approved See attached comments
Signature Chairperson of the HREC ilp l.B.rqtr. Date Signed U\ it1'f l2Ct\
Principal lnvestigator to complete the following:
1. Protocol information
2. Protocol status ftick {
tr Research-related activities are ongoing
tr Data collection is complete, data analysis only
Protocol
Date form submitted 05 /o? (2-cr i3
HREC REF Number Current Ethics Approval was granted until N\^z,ln uc\Z
Protocoltitle ,,\U1lrT 6 p TAe &tt4 r* rT-/ lY)'.,rr'c t crjr c-)F ',11'r'-''l-6 SD2OK6




I t-{e L,r s r r\At:l\4ctyoL*-136vt>ct€(t<
Department / Office
lnternal MailAddress
AS i tlr,,t Uv\r,t uo^ 6u,.\&a r.r.1 I fvtls-r. St\d,^.,'
1.1 Does this protocol receive US Federal funding? tr Yes lff+,"
su
Total number of records or specimens collected, reviewed or stored since the original
aooroval
Total number of records or specimens collected, reviewed or stgred since last progress
report 37c -
Have any research-related outputs (e.9. publications, abstracts, conference




Signature of Pl qfr UA& Date 5 [ ] I ."'s
Signature of Supervisor
(if Pl is a student) '7*---L1i--' Date fu,5oS/ u-]
26 July 2012 Page 1 of 1
(Note: Please complete the Closure form (FHS019) if the study is completed within the approval period)
FHSOl 7
150	  
GROOTE SCHUUR HOSPITAL 
Enquiries: Dr Bhavna Patel 
E-mail : Bhavna.Patel@westerncape.gov.za
G46 Management Suite, Old Main Building, Private Bag X,  
Observatory 7925  Observatory, 7935 
Tel: +27 21 404 6288    fax: +27 21 404 6125 www.capegateway.go.v.za 
Dr Linda De Villiers 
Specialist 
Geriatrics Department 
Groote Schuur Hospital 
NGSH 
Dear Dr De Villiers 
RESEARCH:    Permission to access Financial Records for Costing Study as part of MMED. 
Your recent letter to the hospital refers. 
You are hereby granted permission to proceed with your research until the end of March 
2014. 
Please note the following: 
a) Your research may not interfere with normal patient care
b) Hospital staff may not be asked to assist with the research.
c) No hospital consumables and stationary may be used.
d) No patient folders may be removed from the premises or be inaccessible.
e) Please introduce yourself to the person in charge of an area before commencing.
f) Confidentiality must be maintained at all times.
I would like to wish you every success with the project. 
Yours sincerely 
DR BHAVNA PATEL 
SENIOR MANAGER: MEDICAL SERVICES 
Date: 22 July 2013 
c.c. Mr L Naidoo
Ms W Bryant
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Note: All amendments should include a
notice dated 23 April 2012)
Principal Investigator to complete the following:
1. Protocol information
FACULTY OF HEALTH SCIENCES
Human Research Ethics Committee
Form FHS006: Protocol Amendment
is,f ustifying theihanges for the amendment (olease'see
Date 12 August 2013
HREC REF Number oJstfrf2 Ot'l | ?ct'r
Protocoltitle Audit of the quality and cost of acute stroke care at district and secondary level inthe Cape metropole
Protocol number (if
annlir:ahle\
Principal I nvesti-qator Charle Vilioen
Department / Office
lnternal MailAddress lnstitute of Ageing, 151 Old Main Building, GSH
1.1 Does this protocol receive US Federal fundinq? trYes ltrNo
1.2 ls this a major or a minor amendment? (see FHS006hto) I I tvtaior | tr tvtinor
2. List of Proposed Amendments with Revised Version Numbers and Dates
Please itemise on the page below, all amendments with revised version numbers and dates, which
need approval.
This page will be detached, signed and returned to the PI as notification of approval. Please add extra pages
if necessary.
Ethics committee approvalwas granted for data collection at Groote Schuur Hospital and GF Jooste
hospital. Data will now only be collected at Groote Schuur hospital.
Title will change to;
Audit of the quality and cost of acute stroke care in the general medical wards at Groote Schuur Hospital.
;ilil,tpiJ rI f :ii::Ii F.ili{
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From: Jackie Cogill jackie.cogill@uct.ac.za
Subject: Viljoen: Change of Title
Date: 10 April 2014 at 9:44 AM
To: charleviljoen@gmail.com
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This e-mail is subject to the UCT ICT policies and e-mail disclaimer published on our website at
http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from +27 21 650 9111. This e-mail is intended only for the person(s) to
whom it is addressed. If the e-mail has reached you in error, please notify the author. If you are not the intended recipient of the e-mail
you may not use, disclose, copy, redirect or print the content. If this e-mail is not related to the business of UCT it is sent by the sender in
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